Sentence,class,file
"Acta Physiol Scand 1998; 164:71 –8; PMID:9777027; http://dx.doi.org/10.1046/j.1365-201X.1998.00407.x [35] Montain SJ, Latzka WA, Sawka MN.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Appl Physiol 2002; 93:1630 –7; http://dx.doi.org/10.1152/ japplphysiol.00222.2002 [40] Gagnon D, Crandall CG, Kenny GP.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"JAppl Physiol 2013; 114:394 –401; PMID:23154992; http://dx.doi.org/10.1152/japplphysiol.00877.2012 [41] Inoue Y, Ichinose-Kuwahara T, Funaki C, Ueda H, Tochihara Y, Kondo N. Sex differences in acetylcholine- induced sweating responses due to physical training.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Physiol Anthropol 2014; 33:13; PMID:24887294; http://dx.doi.org/10.1186/1880-6805-33-13 [42] Inoue Y, Tanaka Y, Omori K, Kuwahara T, Ogura Y, Ueda H. Sex- and menstrual cycle-related differences insweating and cutaneous blood ﬂow in response to pas- sive heat exposure.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Eur J Appl Physiol 2005; 94:323 –32; PMID:15729550; http://dx.doi.org/10.1007/s00421-004- 1303-2 [43] Poirier MP, Gagnon D, Friesen BJ, Hardcastle SG, Kenny GP.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Med Sci Sports Exerc 2015;47:390 –400; PMID:24870585; http://dx.doi.org/10.1249/ MSS.0000000000000401 [44] Roberts MF, Wenger CB, Stolwijk JA, Nadel ER.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Adv Exp Med Biol 1995; 393:173 –7; PMID:8629476; http://dx.doi.org/10.1007/978-1-4615-1933-1_34 [46] Fujii N, Honda Y, Hayashi K, Kondo N, Nishiyasu T. Effect of hypohydration on hyperthermic hyperpnea and cutaneous vasodilation during exercise in men.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"JAppl Physiol 2008; 105:1509 –18; PMID:18787094; http://dx.doi.org/10.1152/japplphysiol.01206.2007 [47] Hayashi K, Honda Y, Ogawa T, Kondo N, Nishiyasu T. The cross-sectional relationships among hyperthermia-induced hyperventilation, peak oxygen consumption,and the cutaneous vasodilatory response during exer- cise.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"PMID:19685072; http://dx.doi.org/10.1007/s00421-009- 1152-0 [48] Nybo L, Nielsen B.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Physiol 2001; 534:279 –86; PMID:11433008; http://dx.doi.org/10.1111/j.1469-7793.2001.t01-1-00279.x [49] Mack GW, Nose H, Takamata A, Okuno T, Morimoto T. Inﬂuence of exercise intensity and plasma volume on active cutaneous vasodilation in humans.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Appl Physiol Nutr Metab 2007; 32:721 – 32; PMID:17622287; http://dx.doi.org/10.1139/H07-035 [51] Fan JL, Cotter JD, Lucas RA, Thomas K, Wilson L, Ain- slie PN.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Appl Physiol 2008; 105:433 – 45; PMID:18483173; http://dx.doi.org/10.1152/japplphysiol.00010.2008 [52] Nelson MD, Haykowsky MJ, Stickland MK, Altamir- ano-Diaz LA, Willie CK, Smith KJ, Petersen SR, Ainslie PN.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
Am J Physiol Regul Integr Comp Physiol2007; 292:R195 –203; PMID:17008452; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Appl Physiol 2011; 110:1334 –41; PMID:21393474; http://dx.doi.org/10.1152/ japplphysiol.00010.2010 [57] Martin BJ, Morgan EJ, Zwillich CW, Weil JV.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Physiol 2006;576:947 –58; PMID:16916904; http://dx.doi.org/10.1113/ jphysiol.2006.117507 [62] Wilson TE, Cui J, Zhang R, Crandall CG.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Exp Physiol 2015;100:1309 –18; PMID:26299270; http://dx.doi.org/ 10.1113/EP085259 [65] Adams WC, Fox RH, Fry AJ, MacDonald IC.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Am JPhysiol Regul Integr Comp Physiol 2009; 297:R605 – R14; PMID:19494169; http://dx.doi.org/10.1152/ajpregu.90672.2008 [67] Fujii N, Tsuji B, Honda Y, Kondo N, Nishiyasu T. Effect of short-term exercise-heat acclimation on ventilatory and cerebral blood ﬂow responses to passive heating at rest in humans.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Appl Physiol 2015; 119:435-44; PMID:26159763; http://dx.doi.org/10.1152/japplphysiol.01049.2014 [68] Bain AR, Smith KJ, Lewis NC, Foster GE, Wildfong KW, Willie CK, Hartley GL, Cheung SS, Ainslie PN.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Comp Biochem Physiol A Mol Integr Physiol 2005; 140:309 –16; PMID:15792596; http://dx.doi.org/ 10.1016/j.cbpb.2005.01.012 [71] Maskrey M, Hales JR, Fawcett AA.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Spinal Cord 2006; 44:160 –4; PMID: 16151452; http://dx.doi.org /10.1038/sj.sc.3101823 [77] Dutton K, Blanksby BA, Morton AR.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
Am J Physiol Regul Integr Comp Physiol 2005; 288:R1347 –53; PMID:15677525; http://dx.doi.org/10.1152/ajpregu.00547.2004 [81] Nagashima K. Thermoregulation and menstrual cycle.,Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Temperature 2015; 2:320 –1; http://dx.doi.org/10.1080/ 23328940.2015.1066926 [82] Hayashi K, Kawashima T, Suzuki Y.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Appl Physiol 2012;113:237 –45; PMID:22604882; http://dx.doi.org/10.1152/ japplphysiol.01199.2011 [83] Chapman KR, Cherniack NS.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Gerontol 1987; 42:202 –9; PMID:3819346; http://dx.doi.org/10.1093/geronj/42.2.202 [84] Kronenberg RS, Drage CW.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Clin Invest 1973; 52:1812 –9; PMID:4719663; http://dx.doi.org/ 10.1172/JCI107363 [85] Peterson DD, Pack AI, Silage DA, Fishman AP.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Exp Physiol 2008; 93:1104 –17; PMID:18515472; http://dx.doi.org/10.1113/expphysiol.2008.042580 [87] White MD, Clegg ME, Kim KT, Giles LV, Walsh ML, Koehle MS. Comparions of thermal hyperpnea responses between younger and older males during hyperthermia.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Am J Physiol Regul Integr Comp Physiol 2009; 296:R1473 –95; PMID:19211719; http://dx.doi.org/ 10.1152/ajpregu.91008.2008 [89] Ide K, Eliasziw M, Poulin MJ.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Relationship between middle cerebral artery blood velocity and end-tidalPCO2 in the hypocapnic-hypercapnic range in humans.J Appl Physiol 2003; 95:129 –37; PMID:19278048; http://dx.doi.org/10.1152/japplphysiol.01186.2002 [90] Kety SS, Schmidt CF.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Cli Invest 1948; 27:484 –92; PMID:16695569; http://dx.doi.org/10.1172/JCI101995 [91] Rasmussen P, Stie H, Nielsen B, Nybo L. Enhanced cere- bral CO2 reactivity during strenuous exercise in man.Eur J Appl Physiol 2006; 96:299 –304; PMID:16284788; http://dx.doi.org/10.1007/s00421-005-0079-3 [92] Tsuji B, Honda Y, Ikebe Y, Fujii N, Kondo N, Nishiyasu T. Voluntary suppression of hyperthermia-inducedhyperventilation mitigates the reduction in cerebralblood ﬂow velocity during exercise in the heat.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Am J Physiol Regul Integr Comp Physiol 2015; 308:R669 –79; PMID:25632021; http://dx.doi.org/10.1152/ajpregu.00419.2014 [93] Low DA, Wingo JE, Keller DM, Davis SL, Zhang R, Crandall CG.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Appl Physiol 2008; 104:976 –81; PMID: 18218916; http://dx.doi.org/10.1152/japplphysiol.01040.2007 [94] Nybo L, Secher NH, Nielsen B.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
J Physiol 2002; 545:697 –704; PMID:12456844; http://dx.doi.org/10.1113/jphysiol.,Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Physiol 2009; 587:3921 –7; PMID:19528251; http://dx.doi.org/10.1113/ jphysiol.2009.172023 [96] Visocchi M, Chiappini F, Cioni B, Meglio M. Cerebral blood ﬂow velocities and trigeminal ganglion stimula- tion.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Appl Physiol 2014; 117:1317 –24; PMID:25257867; http://dx.doi.org/10.1152/japplphysiol.00334.2014 [102] White MD, Greiner JG, McDonald PL.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"Point: humans do demonstrate selective brain cooling during hyperthermia.J Appl Physiol 2011; 110:569 –71; PMID:20798268; http:// dx.doi.org/10.1152/japplphysiol.00992.2010 [103] Cabanac M, Caputa M. Natural selective cooling of the human brain: evidence of its occurrence and magnitude.J Physiol 1979; 286:255 –64; PMID:439025; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"J Physiol 1979; 289:163 –74; PMID:458648; http://dx.doi.org/10.1113/jphysiol.1979.sp012730 [105] Mariak Z, White MD, Lewko J, Lyson T, Piekarski P. Direct cooling of the human brain by heat loss from theupper respiratory tract.",OADS,/arxiv_data1/oa_pdf/70/59/ktmp-03-01-1143760.PMC4879782.pdf
"From the Swan Center for Plastic Surgery; Memorial Sloan  Kettering Cancer Center; and Allergan, Inc.Received for publication June 22, 2015; accepted January 21, 2016.This trial is registered under the name “Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms (BIFS),” Clinical Trials.gov identification number NCT00443274 (https://clinicaltrials.gov/ct2/show/NCT00443274).Prospective Analysis of Primary Breast  Augmentation on Body Image Using the  BREAST-Q: Results from a Nationwide StudyOutcomes Article COSMETIC",Non-OADS,/arxiv_data1/oa_pdf/42/aa/prs-137-954e.PMC4879787.pdf
Available at: http://www.plasticsurgery.org/Documents/news-resources/statistics/2013-statistics/plas- tic-surgery-statistics-full-report-2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/42/aa/prs-137-954e.PMC4879787.pdf
Available at: http://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/UCM260090.pdf.,Non-OADS,/arxiv_data1/oa_pdf/42/aa/prs-137-954e.PMC4879787.pdf
Available at: http://www2.sas.com/proceedings/sugi30/196-30.pdf.,Non-OADS,/arxiv_data1/oa_pdf/42/aa/prs-137-954e.PMC4879787.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/6e/num-08-02-30598.PMC4879789.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/eb/num-08-02-35497.PMC4879790.pdf
Available from: http://www.who.int/malaria/ publications/world_malaria_report_2014/en/.,Non-OADS,/arxiv_data1/oa_pdf/ca/f1/JGID-8-59.PMC4879791.pdf
Available from: http://www.nvbdcp.gov.in/malaria3.html.,Non-OADS,/arxiv_data1/oa_pdf/ca/f1/JGID-8-59.PMC4879791.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS331 Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International Abstract Background:  Few reoperations are required in older patients undergoing multilevel  lumbar laminectomy with noninstrumented fusions for spinal stenosis with/without  spondylolisthesis/instability, and they rarely require instrumentation.",Non-OADS,/arxiv_data1/oa_pdf/e9/b6/SNI-7-331.PMC4879839.pdf
"http://surgicalneurologyint.com/Low-reoperation-rate-following-336-multilevel-lumbar-laminectomies-with-noninstrumented-fusions/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/e9/b6/SNI-7-331.PMC4879839.pdf
"Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS366Abstract Background:  There have been rare cases of traumatic cervical spondyloptosis  without neurological compromise.",Non-OADS,/arxiv_data1/oa_pdf/a9/dd/SNI-7-366.PMC4879840.pdf
"http://surgicalneurologyint.com/Traumatic-spondyloptosis-at-the-cervico-thoracic-junction-without-neurological-deficits/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/a9/dd/SNI-7-366.PMC4879840.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f7/66/SNI-7-301.PMC4879841.pdf
"http://surgicalneurologyint.com/Intracranial-subdural-empyema-after-surgery-for-lumbar-lipomyelomeningocele:-A-rare-complication/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/f7/66/SNI-7-301.PMC4879841.pdf
"Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS328Abstract Background: In a prior article, ""Perioperative visual loss (POVL) following prone  spinal surgery: A review,"" Epstein documented that postoperative visual loss (POVL)  occurs in from 0.013% to 0.2% of spine procedures performed in the prone position.",Non-OADS,/arxiv_data1/oa_pdf/3d/57/SNI-7-328.PMC4879842.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/SNI-7-314.PMC4879843.pdf
"http://surgicalneurologyint.com/Intracranial-extra-axial-hemangioma-in-a-newborn:- A-case-report-and-literature-review/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/SNI-7-314.PMC4879843.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/a8/98/SNI-7-305.PMC4879844.pdf
http://surgicalneurologyint.com/ A-rare-case-of-giant-multiseptated-thoracic- myelomeningocele-with-segmental-placode:-Commentary /,Non-OADS,/arxiv_data1/oa_pdf/a8/98/SNI-7-305.PMC4879844.pdf
"Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS370Abstract Background:  Chondromyxoid fibroma (CMF) is an extremely rare, benign  cartilaginous tumor that makes up <0.5% of all bone tumors, typically presenting  in the second or third decade of life.",Non-OADS,/arxiv_data1/oa_pdf/1d/b1/SNI-7-370.PMC4879845.pdf
"http://surgicalneurologyint.com/Chondromyxoid-fibroma-of-the-sacrum:-A-case- report-and-literature-review/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/1d/b1/SNI-7-370.PMC4879845.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/92/2a/SNI-7-307.PMC4879846.pdf
"Methods:  Aiming to define the best term for unilateral FM obstruction, 19 terms  were employed on PubMed database (http://www.ncbi.nlm.nih.gov/pubmed) as  quoted phrases.",OADS,/arxiv_data1/oa_pdf/92/2a/SNI-7-307.PMC4879846.pdf
"http://surgicalneurologyint.com/Hydrocephalus-caused-by-unilateral-foramen-of-Monro-obstruction:-A-review-on-terminology/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/92/2a/SNI-7-307.PMC4879846.pdf
"METHODS The terms asymmetric hydrocephalus (AH), asymmetric  lateral ventricle, asymmetric lateral ventricles, asymmetric  ventricle, asymmetric ventricles, compartmentalized  hydrocephalus, isolated lateral ventricle (ILV), isolated  unilateral hydrocephalus (IUH), isolated ventricle,  isolated ventricles, loculated hydrocephalus, loculated  lateral ventricle, loculated ventricle (LV), monoventricular  hydrocephalus (MH), trapped lateral ventricle, trapped  ventricle, UH, unilateral ventriculomegaly, and  uniloculated hydrocephalus (ULH) were employed on  PubMed database (http://www.ncbi.nlm.nih.gov/pubmed)  as quoted phrases.",OADS,/arxiv_data1/oa_pdf/92/2a/SNI-7-307.PMC4879846.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ef/99/SNI-7-317.PMC4879847.pdf
"http://surgicalneurologyint.com/ Pediatric-knowledge-update:-Approach-to-the- management-of-vein-of-Galen-aneurysmal-malformations-in-neonates /This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/ef/99/SNI-7-317.PMC4879847.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S361Abstract Background:  Surgeons treating metastatic spine disease can use computed  tomography (CT) imaging to determine whether lesions are osteolytic, osteoblastic,  or mixed.",Non-OADS,/arxiv_data1/oa_pdf/cb/e1/SNI-7-361.PMC4879848.pdf
"http://surgicalneurologyint.com/Imaging-characteristic-analysis-of-metastatic-spine-lesions-from-breast,-prostate,-lung,-and-renal-cell-carcinomas-for-surgical-planning:-Osteoly - tic-versus-osteoblastic/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/cb/e1/SNI-7-361.PMC4879848.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS337 Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International Abstract Background:  The reoperation rate, including for adjacent segment disease (ASD),  is lower following multilevel lumbar laminectomy with noninstrumented versus  instrumented fusions.",Non-OADS,/arxiv_data1/oa_pdf/c5/88/SNI-7-337.PMC4879849.pdf
"http://surgicalneurologyint.com/A-review:-Reduced-reoperation-rate-for-multilevel-lumbar-laminectomies-with-noninstrumented-versus-instrumented-fusions/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/c5/88/SNI-7-337.PMC4879849.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/3a/f5/JCIS-6-19.PMC4879851.pdf
"Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS347Abstract Background:  Postoperative visual loss (POVL) following prone spine surgery  occurs in from 0.013% to 1% of cases and is variously attributed to ischemic optic  neuropathy (ION: anterior ION or posterior ION [reported in 1.9/10,000 cases:  constitutes 89% of all POVL cases], central retinal artery occlusion [CRAO],  central retinal vein occlusion [CRVO], cortical blindness [CB], direct compression  [horseshoe, prone pillows, and eye protectors Dupaco Opti‑Gard]), and acute angle  closure glaucoma (AACG).",Non-OADS,/arxiv_data1/oa_pdf/d3/4a/SNI-7-347.PMC4879856.pdf
"Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS375Abstract Background: Intramedullary spinal cord metastases (IMSCM) are typically drop  lesions from intracranial metastases and are a rare manifestation of systemic  malignancy (8.5% of central nervous system metastases).",Non-OADS,/arxiv_data1/oa_pdf/e9/36/SNI-7-375.PMC4879859.pdf
"http://surgicalneurologyint.com/Intramedullary-spinal-cord-metastasis-arising-from-papillary-thyroid-carcinoma:-A-case-report-and-review-of-literature/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/e9/36/SNI-7-375.PMC4879859.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowEditor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S323Abstract Background:  Spinal osteochondromas are typically benign tumors, but patients  may present with myelopathy and neurologic deficits if there is tumor encroachment  within the spinal canal.",Non-OADS,/arxiv_data1/oa_pdf/f9/d9/SNI-7-323.PMC4879861.pdf
"http://surgicalneurologyint.com/Large-solitary-osteochondroma-of-the-thoracic- spine:-Case-report-and-review-of-the-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/f9/d9/SNI-7-323.PMC4879861.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/54/53/lsv053.PMC4879884.pdf
"BBC N EWS, Oct. 28, 2014, available at, http://www.bbc.com/news/science-environment-29760212 (accessed June 15, 2015); Richard A. Fried- man,Infidelity Lurks in Your Genes ,NEWYORKTIMES, May 24, 2015, at p. SR-1; Sharon Begley, OMG, There’s a Credit Card Gene .NEWSWEEK, Nov. 10, 2009, available at, http://www.newsweek.com/ omg-theres-credit-card-gene-76925 (accessedJune15,2015).",Non-OADS,/arxiv_data1/oa_pdf/54/53/lsv053.PMC4879884.pdf
"NATURENEWS, Oct. 30, 2009, available at http://dx.doi.org/10.1038/news.2009.1050 (accessed June 15, 2015); Hank Greely, Another ‘Brain Miti- gation’ Criminal Sentence from Italy.",Non-OADS,/arxiv_data1/oa_pdf/54/53/lsv053.PMC4879884.pdf
"Sept. 3, available at http://blogs.law.stanford.edu/lawandbiosciences/ 2011/09/03/another-brain-mitigation-criminal-sentence-from-italy/ (accessedJune15,2015).",Non-OADS,/arxiv_data1/oa_pdf/54/53/lsv053.PMC4879884.pdf
"27YouGov,https://today.yougov.com/about/about-the-yougov-panel (accessedJune15,2015).",Non-OADS,/arxiv_data1/oa_pdf/54/53/lsv053.PMC4879884.pdf
"28US Census Bureau, Current Population Survey, November 2008 Voting And Registration Supplement File , http://www.census.gov/prod/techdoc/cps/cpsnov08.pdf (accessedJune15,2015).",OADS,/arxiv_data1/oa_pdf/54/53/lsv053.PMC4879884.pdf
"30PewResearch, ReligiousLandscapeSurvey, http://religions.pewforum.org/reports (accessedJune15,2015).",Non-OADS,/arxiv_data1/oa_pdf/54/53/lsv053.PMC4879884.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/40/ac/asjsm-07-01-29577.PMC4879900.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b0/dc/asjsm-07-01-33515.PMC4879901.pdf
"2, 57 –59 http://dx.doi.org/10.1080/21655979.2016.1142635",Non-OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"Chromosome Res 2011; 19(1):37-51; PMID:21274616; http://dx.doi.org/10.1007/s10577-010-9177-0 [3] McNally JG, Mazza D., Fractal geometry in the nucleus.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"EMBO J 2010; 29(1):2-3; PMID:20051993; http://dx.doi.org/10.1038/emboj.2009.375 [4] Bach C, Belardo S. The General Theory of Information: Origin of Truth and Hope2012, North Charleston, SC:CreateSpace at Amazon.com.",Non-OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"Cell 2012; 148(3):458-72; PMID:22265598; http://dx.doi.org/10.1016/j.cell.2012.01.010 [8] Th /C19evenin A, Ein-Dor L, Ozery-Flato M, Shamir R. Func- tional gene groups are concentrated within chromo-somes, among chromosomes and in the nuclear space ofthe human genome.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"Nucleic Acids Res 2014; 42(15):9854-61; PMID:25056310; http://dx.doi.org/ 10.1093/nar/gku667 [9] Jost D, Carrivain P, Cavalli G, Vaillant C. Modeling epi- genome folding: formation and dynamics of topologicallyassociated chromatin domains.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"Nucleic Acids Res 2014;42(15):9553-61; PMID:25092923; http://dx.doi.org/10.1093/nar/gku698 [10] Lieberman-Aiden E, van Berkum NL, Williams L, I m a k a e vM ,R a g o c z yT ,T e l l i n gA ,A m i tI ,L a j o i eB R , Sabo PJ, Dorschner MO, et al.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"Science 2009; 326(5950):289-93; PMID:1981577 6; http://dx.doi.org/ 10.1126/science.1181369 [11] Bach C, Patra PK, Pallis JM, Sherman WB, Bajwa H. Strategy for naturelike designer transcription factors withreduced toxicity.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"IEEE Trans Comput Biol Bioinformat 2013; 10(5):1340-3; PMID:24384718; http://dx.doi.org/ 10.1109/TCBB.2013.107 [12] Consortium, E.P.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
DNA 1989; 8(6):377-87; PMID:2505992; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"Biotechnol Res Int 2014; 2014(Article ID 970595):1-27; PMID:24808958; http://dx.doi.org/10.1155/2014/970595 [15] Weirauch MT, Hughes TR.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"Trends Genet 2010;26(2):66-74; PMID:20083321; http://dx.doi.org/10.1016/j.tig.2009.12.002 [16] Bohm D. Wholeness and the implicate order 2002, New York: Routledge.",Non-OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"Genome Res2006; 16(5):669-77; PMID:16606702; http://dx.doi.org/10.1101/gr.4842106 [18] Emerson RO, Thomas JH, Adaptive evolution in zinc ﬁn- ger transcription factors.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"PLoS Genet 2009; 5(1):e1000325; PMID:19119423; http://dx.doi.org/10.1371/ journal.pgen.1000325 [19] Kellis M, Birren BW, Lander ES, Proof and evolutionary analysis of ancient genome duplication in the yeast Sac-charomyces cerevisiae.",OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
Nature 2004; 428(6983):617-24;PMID:15004568; http://dx.doi.org/10.1038/nature02424BIOENGINEERED 59,Non-OADS,/arxiv_data1/oa_pdf/52/4f/kbie-07-02-1142635.PMC4879989.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/  © SRP Kumar et al.",Non-OADS,/arxiv_data1/oa_pdf/92/b1/mtm201634.PMC4879992.pdf
"Sao Paulo 2016;58:36 http://dx.doi.org/10.1590/S1678-9946201658036 ORIGINAL ARTICLE PREVALENCE OF BACTERIAL RESISTANCE IN HOSPITALIZED CIRRHOTIC PATIENTS IN   SOUTHERN BRAZIL: A NEW CHALLENGE Ane Micheli COSTABEBER(1), Angelo Alves de MATTOS(1) & Teresa Cristina Teixeira SUKIENNIK(2) SUMMARY Background & Aims : An increased frequency of infections by multiresistant bacteria has been described in hospitalized patients.",Non-OADS,/arxiv_data1/oa_pdf/ca/8d/0036-4665-rimtsp-58-00036.PMC4879993.pdf
"Sao Paulo 2016;58:37 http://dx.doi.org/10.1590/S1678-9946201658037 ORIGINAL ARTICLE IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT- RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS Kelly Fernanda Nomura DRESCH(1), Angelo Alves de MATTOS(1), Cristiane Valle TOVO(1,2), Fernanda Quadros de ONOFRIO(1),   Leandro CASAGRANDE(1), Alberi Adolfo FELTRIN(2), Iago Christofoli de BARROS(2) & Paulo Roberto Lerias de ALMEIDA(2) SUMMARY Although the protease inhibitors have revolutionized the therapy of chronic hepatitis C (CHC), the concomitant use of pegylated- interferon (PEG-IFN) and ribavirin (RBV) is associated to a high rate of adverse effects.",Non-OADS,/arxiv_data1/oa_pdf/dd/c6/0036-4665-rimtsp-58-00037.PMC4879994.pdf
Available from:  http://www.hcvguidelines.org.,Non-OADS,/arxiv_data1/oa_pdf/dd/c6/0036-4665-rimtsp-58-00037.PMC4879994.pdf
"Sao Paulo 2016;58:38 http://dx.doi.org/10.1590/S1678-9946201658038 ORIGINAL ARTICLE Echinococcus granulosus sensu lato GENOTYPES IN DOMESTIC LIVESTOCK AND HUMANS IN  GOLESTAN PROVINCE, IRAN Mitra SHARBATKHORI(1,2), Asal TANZIFI(3), Sima ROSTAMI(4), Masoomeh ROSTAMI(2) & Majid FASIHI HARANDI(5) SUMMARY  Cystic echinococcosis (CE) is a globally parasitic zoonosis caused by larval stages of Echinococcus granulosus .",Non-OADS,/arxiv_data1/oa_pdf/fd/0b/0036-4665-rimtsp-58-00038.PMC4879995.pdf
"Sao Paulo 2016;58:39 http://dx.doi.org/10.1590/S1678-9946201658039 ORIGINAL ARTICLE ANTHELMINTIC ACTIVITY OF CHLOROPHYLLIN AGAINST DIFFERENT LARVAL   STAGES OF Fasciola gigantica Divya Jyoti SINGH & Dinesh Kumar SINGH SUMMARY Fasciolosis is a food borne zoonosis, caused by the digenetic trematode Fasciola .",Non-OADS,/arxiv_data1/oa_pdf/bc/af/0036-4665-rimtsp-58-00039.PMC4879996.pdf
"Sao Paulo 2016;58:40 http://dx.doi.org/10.1590/S1678-9946201658040 ORIGINAL ARTICLE EPIDEMIOLOGY OF HONEYBEE STING CASES IN THE STATE OF CEARÁ , NORTHEASTERN BRAZIL Ana Gilza Quaresma DINIZ, José Franscidavid Barbosa BELMINO, Kaliany Adja Medeiros de ARAÚJO, Aluska Tavares VIEIRA & Renner de Souza LEITE SUMMARY In the American continent, honeybee envenomation is a public health problem due to the high incidence and severity of the cases.",Non-OADS,/arxiv_data1/oa_pdf/19/53/0036-4665-rimtsp-58-00040.PMC4879997.pdf
Available from: <http://www.ibge.gov.br/home/estatistica/populacao/censo2010>  7.,Non-OADS,/arxiv_data1/oa_pdf/19/53/0036-4665-rimtsp-58-00040.PMC4879997.pdf
Sao Paulo 2016;58:41 http://dx.doi.org/10.1590/S1678-9946201658041 ORIGINAL ARTICLE PERFORMANCE OF CONVENTIONAL PCRs BASED ON PRIMERS DIRECTED TO NUCLEAR AND  MITOCHONDRIAL GENES FOR THE DETECTION AND IDENTIFICATION OF Leishmania  spp.,Non-OADS,/arxiv_data1/oa_pdf/9d/4f/0036-4665-rimtsp-58-00041.PMC4879998.pdf
"Sao Paulo 2016;58:42 http://dx.doi.org/10.1590/S1678-9946201658042 ORIGINAL ARTICLE PREVALENCE, RISK FACTORS AND SYMPTOMS ASSOCIATED TO INTESTINAL   PARASITE INFECTIONS AMONG PATIENTS WITH GASTROINTESTINAL   DISORDERS IN NAHAVAND, WESTERN IRAN Hamed KIANI(1,2), Ali HAGHIGHI(1) , Ali ROSTAMI(1), Eznollah AZARGASHB(2,3), Seyyed Javad SEYYED  TABAEI(1), Abbas SOLGI(4) & Nozhat ZEBARDAST(1) SUMMARY      We studied the prevalence of intestinal parasites (IPs), their risk factors and associated symptoms among patients with  gastrointestinal disorders.",Non-OADS,/arxiv_data1/oa_pdf/85/96/0036-4665-rimtsp-58-00042.PMC4879999.pdf
Available from: http://www.amar.org.ir/english/ Census-2011.,OADS,/arxiv_data1/oa_pdf/85/96/0036-4665-rimtsp-58-00042.PMC4879999.pdf
Available  from: http://www.cdc.gov/dpdx/blastocystis/tx.html.,OADS,/arxiv_data1/oa_pdf/85/96/0036-4665-rimtsp-58-00042.PMC4879999.pdf
"Sao Paulo 2016;58:43 http://dx.doi.org/10.1590/S1678-9946201658043 ORIGINAL ARTICLE EVALUATION OF THE THERAPEUTIC EFFICACY OF LEVAMISOLE HYDROCHLORIDE ON THIRD- STAGE LARVAE OF Lagochilascaris minor  IN EXPERIMENTALLY INFECTED MICE Dulcinéa Maria Barbosa CAMPOS(1), Alverne Passos BARBOSA(2), Jayrson Araújo OLIVEIRA(3), Carlos Augusto Lopes BARBOSA(2),   Tamara Flavia Correa LOBO(4), Luana Gabriella SILV A(4), Douglas Vieira THOMAZ(4) & Josana de Castro PEIXOTO(1) SUMMARY Lagochilascariosis, a disease caused by Lagochilascaris minor , affects the neck, sinuses, tonsils, lungs, the sacral region, dental  alveoli, eyeballs and the central nervous system of humans.",Non-OADS,/arxiv_data1/oa_pdf/90/59/0036-4665-rimtsp-58-00043.PMC4880000.pdf
Available from: http://www.anvisa.gov.,Non-OADS,/arxiv_data1/oa_pdf/90/59/0036-4665-rimtsp-58-00043.PMC4880000.pdf
Sao Paulo 2016;58:44 http://dx.doi.org/10.1590/S1678-9946201658044 ORIGINAL ARTICLE EVALUATION OF SUBLETHAL EFFECTS OF Ipomoea cairica  LINN.,Non-OADS,/arxiv_data1/oa_pdf/b3/61/0036-4665-rimtsp-58-00044.PMC4880001.pdf
"Sao Paulo 2016;58:45 http://dx.doi.org/10.1590/S1678-9946201658045 REVIEW THE PROCESS OF  Leishmania INFECTION - DISEASE AND NEW PERSPECTIVES OF  PALEOPARASITOLOGY Shênia Patrícia Corrêa NOVO(1), Daniela LELES(2), Raffaella BIANUCCI(3,4,5) & Adauto ARAUJO(6) SUMMARY Species of the genus Leishmania  (Kinetoplastida, Trypanosomatidae) are causative agents of leishmaniasis, a complex disease with  variable clinical spectrum and epidemiological diversity, constituting, in some countries, a serious public health problem.",Non-OADS,/arxiv_data1/oa_pdf/31/7f/0036-4665-rimtsp-58-00045.PMC4880002.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs375/en/.,Non-OADS,/arxiv_data1/oa_pdf/31/7f/0036-4665-rimtsp-58-00045.PMC4880002.pdf
"Sao Paulo 2016;58:46 http://dx.doi.org/10.1590/S1678-9946201658046 CASE REPORT  OCULAR SYPHILIS IN A KIDNEY TRANSPLANT RECIPIENT Elen A. ROMAO(1), Valdes R. BOLELLA(3), Maria Estela P. NARDIN(1,2), Maria Lucia HABIB-SIMAO(4), João Marcelo FURTADO(4) & Miguel MOYSES-NETO(1,2) SUMMARY We present a case of ocular syphilis after a renal transplantation involving progressive vision loss without clinically identifiable  ocular disease.",Non-OADS,/arxiv_data1/oa_pdf/5f/10/0036-4665-rimtsp-58-00046.PMC4880003.pdf
"Sao Paulo 2016;58:47 http://dx.doi.org/10.1590/S1678-9946201658047 BRIEF COMMUNICATION BIOFILM FORMATION OF Vibrio cholerae  ON STAINLESS STEEL USED IN FOOD PROCESSING Milagro FERNÁNDEZ-DELGADO(1), Héctor ROJAS(2), Zoilabet DUQUE(3), Paula SUÁREZ(4), Monica CONTRERAS(1),   M. Alexandra GARCÍA-AMADO(1) & Carlos ALCIATURI(3) SUMMARY Vibrio cholerae  represents a significant threat to human health in  developing countries.",Non-OADS,/arxiv_data1/oa_pdf/0b/c2/0036-4665-rimtsp-58-00047.PMC4880004.pdf
"cholerae O1,  serotype Ogawa, biotype El Tor, obtained from the Centro Venezolano  de Colecciones de Microorganismos  (CVCM 306, http://www.wfcc.",Non-OADS,/arxiv_data1/oa_pdf/0b/c2/0036-4665-rimtsp-58-00047.PMC4880004.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/71/main.PMC4880030.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.09.004 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/b2/71/main.PMC4880030.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2016) 3,5 6e71",Non-OADS,/arxiv_data1/oa_pdf/b2/71/main.PMC4880030.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/e5/mdw135.PMC4880064.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/43/mdw139.PMC4880065.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/91/euv100.PMC4880110.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/45/euv114.PMC4880111.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/c3/euv385.PMC4880114.pdf
http://www.efsa.europa.eu/en/efsajournal/pub/2092.,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
Editorial.http://www.nature.com/news/journals-unite-for-reproducibility-1.16259.,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
http://www.nature.com/news/announcement-reducing-our-irreproducibility-1.12852.,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
http://ntp.niehs.nih.gov/ntp/test_info/ﬁnalntp_toxcarspecsjan2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"http://www.oecd.org/general/searchresults/?q=OECD Series on Testing andAssessment Number 34&cx=012432601748511391518:xzea dub0b0a&cof=FORID:11&ie=UTF-8 Accessed March 30, 2016.. OECD (Organisation for Economic Cooperation and Development).",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
(http://www.oecd.org/chemicalsafety/risk-assessment/49191960.pdf).,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"http://www.onlineuniversities.com/blog/2012/02/the-10-greatest-cases-of-fraud-in-university-research/ Blog, Feb 27, 2012.",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"http://www.sciencemag.org/content/346/6210/679.full.Accessed June 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"http://www.scientiﬁcamerican.com/ar ticle/dollar-costs-of-scientiﬁc-misconduct-smaller-than-feared/ August 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"http://www.scientiﬁcamerican.com/ article/dollar-costs-of-scientiﬁc-misconduct-smaller-than-feared/ August 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
http://www.epa.gov/test-guidelines-pesticides- and-toxic-substances/series-890-endocrine-disruptor-screening-program.,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"https://www.epa.gov/pesticide-science- and-assessing-pesticide-risks/evaluation-guidelines-ecological-toxicity-data-open#guidance Accessed March 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/guidance-considering-and-using-open-literature Accessed March 30, 2016.BORGERT ET AL.",OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"speciﬁcation of identical dosing method for all animals during entire experimental period r. speciﬁcations for administration procedures for doses administered by gavage s. speciﬁcations for clinical observations of animals and clinical conditions, including time and period of effect after dosing t. speciﬁcations for conducting analyses and collecting data (including procedures to limit variation in observations and speciﬁcations of re- cord keeping) u. speciﬁcation and measurements of food and water consumptions v. speciﬁcation for tracking weight of test animals w. speciﬁcation of accepted statistical methods used and signiﬁcance criteria x. speciﬁcation of test reporting criteria in addition to requirements under EPA Good Laboratory Practice Standards y. speciﬁcation of systems developed and maintained to assure and document performance of laboratory staff and equipment Subparts H–I [Reserved] Subpart J—Records and Reports a. speciﬁcation of content of ﬁnal report (including certiﬁcation by study director and independent QA ofﬁcer) b. speciﬁcation of procedures for storage and retrieval of study data and records c. (c) requirements for retention of raw data, study records, samples of test substances, and specimens ahttp://www.gpo.gov/fdsys/pkg/CFR-2011-title40-Vol15102/pdf/CFR-2011-title40-Vol15102-part792.pdf.",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
http://www.epa.gov/ocspp/pubs/frs/publicat ions/Test_ Guidelines/series870.htm.BORGERT ET AL.,OADS,/arxiv_data1/oa_pdf/e4/c1/kfw056.PMC4880141.pdf
"2016;6(1):1-5.   http://dx.doi.org/10.4322/acr.2016.019 The declining rate of autopsies worldwide,  which has been observed in recent decades, has been  extensively debated.",Non-OADS,/arxiv_data1/oa_pdf/1f/71/autopsy-06-01001.PMC4880427.pdf
1963 ;183(13):1106 -6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/71/autopsy-06-01001.PMC4880427.pdf
http://dx.doi.org/10.1007/978-0-85729- 585-9 .,Non-OADS,/arxiv_data1/oa_pdf/1f/71/autopsy-06-01001.PMC4880427.pdf
2008 ;82(3):570-607. http://dx.doi.org/10.1353/ bhm.0.0086 .,Non-OADS,/arxiv_data1/oa_pdf/1f/71/autopsy-06-01001.PMC4880427.pdf
"Available from:  http://www.pro-folia.org/files/1/2004/1/rokitansky.pdf Castagnoli  L, Jonjic  N, Rizzardi  C, Melato  M. Carl von  Rokitansky and the Italian translation of the Handbuch  der Pathologischen Anatomie: a linguistic and  doctrinal enigma.",Non-OADS,/arxiv_data1/oa_pdf/1f/71/autopsy-06-01001.PMC4880427.pdf
2004 ;145(19-20 ):443-53. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/71/autopsy-06-01001.PMC4880427.pdf
2010 ;457(1):3-10. http://dx.doi.org/10.1007/ s00428-010-0934-4 .,Non-OADS,/arxiv_data1/oa_pdf/1f/71/autopsy-06-01001.PMC4880427.pdf
Available  from: http://www.whonamedit.com/doctor.cfm/981.,Non-OADS,/arxiv_data1/oa_pdf/1f/71/autopsy-06-01001.PMC4880427.pdf
2016;6(1):7-9. http://dx.doi.org/10.4322/acr.2016.020Image in Focus   Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2004 ;61(6):958-9. http://dx.doi.org/10.1001/ archneur.61.6.958 .,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2016 ;66(1):7-30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2008 ;93(5):791-2. http://dx.doi.org/10.3324/ haematol.11637 .,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2015 ;37(5):354-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2003 ;78(1):21-33. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2010 ;116(25):5501 - 6. http://dx.doi.org/10.1182/blood-2010-07-298760 .,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
1844 ;27(1):435-98.  http://dx.doi.org/10.1177/095952874402700129 .,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
1850 ;33(1):211-32. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2002 ;17(11):1921 - 5. http://dx.doi.org/10.1359/jbmr.2002.17.11.1921 .,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2009 ;14(3):276- 83. http://dx.doi.org/10.1634/theoncologist.2009-0003 .,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2003 ;349(26):2483 -94. http://dx.doi.org/10.1056/ NEJMoa030847 .,Non-OADS,/arxiv_data1/oa_pdf/39/6b/autopsy-06-01007.PMC4880428.pdf
2016;6(1):11-20. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2008 ;111(12):5446 -56. http://dx.doi.org/10.1182/blood- 2007-06-093906 .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2015 ;65(1):5-29. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2014 ;64(1):9-29. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
1981 ;48(1):198-206. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2008 ;2008 (1):450- 6. http://dx.doi.org/10.1182/asheducation-2008.1.450 .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2013 ;27(1):170-82. http://dx.doi.org/10.1038/ leu.2012.165 .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2001 ;116(19):738-40. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2007 ;82(4):449- 53. http://dx.doi.org/10.4065/82.4.449 .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
1978 ;35(2):87-96. http://dx.doi.org/10.1159/000225262 .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2008 ;8(4):249-52. http://dx.doi.org/10.3816/ CLM.2008.n.034 .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
1981 ;12(5):432-40. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
1987 ;60(4):827-37. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2011 ;7(6):479-87. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2005 ;59(147):53-5.  http://dx.doi.org/10.1111/j.1368-504X.2005.00049.x .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
1980 ;46(6):1479 -84. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2005 ;14(6):324-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
1996 ;18(2):117-9.  http://dx.doi.org/10.1046/j.1365-2257.1996.00164.x .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2011 ;24(11):1433 - 43. http://dx.doi.org/10.1038/modpathol.2011.103 .,OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2015 ;68(6):473-8. http://dx.doi.org/10.1136/ jclinpath-2015-202862 .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2009 ;50(10):1597 -605. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2010 ;23(11):1518 -23. http://dx.doi.org/10.1038/ modpathol.2010.131 .,Non-OADS,/arxiv_data1/oa_pdf/f9/26/autopsy-06-01011.PMC4880429.pdf
2016;6(1):21-26. http://dx.doi.org/10.4322/acr.2016.024 ABSTRACT Gastric volvulus is a rare condition resulting from rotation of the stomach beyond 180 degrees.,Non-OADS,/arxiv_data1/oa_pdf/ca/b2/autopsy-06-01021.PMC4880430.pdf
2011 ;5(2):272-7. http://dx.doi.org/10.1159/000328444 .,Non-OADS,/arxiv_data1/oa_pdf/ca/b2/autopsy-06-01021.PMC4880430.pdf
2010 ;72(2):163-4. http://dx.doi.org/10.1007/s12262- 010-0039-y .,Non-OADS,/arxiv_data1/oa_pdf/ca/b2/autopsy-06-01021.PMC4880430.pdf
2013 ;27(12):4409 -28. http://dx.doi.org/10.1007/ s00464-013-3173-3 .,Non-OADS,/arxiv_data1/oa_pdf/ca/b2/autopsy-06-01021.PMC4880430.pdf
http://dx.doi.org/10.1055/s-2007-966584 .,Non-OADS,/arxiv_data1/oa_pdf/ca/b2/autopsy-06-01021.PMC4880430.pdf
2016;6(1):27-31.   http://dx.doi.org/10.4322/acr.2016.023 ABSTRACT Diagnostic failure can be due to a variety of psychological errors on the part of the diagnostician.,Non-OADS,/arxiv_data1/oa_pdf/58/f8/autopsy-06-01027.PMC4880431.pdf
1993 ;153(17):1991 -5. http://dx.doi.org/10.1001/ archinte.1993.00410170065006 .,Non-OADS,/arxiv_data1/oa_pdf/58/f8/autopsy-06-01027.PMC4880431.pdf
2007 ;93(11):1414 -9. http://dx.doi.org/10.1136/ hrt.2006.103093 .,Non-OADS,/arxiv_data1/oa_pdf/58/f8/autopsy-06-01027.PMC4880431.pdf
2012 ;307(8):813- 22. http://dx.doi.org/10.1001/jama.2012.199 .,Non-OADS,/arxiv_data1/oa_pdf/58/f8/autopsy-06-01027.PMC4880431.pdf
Washington: The National Academies  Press; 2015 .. http://dx.doi.org/10.17226/21794 .,Non-OADS,/arxiv_data1/oa_pdf/58/f8/autopsy-06-01027.PMC4880431.pdf
2013 ;368(26):2445 -8. http://dx.doi.org/10.1056/ NEJMp1303712 .,OADS,/arxiv_data1/oa_pdf/58/f8/autopsy-06-01027.PMC4880431.pdf
2015 ;5(4):1-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/f8/autopsy-06-01027.PMC4880431.pdf
"2016;6(1):33-40. http://dx.doi.org/10.4322/acr.2016.021 ABSTRACT Acanthosis nigricans (AN), an entity recognized since the 19th century, is a dermatopathy associated with insulin-resistant  conditions, endocrinopathies, drugs, chromosome abnormalities and neoplasia.",Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2010 ;11(1):145-50. http://dx.doi.org/10.1186/1471- 2474-11-145 .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2002 ;59(5):773-6. http://dx.doi.org/10.1016/ S0090-4295(02)01533-9 .,OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2008 ;42(6):555-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
http://dx.doi.org/10.5489/cuaj.10061 .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2011 ;50(2):135-9. http://dx.doi.org/10.2169/ internalmedicine.50.3818 .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2007 ;14(9):854-5.  http://dx.doi.org/10.1111/j.1442-2042.2007.01832.x .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2002 ;15(8):847-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2007 ;10(3):251-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2011 ;35(5):757-61. http://dx.doi.org/10.1097/ PAS.0b013e3182147fa8 .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2009 ;2(1):49-52. http://dx.doi.org/10.1186/1757-1626- 2-49.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2004 ;63(6):1021 -6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2010 ;339(5):458-61. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2009 ;2(1):7948 -51. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
1999 ;63(3):164-7. http://dx.doi.org/10.1159/000030440 .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2010 ;16(8):388-91. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2009 ;43(4):334- 6. http://dx.doi.org/10.1080/00365590902811545 .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
1989 ;21(3 pt 1 ):461-9. http://dx.doi.org/10.1016/S0190- 9622(89)70208-5 .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2014 ;14(1):88. http://dx.doi.org/10.1186/1471-2490-14- 88.,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
1909 ;LIII(17):1369 -73. http://dx.doi.org/10.1001/ jama.1909.92550170001001g .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
1980 ;6(11):923-7.  http://dx.doi.org/10.1111/j.1524-4725.1980.tb01003.x .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2015 ;151(12):1381 -3.  http://dx.doi.org/10.1001/jamadermatol.2015.2139 .,Non-OADS,/arxiv_data1/oa_pdf/f3/33/autopsy-06-01033.PMC4880432.pdf
2016;6(1):41-45. http://dx.doi.org/10.4322/acr.2016.027 ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma comprising a heterogeneous group  of disorders with variable histological and clinical behavior.,Non-OADS,/arxiv_data1/oa_pdf/48/77/autopsy-06-01041.PMC4880433.pdf
1995 ;48(3):189-93.  http://dx.doi.org/10.1136/jcp.48.3.189 .,Non-OADS,/arxiv_data1/oa_pdf/48/77/autopsy-06-01041.PMC4880433.pdf
2011 ;29(14):1803 - 11. http://dx.doi.org/10.1200/JCO.2010.33.3252 .,Non-OADS,/arxiv_data1/oa_pdf/48/77/autopsy-06-01041.PMC4880433.pdf
2007 ;21(1):37-43. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/77/autopsy-06-01041.PMC4880433.pdf
2012 ;158(5):608-14. http://dx.doi.org/10.1111/j.1365- 2141.2012.09209.x .,Non-OADS,/arxiv_data1/oa_pdf/48/77/autopsy-06-01041.PMC4880433.pdf
2006 ;39(10):1349 -55. http://dx.doi.org/10.1590/S0100- 879X2006001000011 .,Non-OADS,/arxiv_data1/oa_pdf/48/77/autopsy-06-01041.PMC4880433.pdf
"2016;6(1):47-50. http://dx.doi.org/10.4322/acr.2016.028 ABSTRACT Gastric glomus tumors (GGTs) are unusual benign, subepithelial, mesenchymal neoplasms of modified smooth  muscle cells representing a neoplastic counterpart of glomus bodies.",Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
2011 ;43(Suppl  2):71-2. http://dx.doi.org/10.1055/s-0030-1256041 .,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
2010 ;16(36):4616 -20. http://dx.doi.org/10.3748/wjg.v16.,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
Autopsy and Case Reports  2016;6(1):47-50Incidental gastric glomus tumor after laparoscopic sleeve gastrectomy 502002 ;26(3):301-11. http://dx.doi.org/10.1097/00000478- 200203000-00003 .,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
1951 ;4(4):726-36.  http://dx.doi.org/10.1002/1097-0142(195107)4:4<726::AID- CNCR2820040410>3.0.CO;2-Z .,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
2012 ;20(1):5-14. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
2006 ;40(8):717-20. http://dx.doi.org/10.1097/00004836- 200609000-00011 .,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
2010 ;8(1):19-23. http://dx.doi.org/10.1186/1477-7819- 8-19.,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
1992 ;16(3):291-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
"2002 ;56(4, Suppl ):43-8. http://dx.doi.org/10.1016/S0016- 5107(02)70085-0 .",OADS,/arxiv_data1/oa_pdf/e3/e9/autopsy-06-01047.PMC4880434.pdf
"2016;6(1):51-56. http://dx.doi.org/10.4322/acr.2016.025 ABSTRACT Hysterectomy is the most common surgical gynecologic procedure, which is frequently related to the treatment of  leiomyoma.",Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2002 ;99(2):229-34.  http://dx.doi.org/10.1016/S0029-7844(01)01723-9 .,OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2002 ;9(2):125-30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
1996 ;103(4):345-50.  http://dx.doi.org/10.1111/j.1471-0528.1996.tb09740.x .,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2010 ;17(3):374- 8. http://dx.doi.org/10.1016/j.jmig.2010.02.005 .,OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2011 ;158(1):76- 81. http://dx.doi.org/10.1016/j.ejogrb.2011.03.027 .,OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2009 ;279(4):607- 8. http://dx.doi.org/10.1007/s00404-008-0827-9 .,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2008 ;15(5):559- 65. http://dx.doi.org/10.1016/j.jmig.2008.06.002 .,OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2012 ;19(6):689-94. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2007 ;86(11):1359 -69. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2014 ;16(12):1691 -6. http://dx.doi.org/10.1007/s00464-002-9043-z .,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2004 ;11(4):519-24.  http://dx.doi.org/10.1016/S1074-3804(05)60086-2 .,OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2009 ;279(5):777- 9. http://dx.doi.org/10.1007/s00404-008-0923-x .,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
1996 ;3(4):585-7.  http://dx.doi.org/10.1016/S1074-3804(05)80171-9 .,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2014 ;21(3):460-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2010 ;148(2):172-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2012 ;120(3):516-23. http://dx.doi.org/10.1097/ AOG.0b013e318264f848 .,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
56http://dx.doi.org/10.1016/S0002-9378(11)90787-X .,OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2009 ;279(4):607- 8. http://dx.doi.org/10.1007/s00404-008-0827-9 .,Non-OADS,/arxiv_data1/oa_pdf/be/b7/autopsy-06-01051.PMC4880435.pdf
2016;6(1):57-61. http://dx.doi.org/10.4322/acr.2016.026 ABSTRACT Lymphedema of the penis and scrotum is a rare entity characterized by enlargement of the skin and subcutaneous tissue  of the genital region due to lymphatic drainage impairment.,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2014 ;6(1):88- 90. http://dx.doi.org/10.4103/0974-7796.127025 .,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2011 ;77(5):1228 - 31. http://dx.doi.org/10.1016/j.urology.2010.10.026 .,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2010 ;4(1):196. http://dx.doi.org/10.1186/1752- 1947-4-196 .,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
"Autopsy and Case Reports  2016;6(1):57-61Vives F, García-Perdomo HA, Ocampo-Flórez GM 61http://dx.doi.org/10.4103/0019-5154.117340 .",Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
Int J Surg Case  Rep. 2012 ;3(7):269-71. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2014 ;40(2):205-12. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2013 ;66(2):281-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2011 ;29(Suppl 5 ):27- 37. http://dx.doi.org/10.1016/S0213-005X(11)70041-6 .,OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2013 ;2(1):153- 5. http://dx.doi.org/10.5455/ijmsph.2013.2.153-155 .,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2014 ;34(6):439-47. http://dx.doi.org/10.1002/ micr.22235 .,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
2014 ;67(12):1719 -25. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/cb/autopsy-06-01057.PMC4880436.pdf
"We discovered that 51 genes were exclusively  expressed in male and 50 genes were exclusively expressed in Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> Received 20 February 2016 | Accepted 22 May 2016 | Published 24 May 2016© 2016 Molecular Vision 518Transcriptome analysis of aging mouse meibomian glands Geraint J. Parfitt, Donald J.",Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  519female eyelid tissues.,Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  520sequences.,Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
Sequences trimmed of adaptor sequences were  mapped to the mm10 reference genome downloaded from  UCSC Genome Bioinformatics website ( https://genome.ucsc.,OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
"Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  52165 genes, while the aged animals selectively expressed 201  genes.",Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
"Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  522young mice, two pathways were statistically enriched and  represent genes involved with gland development and cellular  defense.",Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
"Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  523One gene overexpressed in young mice, DKKL1 , encodes  for a Dickkopf-like protein also referred to as Soggy (SGY-1).",Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
"Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  524cultures of immortalized mouse meibocytes were stained for  DKKL1 in the presence or absence of rosiglitazone, a PPAR-γ  agonist.",Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
"Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  525observed in the expression of the cornified envelope protein  Sprr1a, which is integral to the process of keratinization and  cornification.",Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  526APPENDIX 1.,Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
Molecular Vision  2016; 22:518-527 <http://www.molvis.org/molvis/v 22/518> © 2016 Molecular Vision  527the human Dickkopf gene family.,Non-OADS,/arxiv_data1/oa_pdf/02/f1/mv-v22-518.PMC4880544.pdf
"101Review Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.101 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:101-106FIG.",Non-OADS,/arxiv_data1/oa_pdf/25/13/cmj-52-101.PMC4880573.pdf
"Key Words:  Cardiovascular disease; Vascula r stiffness; Echocardiography This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 29, 2016 Revised April 22, 2016 Accepted April 30, 2016 Corresponding Author: Kye Hun Kim Department of Cardiovascular  Medicine, Chonnam National  University Hospital, 42 Jaebong-ro,  Dong-gu, Gwangju 61469, Korea Tel: +82-62-220-6266 Fax: +82-62-220-6264 E-mail: christiankyehun@hanmail.net INTRODUCTION Degenerative changes in the arterial system gradually  progress with aging and can be accelerated by certain risk  factors.1-3 Cardiovascular disease (CVD), associated with  vascular aging, has become a major cause of death in worldwide.",Non-OADS,/arxiv_data1/oa_pdf/25/13/cmj-52-101.PMC4880573.pdf
"107Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.107 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:107-111Evidence-based Medicine versus the Conventional Approach to  Journal Club Sessions: Which One Is More Successful in Teaching Critical Appraisal Skills?",Non-OADS,/arxiv_data1/oa_pdf/3c/9d/cmj-52-107.PMC4880574.pdf
"Key Words:  Emergency medicine; Evid ence-based medicine; Int ernship and residency;  Knowledge This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received November 26, 2015 Revised March 15, 2016 Accepted March 24, 2016 Corresponding Author: Seyed-Mostafa Hosseini-Zijoud Social Development and Health  Promotion Research Center,  Kermanshah University of Medical  Sciences, Kermanshah, Iran Tel: +98-21-82483264Fax: +98-21-82483265E-mail: seyedo2@yahoo.com INTRODUCTION A journal club can be defined as a group of post graduates  who meet regularly to discuss papers in current medical literature.",Non-OADS,/arxiv_data1/oa_pdf/3c/9d/cmj-52-107.PMC4880574.pdf
"112Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.112 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:112-116The Relationship between Anger Expression and Its Indices  and Oral Lichen Planus Masoumeh Mehdipour1, Ali Taghavi Zenouz2, Alireza Farnam3, Rana Attaran2, Sara Farhang3,  Maryam Safarnavadeh4, Narges Gholizadeh5, and Saranaz Azari-Marhabi1,*  1Department of Oral Medicine, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Departments of  2Oral Medicine,  3Psychology, Faculty of Medicine Science, Tabriz, 4Medical Education in Health Ministry, 5Department of Oral Medicine, Faculty of  Dentistry, Tehran University of Medical Sciences, Tehran, Iran Oral lichen planus (OLP) is a common infl ammatory disease with unknown etiology.",Non-OADS,/arxiv_data1/oa_pdf/af/6f/cmj-52-112.PMC4880575.pdf
"Key Words:  Anger; Lichen planus ; Visual analog scale This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received January 12, 2016 Revised March 4, 2016 Accepted March 6, 2016 Corresponding Author: Saranaz Azari-Marhabi Department of Oral Medicine,  School of Dentistry, Shahid Beheshti  University of Medical Sciences, 7th  Floor, 2nd SBUMS Bldg., Next to  Ayatollah Taleghani Hospital, Evin,  Tehran, Iran Tel: +98-2122413897 Fax: +98-2122403075 E-mail: saranazazari@yahoo.com INTRODUCTION Oral lichen planus (OLP) is a common inflammatory dis- ease with a prevalence of 0.5-2.2% in the general popu-lation.",Non-OADS,/arxiv_data1/oa_pdf/af/6f/cmj-52-112.PMC4880575.pdf
"117Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.117 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:117-122The Prevalence of Chronic Obstructive Pulmonary Disease and  the Determinants of Underdiagnosis in Women Exposed to Biomass Fuel in India- a Cross Section Study Vinay KalagoudaMahishale *, Naveen Angadi, Vjayanand metgudmath, Mitchelle Lolly, Ajith Eti,  and Sujeer Khan Department of Pulmonary Medicine, KLE University’s J.  N. Medical College, Belagavi, Karnataka, India Background and Objectives:  Tobacco smoking has been established as a major risk fac- tor for chronic obstructive pulmonary diseas e (COPD) in women of developing coun- tries, but emerging evidence suggests that biomass fuel is an important risk factor as  well.",Non-OADS,/arxiv_data1/oa_pdf/cf/1b/cmj-52-117.PMC4880576.pdf
"Key Words:  Pulmonary disease; Chronic obst ructive; Women; Spirometry This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received February 4, 2016 Revised April 5, 2016 Accepted April 12, 2016 Corresponding Author: Vinay KalagoudaMahishale Department of Pulmonary Medicine KLE University ’s J. N. Medical College,  Nehru Nagar, Belgaum, Karnataka  590010, India Tel: +91-9448920651 E-mail: pulmovinay@yahoo.com INTRODUCTION Despite the fact that the re lative burden of Chronic  Obstructive Pulmonary Disease (COPD) in women is high  in both the developing and developed countries, the occur-rence of COPD in women is not widely appreciated.",Non-OADS,/arxiv_data1/oa_pdf/cf/1b/cmj-52-117.PMC4880576.pdf
Available from: http://www.goldcopd.org/.,Non-OADS,/arxiv_data1/oa_pdf/cf/1b/cmj-52-117.PMC4880576.pdf
"123Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.123 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:123-127Ureteral Stent Insertion in the Management of Renal Colic during  Pregnancy Chang Il Choi, Young Dong Yu, and Dong Soo Park * Department of Urology, CHA University Medical School, Seongnam, Korea To determine an optimal invasive interventi on for renal colic patients during preg- nancy after conservative trea tments have been found to be  unhelpful.",Non-OADS,/arxiv_data1/oa_pdf/ad/53/cmj-52-123.PMC4880577.pdf
"Key Words:  Urinary catheters; Renal colic; Hydron ephrosis; Urolithiasis; Pregnancy This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received January 11, 2016 Revised January 29, 2016 Accepted February 15, 2016 Corresponding Author: Dong Soo Park Department of Urology, CHA University Medical School, 59 Yatap-ro,  Bundang-gu, Seongnam 13496,  Korea Tel: +82-31-780-5000Fax: +82-31-780-1862E-mail: dsparkmd@cha.ac.kr INTRODUCTION Unlike the abdominal discomfort  that is frequently ob- served during pregnancy, rena l colic while often infrequent  during pregnancy is potentially dangerous because it can lead to hospitalization and adverse effects for both the mother and the fetus.",Non-OADS,/arxiv_data1/oa_pdf/ad/53/cmj-52-123.PMC4880577.pdf
Available from: http://emedicine.medscape.com/ar- ticle/455830-overview/.,Non-OADS,/arxiv_data1/oa_pdf/ad/53/cmj-52-123.PMC4880577.pdf
"128Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.128 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:128-135Comparative Effects of Statin Therapy versus Renin-Angiotensin  System Blocking Therapy in Patients with Ischemic Heart Failure Who Underwent Percutaneous Coronary Intervention Jumin Won, Young Joon Hong *, Myung Ho Jeong, Hyuk Jin Park, Min Chul Kim, Woo Jin Kim,  Hyun Kuk Kim, Doo Sun Sim, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, and Jong Chun Park Division of Cardiology, Chonnam National University Hospital, Cardiovascular Convergence Research Center Nominated by Korea  Ministry of Health and Welfare, Gwangju, Korea Statins and renin-angiotensin system (RAS) blockers are key drugs for treating pa- tients with an acute myocardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/e3/c5/cmj-52-128.PMC4880578.pdf
"Key Words: Myocardial Infarction; Heart failure;  Hydroxymethylglutaryl-CoA  Reductase Inhibitors; Renin-Angiotensin System This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received February 25, 2016 Revised March 16, 2016 Accepted March 23, 2016 Corresponding Author: Young Joon Hong Division of Cardiology, Chonnam  National University Hospital,  Cardiovascular Convergence Research Center Nominated by Korea Ministry of  Health and Welfare, 42 Jaebong-ro,  Dong-gu, Gwangju 61469, Korea Tel: +82-62-220-6978 Fax: +82-62-223-3105 E-mail: hyj200@hanmail.net INTRODUCTION Statin therapy is a key treatment for patients with coro- nary heart disease (CHD).",Non-OADS,/arxiv_data1/oa_pdf/e3/c5/cmj-52-128.PMC4880578.pdf
"136Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.136 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:136-140Frequency of Diabetes and Thyroid Autoantibodies in Patients with  Type 1 Diabetes and Their Siblings Ka Young Oh, Yun Hee Kim, Eun Mi Yang, and Chan Jong Kim * Department of Pediatrics, Chonnam National Univ ersity Medical School & Hospital, Gwangju, Korea The aim of this study was to better unders tand the frequency of autoimmune thyroid  and diabetes antibodies in pa tients with type 1 diabete s mellitus (T1DM) compared  with their siblings.",Non-OADS,/arxiv_data1/oa_pdf/71/70/cmj-52-136.PMC4880579.pdf
"Key Words: Diabetes mellitus; Type 1; Autoantibo dies; Thyroiditis; Siblings; Autoi- mmunity This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 10, 2016 Revised April 7, 2016 Accepted April 9, 2016 Corresponding Author: Chan Jong Kim Department of Pediatrics, Chonnam  National University Medical School &  Hospital, 160, Baekseo-ro, Dong-gu, Gwangju 61469, Korea Tel: +82-62-220-6645 Fax: +82-62-222-6103 E-mail: cjkim@jnu.ac.kr INTRODUCTION Type 1 diabetes mellitus (T1DM)  results from lack of in- sulin secretion caused by th e destruction of pancreatic   cells.1 Most patients with T1DM have the diabetes auto- antibodies such as insulin autoantibodies (IAA), glutamic acid decarboxylase (GADA), and islet cell antibody (ICA).",Non-OADS,/arxiv_data1/oa_pdf/71/70/cmj-52-136.PMC4880579.pdf
"141Letters to the Editor www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.141 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:141-142Corresponding Author: Hyoung Lho Department of Emergency Medicine, North York General Hospital 4 001 Leslie St, Toronto, ON M2K 1E1, Canada Tel: +1-416-756-6882, Fax: +1-416-756-6793, E-mail: hyoung.lho@ utoronto.caArticle History: Received March 8, 2016 Revised March 22, 2016 Accepted March 25, 2016TABLE  1.",Non-OADS,/arxiv_data1/oa_pdf/9f/db/cmj-52-141.PMC4880580.pdf
"143Images in Clinical Medicine www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.143 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:143-144 FIG.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/cmj-52-143.PMC4880581.pdf
"75Review Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.75 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:75-80Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein Sunga Choi, Hee Kyoung Joo, and Byeong Hwa Jeon * Research Institute of Medical Sciences, Department of Physiology, College of Medicine, Chungnam National University, Daejeon, K orea Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunc- tional protein that plays a central role in the cellular response to DNA damage and redox  regulation against oxidative stress.",OADS,/arxiv_data1/oa_pdf/b8/5e/cmj-52-75.PMC4880582.pdf
"Key Words: DNA-(apurinic or apyrim idinic site) lyase; Pr otein processing, post-  translational; Oxidatio n-reduction; Biomarkers This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 8, 2016 Revised March 31, 2016 Accepted April 1, 2016 Corresponding Author: Byeong Hwa Jeon Research Institute of Medical  Sciences, Department of Physiology,  College of Medicine, Chungnam  National University, 266 Munhwa-ro,  Jung-gu, Daejeon 35015, Korea Tel: +82-42-580-8214Fax: +82-42-585-8440E-mail: bhjeon@cnu.ac.kr INTRODUCTION Apurinic/apyrimidinic endonuclease 1/redox factor-1  (APE1/Ref-1), also known as APEX1, is the mammalian or-tholog of Escherichia coli  Xth (exonuclease III).",Non-OADS,/arxiv_data1/oa_pdf/b8/5e/cmj-52-75.PMC4880582.pdf
"81Review Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.81 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:81-90Altered Nitric Oxide System in Cardiovascular and Renal Diseases JongUn Lee1,*, Eun Hui Bae2, Seong Kwon Ma2, and Soo Wan Kim2 Departments of 1Physiology and 2Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Nitric oxide (NO) is synthesized by a family of NO synthases (NOS), including neuronal,  inducible, and endothelial NOS (n/i/eNOS).",Non-OADS,/arxiv_data1/oa_pdf/4f/a2/cmj-52-81.PMC4880583.pdf
"Key Words:  Nitric oxide; Hypertension; Atheroscl erosis; Ischemia/reperfusion injury;  Heart failure; Nephrogenic diabet es insipidus; Ureteral obstruction;  Cardio-renal syndrome This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received February 12, 2016 Revised March 14, 2016 Accepted March 22, 2016 Corresponding Author: JongUn Lee Department of Physiology, Chonnam  National University Medical School,  160 Baekseo-ro, Dong-gu, Gwangju  61469, Korea Tel: +82-62-220-4262 Fax: +82-62-232-1242 E-mail: julee@jnu.ac.kr INTRODUCTION Although being initially identi fied as a vasodilator, ni- tric oxide (NO) has emerged as  an important mediator in  a quite diverse range of biological functions.",Non-OADS,/arxiv_data1/oa_pdf/4f/a2/cmj-52-81.PMC4880583.pdf
"91Review Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2016.52.2.91 ⒸChonnam Medical Journal, 2016  Chonnam Med J 2016;52:91-100Vilazodone for the Treatment of Depression: An Update Sheng-Min Wang1,2, Changsu Han3, Soo-Jung Lee1, Ashwin A. Patkar4, Prakash S Masand5, and  Chi-Un Pae1,4,* 1Department of Psychiatry, The Catholic University of Korea College of Medicine, 2International Health Care Center, Seoul St. Mary’s  Hospital, The Catholic University of Korea College of Medicine, 3Department of Psychiatry, College of Medicine, Korea University, Seoul,  Korea, 4Department of Psychiatry and Behavioural Scien ces, Duke University Medical Center, Durham, NC, 5Global Medical Education,  New York, NY, USA Vilazodone is a novel antidepr essant having a selective se rotonin (5-HT) reuptake in- hibitor and 5-HT 1A receptor partial agonist profile, so it has been regarded as a serotonin  partial agonist-reuptake inhibitor (SPARI).",Non-OADS,/arxiv_data1/oa_pdf/41/c0/cmj-52-91.PMC4880584.pdf
"Key Words:  Antidepressive agents; Anxiety di sorders; 5-HT1 receptor agonists;  Serotonin uptake inhibitors; Vilazodone hydrochloride This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received January 22, 2016 Revised March 2, 2016 Accepted March 6, 2016 Corresponding Author: Chi-Un Pae Department of Psychiatry, Bucheon St.  Mary ’s Hospital, The Catholic University of Korea College of Medicine,  327 Sosa-ro, Wonmi-gu, Bucheon  14647, Korea Tel: +82-32-340-7067 Fax: +82-32-340-2255 E-mail: pae@catholic.ac.kr INTRODUCTION Major depressive disorder (MDD), which has a lifetime  prevalence of 15-20%, is a debilitating illness affecting pa-tients ’ general lives by causing severe functional impair- ment.",Non-OADS,/arxiv_data1/oa_pdf/41/c0/cmj-52-91.PMC4880584.pdf
Available from: http://www.frx.com/pi/viibryd_pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/c0/cmj-52-91.PMC4880584.pdf
Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/nda/2011/  022567Orig1s000TOC.cfm.,Non-OADS,/arxiv_data1/oa_pdf/41/c0/cmj-52-91.PMC4880584.pdf
"Fernando Carbonell Tatay MD Abdominal Wall Surgeon Valencia (Spain), February 16th, 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.Hernia (2016) 20:345–347 347 123",Non-OADS,/arxiv_data1/oa_pdf/69/47/10029_2016_Article_1488.PMC4880622.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/41/c6/hgv201611.PMC4880642.pdf
"ﬁg share.hgv.799, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/41/c6/hgv201611.PMC4880642.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Novel OPN1LW /OPN1MW deletion mutations in 2 Japanese BCM patients C Wang et al 4 Human Genome Variation (2016) 16011 © 2016 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/41/c6/hgv201611.PMC4880642.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.Table 4 Risk of bias summary: each risk of bias item for each included randomised controlled study [ 5] Left side reports on expert studies, on the right the non-expert studies354 Hernia (2016) 20:349–356 123",Non-OADS,/arxiv_data1/oa_pdf/18/5c/10029_2016_Article_1483.PMC4880643.pdf
Available from URL: http://www.mophp-ye.,Non-OADS,/arxiv_data1/oa_pdf/cb/62/SaudiMedJ-37-513.PMC4880650.pdf
Available from URL: http://www.iacr.com.fr/index.,Non-OADS,/arxiv_data1/oa_pdf/cb/62/SaudiMedJ-37-513.PMC4880650.pdf
Available from: http://www.ihn-org.com/   8.,Non-OADS,/arxiv_data1/oa_pdf/3a/af/SaudiMedJ-37-538.PMC4880654.pdf
Available from URL: http://www.who.int/bloodsafety/ global_database/en/   9.,Non-OADS,/arxiv_data1/oa_pdf/3a/af/SaudiMedJ-37-538.PMC4880654.pdf
Available from  URL: http://sgh.org.sa/en-us/technicalprograms/healthcare/ bloodbankstransfusionservices.aspx10.,Non-OADS,/arxiv_data1/oa_pdf/3a/af/SaudiMedJ-37-538.PMC4880654.pdf
Sample references are available from:   http://www.nlm.nih.gov/bsd/uniform_requirements.html,Non-OADS,/arxiv_data1/oa_pdf/3a/af/SaudiMedJ-37-538.PMC4880654.pdf
Available from URL: http://www.stats.gov.sa/en  2.,OADS,/arxiv_data1/oa_pdf/17/03/SaudiMedJ-37-575.PMC4880660.pdf
Available from:  http://www.who.int/mediacentre/news/releases/2016/yellow-fever-vaccination/en/,Non-OADS,/arxiv_data1/oa_pdf/cd/a5/SaudiMedJ-37-595.PMC4880668.pdf
"Nutrition Research and Practice 2016;10(3):251-258 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Anti-inflammatory effects of proanthocyanidin-rich red rice extract  via suppression of MAPK, AP-1 and NF- κB pathways in Raw  264.7 macrophages Pornngarm Limtrakul§, Supachai Yodkeeree, Pornsiri Pitchakarn and Wanisa Punfa Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand BACKGROUND/OBJECTIVES:  Several pharmacological properties of red rice extract have been reported including anti-oxidant,  anti-tumor, and reduced cancer cell invasion.",Non-OADS,/arxiv_data1/oa_pdf/52/19/nrp-10-251.PMC4880723.pdf
"Nutrition Research and Practice 2016;10(3):259-264 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Compound K attenuates stromal cell-derived growth factor 1  (SDF-1)-induced migration of C6 glioma cells Hyuck Kim1, Hyo Sun Roh2, Jai Eun Kim3, Sun Dong Park4, Won Hwan Park1 and Jin-Young Moon2§ 1Department of Diagnostics, College of Korean Medicine, Dongguk University, Goyang 10326, Korea 2Department of Acupoint, College of Korean Medicine, Dongguk University, Dongguk-Ro 32, Goyang 10326, Korea 3Department of Pathology, College of Korean Medicine, Dongguk University, Goyang 10326, Korea 4Department of Prescription, College of Korean Medicine, Dongguk University, Goyang 10326, Korea BACKGROUND/OBJECTIVES: Stromal cell-derived growth factor 1 (SDF-1), also known as chemokine ligand 12, and chemokine  receptor type 4 are involved in cancer cell migration.",Non-OADS,/arxiv_data1/oa_pdf/af/bb/nrp-10-259.PMC4880724.pdf
"Nutrition Research and Practice 2016;10(3):265-273 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Effect of Hijikia fusiforme  extracts on degenerative osteoarthritis  in vitro  and in vivo  models Han Ol Kwon1, Minhee Lee1, Ok-Kyung Kim1, Yejin Ha1, Woojin Jun2 and Jeongmin Lee1§ 1Department of Medical Nutrition, Kyung Hee University, 1732, Deogyeong-daero, Gihe ung-gu, Yongin 17104, Korea 2Division of Food and Nutritional Science, Ch onnam National University, Gwangju 61186, Korea  BACKGROUND/OBJECTIVES:  The inhibitory effect of Hijikia fusiforme (HF) extracts on degenerative osteoarthritis was examined  in primary cultured rat cartilage cells and a monosodium iodoacetate (MIA)-induced osteoarthritis rat model.MATERIALS/METHODS:  In vitro , cell survival and the expression of matrix metalloproteinases (MMPs), collagen type I, collagen  type II, aggrecan, and tissue inhibitor of metalloproteinases (TIMPs) was measured after H 2O2 (800 μM, 2 hr) treatment in  primary chondrocytes.",Non-OADS,/arxiv_data1/oa_pdf/62/6f/nrp-10-265.PMC4880725.pdf
Nutrition Research and Practice 2016;10(3):274-281 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Perilla frutescens  var.,Non-OADS,/arxiv_data1/oa_pdf/9a/d8/nrp-10-274.PMC4880726.pdf
"Nutrition Research and Practice 2016;10(3):282-287 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Fermentation of purple Jerusalem artichoke extract to improve the  α-glucosidase inhibitory effect in vitro  and ameliorate blood  glucose in db/db  mice Zhiqiang Wang1, Seung Hwan Hwang1, Sun Youb Lee3,4 and Soon Sung Lim1,2§ 1Department of Food Science and Nutrition, Hallym Un iversity, 1 Hallymdeahak-gil, Chuncheon, 24252 Korea 2Institute of Natural Medicine, Hallym University, Chuncheon, 24252 Korea 3Natural Resources Commercialization, Chuncheon Bioindustry Foundation, Chuncheon, 24252 Korea 4Frontbio Co. Ltd., Chuncheon, 24252 Korea BACKGROUND/OBJECTIVES:  Jerusalem artichoke has inhibitory activity against α-glucosidase and decreases fasting serum glucose  levels, which may be related to its fructan content.",Non-OADS,/arxiv_data1/oa_pdf/5d/59/nrp-10-282.PMC4880727.pdf
"Nutrition Research and Practice 2016;10(3):288-293 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Elevation of heart-femoral pulse wave velocity by short-term low  sodium diet followed by high sodium diet in hypertensive patients  with sodium sensitivity Moo-Yong Rhee1§, Ji-Hyun Kim1, Sang-Hoon Na2, Jin-Wook Chung3, Jun-Ho Bae3, Deuk-Young Nah3, Namyi Gu4 and Hae-Young Kim5 1Cardiovascular Center, Dongguk University Ilsan Hospit al, 27 Dongguk-ro, Ilsandong-gu, Goyang 10326, Korea 2Emergency Medicine and Cardiology, Emergency Medical Center, Department of Internal Medicine, Seoul National University Hospita l, Seoul 03080, Korea 3Division of Cardiology, Department of Internal Medicine, College of Medicine, Dongguk University, Gyeongju 38067, Korea 4Department of Clinical Pharmacology and Therapeutics, Dongguk University Ilsan Hospital, Goyang 10326, Korea 5D e p a r t m e n t  o f  H e a l t h  P o l i c y  a n d  M a n a g e m e n t ,  C o l l e g e  o f  H e a l t h  S c i e n c e  &  D e p a r t m e n t  o f  P u b l i c  H e a l t h  S c i e n c e ,  G r a d u a t e  S c h o o l ,  K orea University, Seoul 02841,  Korea BACKGROUND/OBJECTIVES:  We compared changes in heart-femoral pulse wave velocity (hfPWV) in response to low sodium  and high sodium diet between individuals with sodium sensitivity (SS) and resistance (SR) to evaluate the influence of sodium intake on arterial stiffness.",Non-OADS,/arxiv_data1/oa_pdf/cf/e9/nrp-10-288.PMC4880728.pdf
"Nutrition Research and Practice 2016;10(3):294-304 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Dietary quality differs by consumption of meals prepared at home  vs. outside in Korean adults Kyung Won Lee1, Won O. Song1 and Mi Sook Cho2§ 1Department of Food Science and Human Nutritio n, Michigan State University, MI 48824, USA 2Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Sodaemun-gu, Seoul 03760, Ko rea BACKGROUND/OBJECTIVES: Eating out has been reported to have negative effects on nutritional status.",Non-OADS,/arxiv_data1/oa_pdf/97/96/nrp-10-294.PMC4880729.pdf
"2016 Published online 2016 March 22 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Development of dietary pattern evaluation tool for adults and  correlation with Dietary Quality Index Yeo Do Lee1, Kyung Won Kim2, Kyung-Suk Choi3, Misung Kim1, Yeo Jin Cho1 and Cheongmin Sohn1§ 1Department of Food and Nutrition, Wonkwang Un iversity, 460 Iksan-daero, Jeonbuk 54538, Korea 2Department of Food and Nutrition, Seou l Women’s University, Seoul 01797, Korea 3Department of Food Science and Nutrition, Daejin University, Gyeonggi 11159, Korea BACKGROUND/OBJECTIVES:  As the prevalence of chronic diseases has risen, the need for straightforward diagnostic tools for  monitoring nutrition status to improve nutrition counseling and disease prevention has likewise increased.",Non-OADS,/arxiv_data1/oa_pdf/93/bd/nrp-10-305.PMC4880730.pdf
Available from: http://hi.nhis.or.kr.,Non-OADS,/arxiv_data1/oa_pdf/93/bd/nrp-10-305.PMC4880730.pdf
Available from: http://www.dietnet.or.kr.,Non-OADS,/arxiv_data1/oa_pdf/93/bd/nrp-10-305.PMC4880730.pdf
Available from:  http://dhra.khidi.or.kr.,Non-OADS,/arxiv_data1/oa_pdf/93/bd/nrp-10-305.PMC4880730.pdf
Available from: http://www.yourdiseaserisk.wustl.edu.,Non-OADS,/arxiv_data1/oa_pdf/93/bd/nrp-10-305.PMC4880730.pdf
"Nutrition Research and Practice 2016;10(3):313-320 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Associations of dietary intake and metabolic syndrome risk  parameters in Vietnamese female marriage immigrants in South  Korea: The KoGES follow-up study Hyesu Yang1*, Hyesook Kim1*, Ji-Myung Kim2, Hye Won Chung3 and Namsoo Chang1§ 1Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, K orea 2Food and Nutrition Major, Division of Food Science and Culinary Arts, Shinhan University, Gyeonggi 11644, Korea 3Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul 03760, Korea BACKGROUND/OBJECTIVES:  This study was conducted to compare the overall changes in dietary intake and metabolic syndrome  risk parameters in Vietnamese marriage-based female immigrants over time.SUBJECTS/METHODS:  The subjects of this study were 581 Vietnamese marriage-based female immigrants, who were recruited  from local clinical centers in Korea.",Non-OADS,/arxiv_data1/oa_pdf/dd/ff/nrp-10-313.PMC4880731.pdf
Seoul: Ministry of Security and Public Administration; 2014 [cited  2015 August 13] Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/dd/ff/nrp-10-313.PMC4880731.pdf
"Nutrition Research and Practice 2016;10(3):321-327 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Student feedback to improve the United States Department of  Agriculture Fresh Fruit and Vegetable Program Yi-Chun Lin and Alyce D. Fly§ School of Public Health, Indiana University Bloomington,  1025 E 7th St., PH 116, Bloomington, IN 47405, USA BACKGROUND/OBJECTIVES: Fruit and vegetable consumption of children in the United States falls below recommendations.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/nrp-10-321.PMC4880732.pdf
Available from: http://www.fns.usda.,Non-OADS,/arxiv_data1/oa_pdf/ab/b2/nrp-10-321.PMC4880732.pdf
Available from:  http://www.fns.usda.gov/sites/default/files/handbook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ab/b2/nrp-10-321.PMC4880732.pdf
Available from: http://compass.doe.in.gov/  dashboard/overview.aspx.,OADS,/arxiv_data1/oa_pdf/ab/b2/nrp-10-321.PMC4880732.pdf
"Nutrition Research and Practice 2016;10(3):328-335 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Effects of vitamin D supplementation on metabolic indices and  hs-CRP levels in gestational diabetes mellitus patients: a  randomized, double-blinded, placebo-controlled clinical trial Roya Yazdchi1, Bahram Pourghassem Gargari2§, Mohammad Asghari-Jafarabadi3 and Farnaz Sahhaf4 1Department of Biochemistry and Diet Therapy, Faculty of Nutrition, Students' Research Committee, Tabriz University of Medical S ciences, Tabriz, Iran 2Nutrition Research Center, Department of Biochemistry and Diet Th erapy, Faculty of Nutrition, Tabriz University of Medical Scie nces, Tabriz, Iran 3Department of Statistics and Epidemiology, Faculty of He alth, Tabriz University of Medical Sciences, Tabriz, Iran 4Department of Obstetrics and Gynecology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran BACKGROUND/OBJECTIVES: Vitamin D plays an important role in the etiology of gestational diabetes mellitus (GDM).",Non-OADS,/arxiv_data1/oa_pdf/c8/47/nrp-10-328.PMC4880733.pdf
"Nutrition Research and Practice 2016;10(3):336-341 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Association between nutrient intake and thyroid cancer risk in  Korean women Young Ae Cho, Jeonghee  Lee and Jeongseon Kim§ Molecular Epidemiology Branch, Division of Cancer Epidemiology and Prevention, Research Institute, National Cancer Center, 323,  Ilsan-ro, Ilsandong-gu, Gyeonggi  10408, Korea BACKGROUND/OBJECTIVES:  The incidence of thyroid cancer has increased in many countries, including Korea.",Non-OADS,/arxiv_data1/oa_pdf/c0/30/nrp-10-336.PMC4880734.pdf
"Nutrition Research and Practice 2016;10(3):342-351 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   The development of a mobile u-Health program and evaluation for  self-diet management for diabetic patients Yun Ahn1,3, Jeahurn Bae2,3 and Hee-Seon Kim3§ 1Department of Food Science and Nutrition, Seoul Women’s University, Seoul 01797, Korea 2Nutrition Team, Soonchunhyang University Hospital, Gyeonggi 14584, Korea 3Department of Food Science and Nutrition, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myun, Asan, Chungnam 31538, Korea  BACKGROUND/OBJECTIVES: This study aims to develop a mobile nutritional management program for integration into the  already developed web-based program, Diabetes Mellitus Dietary Management Guide (DMDMG) for diabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/4c/6d/nrp-10-342.PMC4880735.pdf
"SUBJECTS AND METHODS In this study, a mobile u-Health program was developed for  integration into the existing web-based self-diet management u-Health program (DMDMG, http://uhdm.dongeunit.com).",Non-OADS,/arxiv_data1/oa_pdf/4c/6d/nrp-10-342.PMC4880735.pdf
"Nutrition Research and Practice 2016;10(3):352-358 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Health Blief Model-based intervention to improve nutritional  behavior among elderly women Jamileh Amirzadeh Iranagh1§, Hejar Abdul Rahman2 and Seyedeh Ameneh Motalebi3 1Department of Public Health, Health and Paramedical Faculty, 5714783734, Nazlou Campus, Urmia, Iran 2Faculty of Medical and Health Sciences, Uneversiti Putr a Malaysia (UPM), 43400, Serdang, Selangor, Malaysia 3Faculty of Nursing and Midwifery, Ilam University  of Medical Sciences, Pazhuhesh Blvd., Ilam, Iran BACKGROUND/OBJECTIVES:  Nutrition is a determinant factor of health in elderly people.",Non-OADS,/arxiv_data1/oa_pdf/1f/9a/nrp-10-352.PMC4880736.pdf
"Nutrition Research and Practice 2016;10(3):359-363 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org Short Communication Associations between Japanese schoolchildren’s involvement in  at-home meal preparation, their food intakes, and cooking skills Miho Nozue1§, Hiromi Ishida2, Sayaka Hazano3, Akemi Nakanishi2, Taeko Yamamoto4, Aya Abe5, Nobuo Nishi1, Tetsuji Yokoyama6 and Nobuko Murayama7 1National institutes of Biomedical Innovation, Health and Nutrition, 1-23-1 Toyama, Shinjuku, Tokyo 162-8636, Japan 2Faculty of Nutrition, Kagawa Nutritio n University, Saitama 350-0288, Japan 3Department of Health and Nutritional Scie nce, Faculty of Human Health Science, Matsumoto University, Nagano 390-1295, Japan 4School of Nutrition and Dietetic, Faculty of Health and Social Services, Kanagawa University of Human Services , Kanagawa 238-8 522, Japan 5Faculty of Urban Liberal Arts, Tokyo Metropolitan University, Tokyo 192-0397, Japan 6Department of Health Promotion, National Institute of Public Health, Saitama 351-0197, Japan 7Department of Health and Nutrition, Faculty of Human Life Stud ies, University of Niigata Prefecture, Niigata 950-8680, Japan BACKGROUND/OBJECTIVES:  This study aimed to examine the association of Japanese schoolchildren’s involvement in at-home  meal preparation with food intake and cooking skill.SUBJECTS/METHODS:  We included 1,207 fifth-grade children aged 10-11 years and one parent of each child.",Non-OADS,/arxiv_data1/oa_pdf/9b/3e/nrp-10-359.PMC4880737.pdf
Available from: http://extensionpublications.unl.edu/  assets/pdf/g1086.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/3e/nrp-10-359.PMC4880737.pdf
Available from: http://www8.cao.go.jp/syokuiku/about/  plan/pdf/2kihonkaiteihonbun.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/3e/nrp-10-359.PMC4880737.pdf
"Nutrition Research and Practice 2016;10(3):364 ⓒ2016 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Erratum: Onion peel extract reduces the percentage of body fat in overweight  and obese subjects: a 12-week, randomized, double-blind,  placebo-controlled study Ji-Sook Park, Yong-Jun Cha, Kyung-Hea Lee and Jung-Eun Yim§ Department of Food and Nutrition, Changwon  National University, 20 Changwondaehak-ro, Uichang-gu, Changwon, Gyeongnam 51140, Ko rea Nutrition Research and Practice 2016 March 2; pISSN 1976-1457 eISSN 2005-6168 Nutrition Research and Practice 2016;10(3):364; doi:10.4162/nrp.2016.10.3.364; pISSN 1976-1457 eISSN 2005-6168 To the Editor, There was an error in our published article titled “Onion peel extract reduces the percentage of body fat in overweight and obe se  subjects: a 12-week, randomized, double-blind, placebo-controlled study” Nutrition Research and Practice 2016 Marh 2; pISSN 1976-1457 eISSN 2005-6168 We made a mistake in presenting author name.",Non-OADS,/arxiv_data1/oa_pdf/f8/36/nrp-10-364.PMC4880738.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Next generation sequencing RNA and whole-genome sequencingUltra-low input sequencingSingle cellEmbryonic stem cells Speci ﬁcations Organism/cell line/tissueHuman embryonic stem cells (line H1) Sex Male Sequencer or array typeIllumina HiSeq 2000 Data format Raw Experimental factorsStandard cell culture Experimental featuresCombined DNA and RNA extraction from 150 –200 cells, con- version to ampli ﬁed cDNA and WGA-DNA, paired end sequencing Consent NASample source locationWiCell Research Institute, Madison, WI, United States 1.",Non-OADS,/arxiv_data1/oa_pdf/98/6c/main.PMC4880790.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69471 .2.,OADS,/arxiv_data1/oa_pdf/98/6c/main.PMC4880790.pdf
http://dx.doi.org/10.1016/j.gdata.2016.04.014 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/main.PMC4880790.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/6c/main.PMC4880790.pdf
"JA acknowl- edges support from the EU FP7 project AgedBrainSYSBIO (Grant Agree- ment No 305299) ( http://www.agedbrainsysbio.eu ), the Duesseldorf School of Oncology (funded by the Comprehensive Cancer Center Düsseldorf/Deutsche Krebshilfe and the Medical Faculty HHU Düsseldorf).",Non-OADS,/arxiv_data1/oa_pdf/98/6c/main.PMC4880790.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/8f/main.PMC4880946.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 299 –304 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.001 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e5/8f/main.PMC4880946.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/8f/main.PMC4880946.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/ba/main.PMC4880947.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 241 –244 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.005 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/25/ba/main.PMC4880947.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/ba/main.PMC4880947.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/1f/main.PMC4880949.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 305 –311 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.002 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6b/1f/main.PMC4880949.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/1f/main.PMC4880949.pdf
A specially designed modelling system – E-3D Biomedical Modeler ( http://www.e-feature.net/con- tent/fea ) was employed to build a ﬁnite element model.,OADS,/arxiv_data1/oa_pdf/6b/1f/main.PMC4880949.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/d8/main.PMC4880951.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 312 –317 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.003 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/16/d8/main.PMC4880951.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/d8/main.PMC4880951.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/03/main.PMC4881149.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 292 –298 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.023 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/aa/03/main.PMC4881149.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/03/main.PMC4881149.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 67 e69 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.02.003 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e4/99/main.PMC4881150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/99/main.PMC4881150.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/15/main.PMC4881151.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 76 e81 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.001 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/14/15/main.PMC4881151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/15/main.PMC4881151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/f0/main.PMC4881152.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 254 –257 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.010 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/f6/f0/main.PMC4881152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/f0/main.PMC4881152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/eb/main.PMC4881153.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 354 –362 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.017 1319-0164 /C2112015 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/f4/eb/main.PMC4881153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/eb/main.PMC4881153.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/1d/main.PMC4881154.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 115 e124 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.11.002 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/39/1d/main.PMC4881154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/1d/main.PMC4881154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/be/main.PMC4881155.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 363 –370 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.022 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/fa/be/main.PMC4881155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/be/main.PMC4881155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC4881156.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 250 –253 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.008 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC4881156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC4881156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/c5/main.PMC4881157.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 273 –278 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.019 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bb/c5/main.PMC4881157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/c5/main.PMC4881157.pdf
The sequences were then aligned using the data from a GenBank at the NCBI ( http://www.ncbi.nlm.nih.gov ) and the most identical sequences of fungi were identiﬁed.,OADS,/arxiv_data1/oa_pdf/bb/c5/main.PMC4881157.pdf
These DNA nucleotide sequences have been identiﬁed and deposited in European Nucleotide Archive (ENA) European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena/ ) with the accession number ( Table 2 ).,OADS,/arxiv_data1/oa_pdf/bb/c5/main.PMC4881157.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/19/main.PMC4881158.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 103 e109 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.11.001 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fe/19/main.PMC4881158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/19/main.PMC4881158.pdf
Available at: http://www.who.int/ncd/vision2020_actionplan/documents/ WHO_PBL_00.77 .,Non-OADS,/arxiv_data1/oa_pdf/fe/19/main.PMC4881158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/75/main.PMC4881160.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 329 –332 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.009 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/2b/75/main.PMC4881160.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/75/main.PMC4881160.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/7e/main.PMC4881164.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 341 –347 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.014 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/65/7e/main.PMC4881164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/7e/main.PMC4881164.pdf
"http://dx.doi.org/10.1136/ bmj.39346.495880.AE .Levy, M.M.",Non-OADS,/arxiv_data1/oa_pdf/65/7e/main.PMC4881164.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 279 –285 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.020 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e2/67/main.PMC4881165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/67/main.PMC4881165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/67/main.PMC4881165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/b8/main.PMC4881174.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 258 –264 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.012 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/5d/b8/main.PMC4881174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/b8/main.PMC4881174.pdf
"J. Nanotechnol 2016, 6. http://dx.doi.org/10.1155/2016/ 3129561 .",OADS,/arxiv_data1/oa_pdf/5d/b8/main.PMC4881174.pdf
"(in press), doi:http://dx.doi.org/10.1016/j.chaos.2015.11.035 .",OADS,/arxiv_data1/oa_pdf/5d/b8/main.PMC4881174.pdf
http://dx.doi.org/ 10.1155/2014/906254 .,Non-OADS,/arxiv_data1/oa_pdf/5d/b8/main.PMC4881174.pdf
http://dx.doi.org/10.1155/2015/418106 .,Non-OADS,/arxiv_data1/oa_pdf/5d/b8/main.PMC4881174.pdf
2016.http://dx.doi.org/10.1155/2016/3216327 .,Non-OADS,/arxiv_data1/oa_pdf/5d/b8/main.PMC4881174.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/ba/main.PMC4881186.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 99 e102 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.002 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/46/ba/main.PMC4881186.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/ba/main.PMC4881186.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/main.PMC4881187.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 70 e75 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.12.001 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0b/c3/main.PMC4881187.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/c3/main.PMC4881187.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3a/c6/main.PMC4881189.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 233 –240 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.018 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3a/c6/main.PMC4881189.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3a/c6/main.PMC4881189.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/d1/main.PMC4881190.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 92 e98 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.10.007 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/96/d1/main.PMC4881190.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/d1/main.PMC4881190.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/52/main.PMC4881191.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 286 –291 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.021 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0d/52/main.PMC4881191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/52/main.PMC4881191.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/e0/main.PMC4881192.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 110 e114 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.12.002 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f9/e0/main.PMC4881192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/e0/main.PMC4881192.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 371 –378 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.026 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/db/57/main.PMC4881193.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/57/main.PMC4881193.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/57/main.PMC4881193.pdf
http://dx.doi.org/10.1371/ journal.pmed.0050218 .,Non-OADS,/arxiv_data1/oa_pdf/db/57/main.PMC4881193.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/b0/main.PMC4881198.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 129 e131 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.12.005 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6d/b0/main.PMC4881198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/b0/main.PMC4881198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/b7/main.PMC4881199.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 333 –336 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.011 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/12/b7/main.PMC4881199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/b7/main.PMC4881199.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/cc/main.PMC4881216.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 32 e36 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.003 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/dc/cc/main.PMC4881216.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/cc/main.PMC4881216.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/44/main.PMC4881217.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 245 –249 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.006 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b9/44/main.PMC4881217.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/44/main.PMC4881217.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/a8/main.PMC4881218.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 43 e45 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.11.004 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/29/a8/main.PMC4881218.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/a8/main.PMC4881218.pdf
Available from: http://www.amar.org.ir/Default.aspx?tabid ¼1604 .,Non-OADS,/arxiv_data1/oa_pdf/29/a8/main.PMC4881218.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/main.PMC4881219.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 21 e26 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.009 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5d/a0/main.PMC4881219.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/main.PMC4881219.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/ef/main.PMC4881220.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 5 e11 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.008 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/43/ef/main.PMC4881220.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/ef/main.PMC4881220.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/34/main.PMC4881222.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 12 e16 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.02.001 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1f/34/main.PMC4881222.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/34/main.PMC4881222.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/main.PMC4881223.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 46 e47 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.02.004 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5f/a1/main.PMC4881223.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/main.PMC4881223.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 3 e4 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.03.006 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f5/a0/main.PMC4881224.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/a0/main.PMC4881224.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/a0/main.PMC4881225.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 125 e128 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.11.005 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8f/a0/main.PMC4881225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/a0/main.PMC4881225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/25/main.PMC4881226.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 318 –321 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.004 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3d/25/main.PMC4881226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/25/main.PMC4881226.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/7a/main.PMC4881227.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 48 e51 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.12.004 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9b/7a/main.PMC4881227.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/7a/main.PMC4881227.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/eb/main.PMC4881228.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 132 e135 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.11.003 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c9/eb/main.PMC4881228.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/eb/main.PMC4881228.pdf
2014 Aug 13 http://dx.doi.org/ 10.14496/dia.4104640117.16 .,Non-OADS,/arxiv_data1/oa_pdf/c9/eb/main.PMC4881228.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/79/main.PMC4881229.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 37 e42 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.007 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b0/79/main.PMC4881229.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/79/main.PMC4881229.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/37/main.PMC4881230.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 27 e31 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.004 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/92/37/main.PMC4881230.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/37/main.PMC4881230.pdf
2012;2012: 832070. http://dx.doi.org/10.1155/2012/832070 .,Non-OADS,/arxiv_data1/oa_pdf/92/37/main.PMC4881230.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/85/main.PMC4881232.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 337 –340 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.013 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/b6/85/main.PMC4881232.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/85/main.PMC4881232.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/04/main.PMC4881233.pdf
"Peer review under responsibility of the Iranian Society of Ophthalmology HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 82 e86 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.11.007 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a0/04/main.PMC4881233.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/04/main.PMC4881233.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/af/main.PMC4881235.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 322 –328 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.007 1319-0164 /C2112016 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/25/af/main.PMC4881235.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/af/main.PMC4881235.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/main.PMC4881236.pdf
"With 34 Helicobacter species now formally named according to LPSN (http://www.bacterio.net/h/helicobacter.html), it is clear that*Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/fa/7f/main.PMC4881236.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 265 –272 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.015 1319-0164 /C2112015 Production and Hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/fa/7f/main.PMC4881236.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/main.PMC4881236.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 1 e2 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.006 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/main.PMC4881237.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/04/main.PMC4881237.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/cd/main.PMC4881238.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 17 e20 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.01.005 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/64/cd/main.PMC4881238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/cd/main.PMC4881238.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/0f/main.PMC4881241.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 27 (2015) 87 e91 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2015.11.006 2452-2325/Copyright ©2015, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9f/0f/main.PMC4881241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/0f/main.PMC4881241.pdf
" Case Rep Oncol  2016;9:280 –284  DOI: 10.1159/000446066   Published online: April 29, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/16/0091‒0280$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/81/28/cro-0009-0280.PMC4881242.pdf
" Case Rep Oncol  2016;9:255 –261  DOI: 10.1159/000445940   Published online: April 27, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/16/0091‒0255$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/0c/b2/cro-0009-0255.PMC4881243.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: April 30, 2016 EXTRA  Benedicte Sørensen Strøm   Center for Diakonia and Professional Practice, VID Specialized University    PO Box 184 Vinderen   NO–0319 Oslo (Norway)   E-Mail benedicte.strom   @   vid.no www.karger.com/dee DOI: 10.1159/000444789  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/54/da/dee-0006-0150.PMC4881245.pdf
" Case Rep Oncol  2016;9:267 –272  DOI: 10.1159/000445498   Published online: April 29, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/16/0091‒0267$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/56/c3/cro-0009-0267.PMC4881246.pdf
" Case Rep Oncol 2 016;9:246 –248  DOI: 10.1159/000446064   Published online: April 23, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0246$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/d7/0b/cro-0009-0246.PMC4881250.pdf
" Case Rep Neurol 2016;8:87 –91  DOI: 10.1159/000445869   Published online: April 30, 2016  © 2016 The Author(s)   Published by S. Karger AG, B asel  1662‒680X/16/0081‒0087$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/a9/71/crn-0008-0087.PMC4881252.pdf
" Case Rep Ophthalmol 2016;7:191 –194  DOI: 10.1159/000445285   Published online: April 2, 2016  © 2016 The Author(s)   Published by S.  Karger AG, Basel   1663‒2699/16/007 1‒0191$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/a8/e7/cop-0007-0191.PMC4881253.pdf
" Case Rep Neurol  2016;8:97 –101  DOI: 10.1159/000446106   Published online: April 28, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒680X/16/0081‒0097$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/83/62/crn-0008-0097.PMC4881256.pdf
" Case Rep Oncol  2016;9:249 –254  DOI: 10.1159/000446107   Published online: April 26, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/16/0091‒0249$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/17/aa/cro-0009-0249.PMC4881273.pdf
"Anal Carcinom a  (Version 1, 2016), http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.",Non-OADS,/arxiv_data1/oa_pdf/17/aa/cro-0009-0249.PMC4881273.pdf
"Rectal Cancer  (Version 1, 2016), http://www.nccn.org/professionals/physician_gls/f_ guidelines.asp.",Non-OADS,/arxiv_data1/oa_pdf/17/aa/cro-0009-0249.PMC4881273.pdf
" Case Rep Oncol 2016;9:262 –266  DOI: 10.1159/000446065   Published online: April 27, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0262$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/0b/24/cro-0009-0262.PMC4881275.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016www.nature.com/npjpcrm Published in partnership with Primary Care Respiratory Society UK",Non-OADS,/arxiv_data1/oa_pdf/2d/19/npjpcrm201629.PMC4881283.pdf
"), jaenisch@wi.mit.edu (R.J.) http://dx.doi.org/10.1016/j.stemcr.2015.10.011 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/6a/5a/main.PMC4881284.pdf
"Bru¨stle also gave an update on the StemCell- Factory project, an automated platform for parallelizedindustrial-scale cell reprogramming and neural differentia-tion ( http://www.stemcellfactory.de/ ).",OADS,/arxiv_data1/oa_pdf/6a/5a/main.PMC4881284.pdf
"He solicited feedback on NIMH priorities for advancing the ﬁeld, which involve in- vestigators working together to: (1) implement centralizedsharing of patient and reference cell lines with geneticand clinical data, such as through the NIMH Repositoryand Genomics Resource ( https://www.nimhgenetics.org/ ); (2) arrive at common cell-line quality control methodsand standards for validating hiPSCs and differentiatedcell types; (3) keep improving hiPSC-based technology, including developing easier and quicker targeting methods, optimizing the ﬁdelity of ‘‘in vivo’’surrogate assays like chi-meras and organoids, improving assay miniaturization, andscaling up to increase the number of individuals who can becontrasted by these strategies; (4) focus on robustness andreproducibility, which can include studying genetic vari-ants of large effect from fully characterized patients andmaintaining consistency and transparency in protocols/ samples across labs; and (5) remain mindful of the criticalvalue of collaboration and training and supporting the rapid dissemination of best practices ( Panchision, 2013 ).",Non-OADS,/arxiv_data1/oa_pdf/6a/5a/main.PMC4881284.pdf
); the North Rhine WestphalianMinistry of Innovation through grant 1403ts007e (StemCellFactory; http://www.stemcellfactory.de ) (O.B.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/main.PMC4881284.pdf
(Available from: http://www.unaids.org/sites/default/ﬁles/media_asset/ UNAIDS_Gap_report_en.pdf) [17 Aug 2015].,OADS,/arxiv_data1/oa_pdf/43/83/TMI-21-479.PMC4881304.pdf
(Available from: http://www.who.int/hiv/pub/guidelines/ 9789241595568_en.pdf) [25 May 2015].,Non-OADS,/arxiv_data1/oa_pdf/43/83/TMI-21-479.PMC4881304.pdf
(Available from: http://www.unaids.org/sites/default/ﬁles/en/media/unaids/con- tentassets/documents/epidemiology/2013/gr2013/UNAIDS_- Global_Report_2013_en.pdf) [4 Jun 2015].,Non-OADS,/arxiv_data1/oa_pdf/43/83/TMI-21-479.PMC4881304.pdf
(Available from: http://www.who.int/healthsystems/TTR-TaskShifting.pdf) [25 May 2015].42.,Non-OADS,/arxiv_data1/oa_pdf/43/83/TMI-21-479.PMC4881304.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/e6/22/ceo-2015-00955.PMC4881314.pdf
"2: 123- 130, June 2016 http://dx.doi.org/10.21053/ceo.2015.00955 Original Article INTRODUCTION The prevalence of age-related hearing loss (ARHL) gradually in - creases as the general population ages.",Non-OADS,/arxiv_data1/oa_pdf/e6/22/ceo-2015-00955.PMC4881314.pdf
Avail - able from: http://health.mw.go.kr/HealthPromotionArea/HealthIn - fo/View.do?idx=5800&subIdx=4&searchCate=&searchT ype=&sear chKey=&pageNo=1.,OADS,/arxiv_data1/oa_pdf/e6/22/ceo-2015-00955.PMC4881314.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/e8/e2/ceo-2015-00626.PMC4881315.pdf
"2: 116- 122, June 2016 http://dx.doi.org/10.21053/ceo.2015.00626 Original Article INTRODUCTION Eustachian tube (ET) dysfunction is most common in children  and almost 40% of children under 10 years of age experience  temporary ET dysfunction [1].",Non-OADS,/arxiv_data1/oa_pdf/e8/e2/ceo-2015-00626.PMC4881315.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/87/44/ceo-2015-00542.PMC4881316.pdf
"2: 98- 103, June 2016 http://dx.doi.org/10.21053/ceo.2015.00542  Original Article INTRODUCTION Despite the increasing number of research concerning the appli - cations of the Laser Doppler Vibrometry (LDV) in medicine, its  usefulness is still under discussion.",Non-OADS,/arxiv_data1/oa_pdf/87/44/ceo-2015-00542.PMC4881316.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/5b/14/ceo-2014-01851.PMC4881317.pdf
"2: 89- 97, June 2016 http://dx.doi.org/10.21053/ceo.2014.01851  Review Article INTRODUCTION Peritonsillar abscesses (PTAs), formed in the potential space be - tween the tonsillar capsule and superior constrictor muscle, are  a complication of acute tonsillitis and the most common deep  infection of the head and neck.",Non-OADS,/arxiv_data1/oa_pdf/5b/14/ceo-2014-01851.PMC4881317.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/7f/e0/ceo-2015-00087.PMC4881318.pdf
"2: 163- 167, June 2016 http://dx.doi.org/10.21053/ceo.2015.00087  Original Article INTRODUCTION Stenosis developing in the upper respiratory tract due to various  causes may further lead to obstructive sleep apnea, increased pulmonary artery pressure and right ventricular failure.",Non-OADS,/arxiv_data1/oa_pdf/7f/e0/ceo-2015-00087.PMC4881318.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/44/6e/ceo-2015-00591.PMC4881319.pdf
"2: 143- 149, June 2016 http://dx.doi.org/10.21053/ceo.2015.00591  Original Article INTRODUCTION Endoscopic sinus surgery (ESS) has become a widely accepted  procedure for the treatment of medically refractory chronic rhi - nosinusitis (CRS) and nasal polyps [1].",Non-OADS,/arxiv_data1/oa_pdf/44/6e/ceo-2015-00591.PMC4881319.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/99/ba/ceo-2015-00416.PMC4881320.pdf
"2: 131- 135, June 2016 http://dx.doi.org/10.21053/ceo.2015.00416  Original Article INTRODUCTION Epistaxis is one of the most common otorhinolaryngologic emer - gencies representing more than 12% of conditions managed at  Ear, Nose and Throat (ENT) Emergency Consulting Room (ECR) of our Otorhinolaryngologic Unit each year.",Non-OADS,/arxiv_data1/oa_pdf/99/ba/ceo-2015-00416.PMC4881320.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence To the editor: We have taken great interest in the recently published article  entitled “Five-Year Subjective Outcomes of Obstructive Sleep  Apnea Surgery: A Multi-Institutional Study’’ by Choi et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/4e/ceo-2015-02005.PMC4881321.pdf
"2: 182- 182, June 2016 http://dx.doi.org/10.21053/ceo.2015.02005  pISSN 1976-8710   eISSN 2005-0720",Non-OADS,/arxiv_data1/oa_pdf/e1/4e/ceo-2015-02005.PMC4881321.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/cd/a1/ceo-2015-00129.PMC4881322.pdf
"2: 104- 108, June 2016 http://dx.doi.org/10.21053/ceo.2015.00129 Original Article INTRODUCTION Otitis media with effusion (OME), also known as secretory oti - tis, is a childhood disease that has become increasingly more  common in the last decade.",Non-OADS,/arxiv_data1/oa_pdf/cd/a1/ceo-2015-00129.PMC4881322.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/ca/97/ceo-2015-00199.PMC4881323.pdf
"2: 157- 162, June 2016 http://dx.doi.org/10.21053/ceo.2015.00199  Original Article INTRODUCTION Recently, thyroidectomies are being performed more frequently  and the importance of managing and treating vocal changes af - ter thyroidectomy are being emphasized due to an increasing  trend in the incidence of thyroid diseases.",Non-OADS,/arxiv_data1/oa_pdf/ca/97/ceo-2015-00199.PMC4881323.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/ef/db/ceo-2015-00409.PMC4881324.pdf
"2: 168- 172, June 2016 http://dx.doi.org/10.21053/ceo.2015.00409 Original Article INTRODUCTION Pediatric laryngopharyngeal reflux (LPR) is a common pediatric  disorder that has gained increasing recognition over the past few  years.",Non-OADS,/arxiv_data1/oa_pdf/ef/db/ceo-2015-00409.PMC4881324.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/1f/f8/ceo-2015-00584.PMC4881325.pdf
"2: 136- 142, June 2016 http://dx.doi.org/10.21053/ceo.2015.00584Letter Original Article INTRODUCTION Sleep disordered breathing (SDB) is common in children, affect - ing approximately 11%–40% of the pediatric population [1].",Non-OADS,/arxiv_data1/oa_pdf/1f/f8/ceo-2015-00584.PMC4881325.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/2d/ceo-2014-01543.PMC4881326.pdf
"2: 178- 181, June 2016 http://dx.doi.org/10.21053/ceo.2014.01543  CASE REPORT INTRODUCTION Spontaneous retropharyngeal and mediastinal emphysema (SRE  and SME) are rare clinical entities where free air is present with - in the confines of retropharyngeal space and mediastinum re - spectively, without apparent cause.",Non-OADS,/arxiv_data1/oa_pdf/40/2d/ceo-2014-01543.PMC4881326.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/99/e4/ceo-2014-02012.PMC4881327.pdf
"2: 109- 115, June 2016 http://dx.doi.org/10.21053/ceo.2014.02012 Original Article INTRODUCTION The semicircular canals which perceive the head rotation and an - gular acceleration sit deeply in the petrous temporal bone.",Non-OADS,/arxiv_data1/oa_pdf/99/e4/ceo-2014-02012.PMC4881327.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/5b/28/ceo-2015-00073.PMC4881328.pdf
"2: 173- 177, June 2016 http://dx.doi.org/10.21053/ceo.2015.00073  Original Article INTRODUCTION Neck dissection (ND) as a therapeutic or elective intention is  one of the most commonly used surgical procedures in the treat - ment of various head and neck cancers.",Non-OADS,/arxiv_data1/oa_pdf/5b/28/ceo-2015-00073.PMC4881328.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/23/0f/ceo-2015-01053.PMC4881329.pdf
"2: 150- 156, June 2016 http://dx.doi.org/10.21053/ceo.2015.01053 Original Article INTRODUCTION Chronic rhinosinusitis (CRS) is a disease characterized by muco - sal inflammation affecting the nasal cavity and paranasal sinus - es.",Non-OADS,/arxiv_data1/oa_pdf/23/0f/ceo-2015-01053.PMC4881329.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence We appreciate your interest in our recently published study en - titled “Five-Year Subjective Outcomes of Obstructive Sleep Ap - nea Surgery: A Multi-Institutional Study” [1].",Non-OADS,/arxiv_data1/oa_pdf/31/78/ceo-2016-00311.PMC4881330.pdf
"2: 183- 184, June 2016 http://dx.doi.org/10.21053/ceo.2016.00311 pISSN 1976-8710   eISSN 2005-0720",Non-OADS,/arxiv_data1/oa_pdf/31/78/ceo-2016-00311.PMC4881330.pdf
Available from: http://www.elso.org/ Portals/0/IGD/Archive/FileManager/970009 63d6cusersshyerdocumentselsoguidelines   fortrainingandcontinuingeducationofecmospecialists.,Non-OADS,/arxiv_data1/oa_pdf/b1/de/ACA-18-185.PMC4881651.pdf
Available from: http://www.ihi.org/resources/Pages/ IHIWhitePapers/GoingLeaninHealthCare.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e0/14/ACA-18-464.PMC4881659.pdf
Available from: http://www.ihi.org/resources/Pages/ IHIWhitePapers/AFrameworkforSpreadWhitePaper.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e0/14/ACA-18-464.PMC4881659.pdf
Available  from: http://www.ihi.org.,Non-OADS,/arxiv_data1/oa_pdf/e0/14/ACA-18-464.PMC4881659.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC29027.,Non-OADS,/arxiv_data1/oa_pdf/08/d9/ACA-18-575.PMC4881662.pdf
Available from: http://www.abiomed.com/ assets/HCS‑PM00522‑rA_Product‑Page.pdf.,OADS,/arxiv_data1/oa_pdf/56/4a/ACA-18-467.PMC4881681.pdf
Web Site (https://www.nhlbi.nih.gov/ health-pro/guidelines/current/asthma-guidelines/full- report).,Non-OADS,/arxiv_data1/oa_pdf/2e/91/ACA-18-479.PMC4881686.pdf
"Z score was calculated for individual patient using  WHO Anthro software version 3.2.2, January 2011,  (World Health Organization, Geneva, Switzerland)  available from http://www.who.int/childgrowth/en.",Non-OADS,/arxiv_data1/oa_pdf/80/35/ACA-18-367.PMC4881691.pdf
Available from:  http://www.newsroom.accenture.com/news/ despite- increased-use-of-electronic-medical-records-fewer- usdoctors-believe-it-improves-health-outcomes-accenture- survey-shows.htm.,Non-OADS,/arxiv_data1/oa_pdf/66/6e/ACA-18-290.PMC4881700.pdf
Available from: http://www.imedicalapps.,Non-OADS,/arxiv_data1/oa_pdf/66/6e/ACA-18-290.PMC4881700.pdf
Available from: http://www.healthcareitnews.com/ news/ehr -vendors -extending -platforms -apps -apis.,OADS,/arxiv_data1/oa_pdf/66/6e/ACA-18-290.PMC4881700.pdf
The articles can be submitted either  on jow Link http://www.journalonweb.com/aca.,Non-OADS,/arxiv_data1/oa_pdf/1f/0c/ACA-18-416.PMC4881704.pdf
"Also find us on Social Media on T witter: https://twitter.com/ ACA, Linkedin: www.linkedin.com /ACA and Facebook: https://www.facebook.com/ACA.",Non-OADS,/arxiv_data1/oa_pdf/1f/0c/ACA-18-416.PMC4881704.pdf
Log on to http://blog.annals.in from more on interesting images – Heart to Heart blog.,Non-OADS,/arxiv_data1/oa_pdf/1f/0c/ACA-18-416.PMC4881704.pdf
The articles can be submitted either  on jow Link http://www.journalonweb.com/aca.,Non-OADS,/arxiv_data1/oa_pdf/34/4b/ACA-18-445.PMC4881708.pdf
"Also find us on Social Media on T witter: https://twitter.com/ ACA, Linkedin: www.linkedin.com /ACA and Facebook: https://www.facebook.com/ACA.",Non-OADS,/arxiv_data1/oa_pdf/34/4b/ACA-18-445.PMC4881708.pdf
Log on to http://blog.annals.in from more on interesting images – Heart to Heart blog.,Non-OADS,/arxiv_data1/oa_pdf/34/4b/ACA-18-445.PMC4881708.pdf
The articles can be submitted either  on jow Link http://www.journalonweb.com/aca.,Non-OADS,/arxiv_data1/oa_pdf/45/17/ACA-18-343.PMC4881710.pdf
"Also find us on Social Media on T witter: https://twitter.com/ ACA, Linkedin: www.linkedin.com /ACA and Facebook: https://www.facebook.com/ACA.",Non-OADS,/arxiv_data1/oa_pdf/45/17/ACA-18-343.PMC4881710.pdf
Log on to http://blog.annals.in from more on interesting images – Heart to Heart blog.,Non-OADS,/arxiv_data1/oa_pdf/45/17/ACA-18-343.PMC4881710.pdf
2. http://www.ama-assn.org/ama/pub/physician-resources/ medicalethics/code-medical-ethics/opinion9124.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/ACA-18-283.PMC4881718.pdf
http://www.fsmb.org/ pdf/pub-social-media-guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/ACA-18-283.PMC4881718.pdf
4. https://www.wsma.org/Media/Legal-pdfs/Social_media_ WSMA%20 Statement_20130821.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/ACA-18-283.PMC4881718.pdf
The articles can be submitted either  on jow Link http://www.journalonweb.com/aca.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/ACA-18-283.PMC4881718.pdf
"Also find us on Social Media on T witter: https://twitter.com/ ACA, Linkedin: www.linkedin.com /ACA and Facebook: https://www.facebook.com/ACA.",Non-OADS,/arxiv_data1/oa_pdf/45/b8/ACA-18-283.PMC4881718.pdf
Log on to http://blog.annals.in from more on interesting images – Heart to Heart blog.,Non-OADS,/arxiv_data1/oa_pdf/45/b8/ACA-18-283.PMC4881718.pdf
Ramsay Sedation Scale: Available from: http://www.frca.,Non-OADS,/arxiv_data1/oa_pdf/c3/0c/ACA-18-306.PMC4881724.pdf
Available at:http://www.ema.europa.eu/ema/index.jsp?curl =pages/medicines/ human/medicines/002202/human_med_001433.jsp&mid = WC0b01ac058001d124 .,Non-OADS,/arxiv_data1/oa_pdf/a3/b9/cad-27-560.PMC4881728.pdf
Available at: https://www.pharma.us.novartis.com/product/pi/pdf/afinitor.,Non-OADS,/arxiv_data1/oa_pdf/84/6a/cad-27-475.PMC4881730.pdf
Available at: http://www.pfizerpro.com/content/showlabeling.asp?id =490.,Non-OADS,/arxiv_data1/oa_pdf/84/6a/cad-27-475.PMC4881730.pdf
Available at: https://www.clinicaltrials.gov/ct2/ show/NCT01033721?term =palomid&rank =2.,Non-OADS,/arxiv_data1/oa_pdf/84/6a/cad-27-475.PMC4881730.pdf
Available at: https://www.clinicaltrials.gov/ct2/show/ NCT01271270?term =palomid&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/84/6a/cad-27-475.PMC4881730.pdf
Available at: http://globenewswire.com/news-release/2015/01/ 28/700603/10117109/en/RestorGenex-Granted-Orphan-Drug- Designation-for-RES-529-for-Treatment-of-Glioblastoma-Multiforme.html .,Non-OADS,/arxiv_data1/oa_pdf/84/6a/cad-27-475.PMC4881730.pdf
Available at: http://www.nccn.org/professionals/ physician_gls/pdf/cns.pdf .,Non-OADS,/arxiv_data1/oa_pdf/84/6a/cad-27-475.PMC4881730.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/d6/ott-9-2865.PMC4881731.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2865–2871OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2865Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10346 0 mir-486-5p attenuates tumor growth and  lymphangiogenesis by targeting neuropilin-2 in  colorectal carcinoma chengxia liu Ming li Yingbin hu ning shi haisheng Yu haiyan liu haifeng lian Department of gastroenterology,   the affiliated hospital of Binzhou  Medical University, Binzhou, shandong  Province, People’s republic of chinaAbstract:  Increasing evidence suggests that microRNAs are associated with many important  biologic processes in carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/d0/d6/ott-9-2865.PMC4881731.pdf
"Conversely, miR-486-5p correspondence: haifeng lian Department of gastroenterology, the  Affiliated Hospital of Binzhou Medical  University, 661 huanghe 2nd road,  Binzhou, shandong, 256603, People’s  republic of china Tel +86 151 6609 8756 email lianhaifeng01@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: miR-486-5p targeting NRP2 in colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S103460",Non-OADS,/arxiv_data1/oa_pdf/d0/d6/ott-9-2865.PMC4881731.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d0/d6/ott-9-2865.PMC4881731.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/d6/ott-9-2865.PMC4881731.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/59/ott-9-2987.PMC4881732.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2987–2992OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2987Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10094 9association between cooking oil fume exposure  and lung cancer among chinese nonsmoking  women: a meta-analysis Yingbo Xue Ying Jiang shan Jin Y ong li Department of Oncology, guizhou  Provincial People’s hospital, guiyang,   guizhou, People’s republic of chinaAbstract:  Lung cancer has been the main cause of cancer death around the world.",Non-OADS,/arxiv_data1/oa_pdf/c1/59/ott-9-2987.PMC4881732.pdf
"Lung cancer susceptibilities of population differ in the same envi - ronment due to genetic susceptibility.12 MicroRNAs play an important role in some correspondence: Yingbo Xue Department of Oncology, guizhou  People’s hospital, no 83 Zhongshan  east road, guiyang, guizhou 550002,  People’s republic of china Tel +86 851 8560 1796 email xueyingbo0619@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xue et al Running head recto: Association of cooking oil fume exposure with lung cancer DOI: http://dx.doi.org/10.2147/OTT.S100949",Non-OADS,/arxiv_data1/oa_pdf/c1/59/ott-9-2987.PMC4881732.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c1/59/ott-9-2987.PMC4881732.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/59/ott-9-2987.PMC4881732.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/0a/ott-9-2993.PMC4881733.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2993–2999OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2993Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10491 9Prognostic value of the standardized uptake  value maximum change calculated by dual-time- point 18F-fluorodeoxyglucose positron emission  tomography imaging in patients with advanced  non-small-cell lung cancer Feng Jin1,2 hui Zhu2 Zheng Fu3 li Kong2 Jinming Yu2 1school of Medicine and life sciences,   University of Jinan- shandong academy  of Medical sciences, 2Department of  radiation Oncology, shandong cancer  hospital affiliated to shandong  University, shandong academy of  Medical sciences, 3Department of  nuclear Medicine, shandong cancer  hospital affiliated to shandong  University, shandong academy of  Medical sciences, Jinan, People’s  republic of chinaPurpose:  The purpose of this study was to investigate the prognostic value of the standardized  uptake value maximum (SUVmax) change calculated by dual-time-point 18F-fluorodeoxyglucose  positron emission tomography (PET) imaging in patients with advanced non-small-cell lung  cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/f1/0a/ott-9-2993.PMC4881733.pdf
"Moreover, despite the careful evaluation of clinical prognostic factors, correspondence: Jinming Yu Department of radiation Oncology,  Shandong Cancer Hospital Affiliated to  shandong University, shandong academy  of Medical sciences, no 440 Jiyan road,  Jinan, shandong Province, 250117,  People’s republic of china Tel +86 531 8798 4729 Fax +86 531 8798 4079 email sdyujinming@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jin et al Running head recto: Prognostic value of the SUVmax change in advanced NSCLC DOI: http://dx.doi.org/10.2147/OTT.S104919",Non-OADS,/arxiv_data1/oa_pdf/f1/0a/ott-9-2993.PMC4881733.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f1/0a/ott-9-2993.PMC4881733.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/0a/ott-9-2993.PMC4881733.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/ad/ott-9-2961.PMC4881734.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2961–2973OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2961Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9634 1non-small-cell lung cancer cells combat epidermal  growth factor receptor tyrosine kinase inhibition  through immediate adhesion-related responses hsian-Yu Wang1,2 Min-Kung hsu3,4 Kai-hsuan Wang1 ching-Ping Tseng2,4 Feng-chi chen3,4 John T -a hsu1,4 1institute of Biotechnology and  Pharmaceutical research, national  health research institutes (nhri),   Zhunan, Miaoli county, 2institute  of Molecular Medicine and  Bioengineering, national chiao Tung  University (ncTU), hsinchu, 3Division  of Biostatistics and Bioinformatics,   institute of Population health  sciences, national health research  institutes (nhri), Zhunan, Miaoli  county, 4Department of Biological  science and Technology, national  chiao T ung University (ncTU),   hsinchu, Taiwan, republic of chinaBackground:  Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs),  such as gefitinib, erlotinib, and afatinib, have greatly improved treatment efficacy in non-small  cell lung cancer (NSCLC) patients with drug-sensitive EGFR mutations.",Non-OADS,/arxiv_data1/oa_pdf/17/ad/ott-9-2961.PMC4881734.pdf
"Targeted therapeutics, such as the tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib,  and afatinib, have become the first-line treatment for non-small-cell lung cancer  (NSCLC) patients with specific epidermal growth factor receptor (EGFR) mutations,  such as exon 19 deletion or an exon 21 substitution (L858R).1 Despite the successful  use of EGFR TKIs in the treatment of patients harboring specific EGFR mutations,  all responding patients eventually develop resistance to EGFR TKIs after a period of  treatment.2,3 In previous studies, .20 different nodes in distinct signaling pathways  were reported as mechanisms for combating resistance to EGFR-targeted therapies.4 correspondence: John T-a hsu institute of Biotechnology and  Pharmaceutical research, national health  research institutes (nhri), no 35,  Keyan road, Zhunan, Miaoli county 350,  Taiwan, republic of china email tsuanhsu@nhri.org.t w Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: NSCLC cells combat EGFR tyrosine kinase inhibition DOI: http://dx.doi.org/10.2147/OTT.S96341",Non-OADS,/arxiv_data1/oa_pdf/17/ad/ott-9-2961.PMC4881734.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/17/ad/ott-9-2961.PMC4881734.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/ad/ott-9-2961.PMC4881734.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2975–2986OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2975Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9512 9integrated mirna–risk gene–pathway pair  network analysis provides prognostic biomarkers  for gastric cancer hui cai1 Jiping Xu2 Yifang han3 Zhengmao lu1 Ting han1 Yibo Ding4 liye Ma1 1Department of general surgery,   changhai hospital, second  Military Medical University,   shanghai, 2Department of Medical  administration, changhai hospital,   second Military Medical University,   shanghai, 3Department of  epidemiology, research institute  for Medicine of nanjing command,   nanjing, 4Department of epidemiology,   changhai hospital, second Military  Medical University, shanghai, People’s  republic of chinaPurpose:  This study aimed to identify molecular prognostic biomarkers for gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
"Recently, several studies have been performed to investigate  prognostic biomarkers for gastric cancer and their prognostic effects.4,5 For example,  overexpression of stomatin-like protein 2 is reported to be associated with invasion  depth, tumor node metastasis stage, as well as lymph node and distant metastases,  leading to poor prognosis in gastric cancer.6 Notch-1 has also been proven to be correspondence: liye Ma Department of general surgery,  changhai hospital, second Military  Medical University, 800 Xiangyin road,  shanghai 200433, People’s republic  of china Tel/fax +86 021 3116 1591 email majdhjasdh7868dsa@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cai et al Running head recto: Molecular prognostic biomarkers for gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S95129",Non-OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
Methods mRNA and miRNA expression profiles The mRNA microarray profiles of human gastric cancer  samples were retrieved from Gene Expression Omnibus  (GEO; http://www.ncbi.nlm.nih.gov/ge o).,OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
"Potential gastric cancer-related genes The targets of the DEmiRs were first identified from the fol - lowing four databases: PicTar ( http://pictar.mdc-berlin.de /),  TargetScan ( http://www.targetscan.org /), PITA ( http://genie.",Non-OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
"weizmann.ac.il/pubs/mir07/mir07_data.htm l), and miRanda  (http://www.microrna.org/microrna/getDownloads.d o).",OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
Pathway expression profile The Kyoto Encyclopedia of Genes and Genomes (KEGG;  http://www.genome.jp/kegg/pathway.ht m) is a database for  the functional analysis of genes.,OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/59/ott-9-2975.PMC4881735.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/b6/78/mtna201527a.PMC4881755.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/23/92/mtna201528a.PMC4881756.pdf
"Briefly, 3  × 10 5 cells (per tube), washed once with  wash buffer, were fixed for 20 minutes on ice, washed twice with Perm/Wash Buffer, and then stained with primary anti- body (specificity: IRF-1 (Clone C-20; Santa Cruz Biotechnol- ogy; ab26109, http://www.abcam.com) or rabbit IgG control (Jackson ImmunoResearch Laboratories, West Grove, PA)).",Non-OADS,/arxiv_data1/oa_pdf/3b/c2/mtna201529a.PMC4881757.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/3b/c2/mtna201529a.PMC4881757.pdf
"The optimized parameters, detailed in the configuration files (http://dx.doi.org/10.5061/dryad.fs4cp), were used to obtain the raw distribution of reads in the ref-erences for the experimental and control samples (Supple-mentary Table S5).",OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
"The reference sequences of the rAAV  genome, vector plasmid backbone, helper plasmid and ade- novirus 5 (Ad5) sequence are available in fasta format and  annotated GenBank format from the Dryad Digital Reposi-tory: http://dx.doi.org/10.5061/dryad.fs4cp.",OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
The open source code for the software is freely available with its documentation at https://github.com/a-slide/fastq_control_sampler.,Non-OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
The Fastq  and raw output files are available from the Dryad Digital  Repository: http://dx.doi.org/10.5061/dryad.fs4cp.,OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
"The pro-gram is still under active development, but the version used for the analyses performed in this study (v0.2) is freely avail-able with extensive user and developer documentation at  https://github.com/a-slide/ContaVect/tree/v0.2.",OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
"The vector graphics pictures were postprocessed with Inkscape 0.48 (https://inkscape.org) for aesthetic pur-poses (alignment, legends, fonts, etc.).",Non-OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
Raw tables contain- ing the data are provided directly in the manuscript (Figure 2)  or are available at the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.fs4cp (Figures 3–5).,Non-OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/ VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM319573.pdf.,Non-OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
http://www.google.com/patents/US20130023034.,Non-OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/de/bd/mtna201532a.PMC4881760.pdf
"74 The  reduction of TfR1 in the hippocampus is also thought to be  protective against oxidative stress in AD.75 GAPVD1, also  known as RAP6, is a regulator of endocytosis76 and regu- lates Glut4 trafficking mainly in adipocytes.77 Although the  role of GAPVD1 in the brain is unknown, profiling studies suggest the GAPVD1 mRNA is upregulated in AD patients  (NextBio databank: http://www.nextbio.com).",Non-OADS,/arxiv_data1/oa_pdf/ba/70/mtna201533a.PMC4881761.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/ba/70/mtna201533a.PMC4881761.pdf
http://dx.doi.org/10.1016/j.atg.2013.07.002 Contents lists available at ScienceDirect Applied & Translational Genomics journal homepage: www.elsevier.com/locate/atg,OADS,/arxiv_data1/oa_pdf/95/ca/main.PMC4881763.pdf
The power of the present study was found to be N80% as analyzed by power genetic association analysis software (http://dceg.cancer.gov/bb/tools/pga ) at the level of signiﬁ cance α= 0.05 with sample size of 750 in HNSCC and 750 in controls.,OADS,/arxiv_data1/oa_pdf/95/ca/main.PMC4881763.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/53/70/mt201612a.PMC4881765.pdf
Western blots were quantified using the Image J software package  (http://imagej.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/41/d1/mt201613a.PMC4881766.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/41/d1/mt201613a.PMC4881766.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/   by-nc-sa/4.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/01/ea/mt201639a.PMC4881773.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/   by-nc-sa/4.0/ 936 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/mt201642a.PMC4881775.pdf
"Official journal of the American Society of Gene & Cell TherapySSRP1 in Hepatocellular Carcinoma from the NCI website (http://dtp.nci.nih.gov), where the -logGI50  of thousands small molecules and natural products, as well as  mRNA expression microarray data were available for 58 human  tumor cell lines.",OADS,/arxiv_data1/oa_pdf/9e/ff/mt20169a.PMC4881782.pdf
JAV A program for GSEA (http://www.broadinstitute.org/gsea)13   was used to analyze the potential genes influenced by SSRP1 low expres- sion.,OADS,/arxiv_data1/oa_pdf/9e/ff/mt20169a.PMC4881782.pdf
"The mutation counts and fraction of copy number  altered genome data for each TCGA hepatocellular carcinoma individuals  were directly downloaded from the cBioPortal for Cancer Genomics (http:// cbioportal.org).14,15 The logGI50 of small molecules and natural products,  and the mRNA expression microarray data of human tumor cell lines were downloaded from the NCI website (http://dtp.nci.nih.gov).",OADS,/arxiv_data1/oa_pdf/9e/ff/mt20169a.PMC4881782.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ 914 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/9e/ff/mt20169a.PMC4881782.pdf
http://dx.doi.org/10.1016/j.atg.2013.07.002 Contents lists available at ScienceDirect Applied & Translational Genomics journal homepage: www.elsevier.com/locate/atg,OADS,/arxiv_data1/oa_pdf/bd/7e/main.PMC4881805.pdf
The power of the present study was found to be N80% as analyzed by power genetic association analysis software (http://dceg.cancer.gov/bb/tools/pga ) at the level of signiﬁ cance α= 0.05 with sample size of 750 in HNSCC and 750 in controls.,OADS,/arxiv_data1/oa_pdf/bd/7e/main.PMC4881805.pdf
http://dx.doi.org/10.1016/j.atg.2013.10.001 Contents lists available at ScienceDirect Applied & Translational Genomics journal homepage: www.elsevier.com/locate/atg,OADS,/arxiv_data1/oa_pdf/6e/f2/main.PMC4881820.pdf
"Whole genome sequence of different Bacillus ,Exiguobacterium and Pseudomonas genera ( http://www.ncbi.nlm.nih.gov/genome )a l l o w e d for the designing of primers in the region ﬂanking dnaK gene.",Non-OADS,/arxiv_data1/oa_pdf/6e/f2/main.PMC4881820.pdf
"Protein identity from peptide mass ﬁngerprints was determined by the MASCOT program (Matrix Science Inc., Boston, MA; http://www.matrixsciende.com/ search-form-select.html ).",OADS,/arxiv_data1/oa_pdf/6e/f2/main.PMC4881820.pdf
Based on the avail- able information in the database ( http://tw.expasy.org/Swiss-Prot/ Fig.,OADS,/arxiv_data1/oa_pdf/6e/f2/main.PMC4881820.pdf
http://dx.doi.org/10.1007/s13213-013-0709-7 .,Non-OADS,/arxiv_data1/oa_pdf/6e/f2/main.PMC4881820.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/64/a6/ppa-10-871.PMC4881919.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 871–878Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  871OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10410 0 Obstructive sleep apnea affects the clinical  outcomes of patients undergoing percutaneous  coronary intervention Jun-jie Zhang1,2,* Xiao-fei gao1,* Zhen ge1,2 Xiao-Min Jiang1 Ping-xi Xiao1,2 nai-liang Tian1,2 Jing Kan2 chi-hang lee3 shao-liang chen1,2 1Department of cardiology,   nanjing First hospital, nanjing  Medical University, 2Department  of cardiology, nanjing heart center,   nanjing, People’s republic of china;   3Department of cardiology, national  University heart center, singapore *These authors contributed equally  to this workBackground:  There is a paucity of evidence regarding the association between obstructive  sleep apnea (OSA) and patients undergoing percutaneous coronary intervention (PCI) for  coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/64/a6/ppa-10-871.PMC4881919.pdf
"In 89 consecutive patients correspondence: shao-liang chen Department of cardiology, nanjing First  hospital, nanjing Medical University,  68 changle road, 210006 nanjing,  People’s republic of china Tel/fax +86 25 5220 8048 email chmengx@126.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhang et al Running head recto: OSA in patients undergoing PCI DOI: http://dx.doi.org/10.2147/PPA.S104100",Non-OADS,/arxiv_data1/oa_pdf/64/a6/ppa-10-871.PMC4881919.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/64/a6/ppa-10-871.PMC4881919.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/77/ott-9-3001.PMC4881920.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3001–3007OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3001Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10558 7 Onivyde for the therapy of multiple solid tumors Haijun Zhang Department of Oncology, Zhongda  Hospital, Medical School, Southeast  University, Nanjing, People’s Republic  of ChinaAbstract:  Drug delivery system based on nanobiotechnology can improve the pharmacokinetics  and therapeutic index of chemotherapeutic agents, which has revolutionized tumor therapy.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/ott-9-3001.PMC4881920.pdf
"Nano-DDS is capable of passive drug delivery through the enhanced  permeability and retention (EPR) effect or active targeting via binding to receptors  associated with the tumor, thus improving the pharmacokinetics and therapeutic  index of chemotherapeutic agents.12–16 Due to the perfect biocompatibility, liposome- based drug carrier has become a favorable DDS for various purposes.7,8 For example,  liposomal doxorubicin, and particularly pegylated liposomal doxorubicin, has shown Correspondence: Haijun Zhang Department of Oncology, Zhongda  Hospital, Medical School, Southeast  University, 87 Dingjiaqiao, Nanjing  210009, People’s Republic of China Tel/fax +86 25 8327 5416 email zhanghaijunseu@163.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Zhang Running head recto: Onivyde for tumor therapy DOI: http://dx.doi.org/10.2147/OTT.S105587",Non-OADS,/arxiv_data1/oa_pdf/e5/77/ott-9-3001.PMC4881920.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/ott-9-3001.PMC4881920.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/77/ott-9-3001.PMC4881920.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/db/f5/ijgm-9-137.PMC4881921.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/db/f5/ijgm-9-137.PMC4881921.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Diagnostic errors in older patients: a systematic  review of incidence and potential causes in seven  prevalent diseases Thomas R Skinner1  Ian A Scott2,3  Jennifer H Martin3,4 1Department of Internal Medicine,   Sunshine Coast Health Service  District, Nambour Hospital, Nambour,   QLD, Australia; 2Internal Medicine  and Clinical Epidemiology, Princess  Alexandra Hospital, Woolloongabba,   QLD, Australia; 3Southern School of  Medicine, University of Queensland,   Brisbane, QLD, Australia; 4School of  Medicine and Public Health, University  of Newcastle, Newcastle, NSW,   Australia Correspondence: Thomas R Skinner   Royal Brisbane and Women’s Hospital,  Butterfield St, Herston, QLD, 4029,  Australia   T el +61 421 633 507   Email thomas.skinner@uqconnect.edu.a uBackground:  Misdiagnosis, either over- or underdiagnosis, exposes older patients to increased  risk of inappropriate or omitted investigations and treatments, psychological distress, and  financial burden.",Non-OADS,/arxiv_data1/oa_pdf/db/f5/ijgm-9-137.PMC4881921.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/db/f5/ijgm-9-137.PMC4881921.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/f5/ijgm-9-137.PMC4881921.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).ClinicoEconomics and Outcomes Research 2016:8 215–226ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  215ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S9888 8Cost-effectiveness of edoxaban versus  rivaroxaban for stroke prevention in patients with  nonvalvular atrial fibrillation (NVAF) in the US Jeffrey D Miller1 Xin Ye2 gregory M lenhart1 amanda M Farr1 Oth V Tran1 W Jackie Kwong2 Elizabeth a Magnuson3 William s Weintraub4 1Truven health analytics inc,   Cambridge, M a, 2Daiichi sankyo  inc, Parsippany, nJ, 3st luke Mid- america heart institute, Kansas City,   MO, 4Center for Heart and Vascular  health, Christiana Care health  System, Newark, DE, USA Correspondence: Jeffrey D Miller   Truven health analytics inc,  150 Cambridge Park Drive – 2nd floor,  Cambridge, MA 02140, USA   Email jeffrey.d.miller@truvenhealth.co mBackground:  Understanding the value of new anticoagulation therapies compared with   existing therapies is of paramount importance in today’ s cost-conscious and efficiency-driven  health care environment.",Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
"Available from:  http://dsi.com/prescribing-information-portlet/getPIContent?productN ame=Savaysa&inline=tru e. Accessed January 2, 2016.",OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
"Available from:  http://www.drugs.com/stats/top100/sale s. Accessed January 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
Available from: http://www.nice.org.uk/guidance/ta275/ documents/ stroke-and-systemic-embolism-prevention-nonvalvular-atrial-  fibrillation-apixaban-bristolmyers-squibb-and-pfizer 2.,Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
"Available from:  http://www.fdbhealth.com/fdb-medknowledge-drug-pricin g. Accessed  January 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
Available from: http://www.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
"Available from: http://amcp.org/practice-resources/amcp-format- formulary-submisions.pd f. Accessed January 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
Available  at http://cadth.ca/media/pdf/NOAC_Therapeutic_Review_final_report.,Non-OADS,/arxiv_data1/oa_pdf/2a/1e/ceor-8-215.PMC4881922.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0e/5d/ceor-8-207.PMC4881923.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/0e/5d/ceor-8-207.PMC4881923.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).ClinicoEconomics and Outcomes Research 2016:8 207–214ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  207ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S10224 3The changing landscape of antiviral treatment of  herpes zoster: a 17-year population -based cohort  study Kevin J Friesen1 silvia alessi-severini1 Dan Chateau2 Jamie Falk1 shawn Bugden1 1College of Pharmacy, Faculty of  health sciences, University of  Manitoba, 2Department of Community  health sciences, College of Medicine,   Faculty of health sciences, University  of Manitoba, Winnipeg, MB, Canada Correspondence: shawn Bugden   College of Pharmacy, Faculty of health  sciences, University of Manitoba, 750  McDermot avenue, Winnipeg, MB, Canada   Email shawn.Bugden@umanitoba.c aBackground:  Herpes zoster (HZ) is a common viral disease that produces a painful vesicular  rash.",Non-OADS,/arxiv_data1/oa_pdf/0e/5d/ceor-8-207.PMC4881923.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/0e/5d/ceor-8-207.PMC4881923.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/5d/ceor-8-207.PMC4881923.pdf
Available from: http://www.statcan.,OADS,/arxiv_data1/oa_pdf/0e/5d/ceor-8-207.PMC4881923.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/38/93/jpr-9-293.PMC4881924.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/38/93/jpr-9-293.PMC4881924.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain research 2016:9 293–302submit your manuscript | www.dovepress.co m Dove press  293 http: //dx.doi.org/10.2147/JPR.S10274 4Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/38/93/jpr-9-293.PMC4881924.pdf
"Or use: http://youtu.be/0bXeRF-5Gp wReal-life efficacy of pregabalin for the treatment  of peripheral neuropathic pain in daily clinical  practice in Denmark: the NEP-TUNE study Michael e crawford1 Peter Bo Poulsen2 Berit schiøttz-christensen3 Andreas Habicht4 Mette strand2 Flemming W Bach5 1Copenhagen City Pain Clinic,   Copenhagen K, 2Pfizer Denmark ApS,   Ballerup, 3spine center southern  Denmark, Lillebælt Hospital,   Middelfart, 4Signifikans ApS, Vedbæk,   5Department of Neurology, Aalborg  University Hospital, Aalborg, Denmark correspondence: Peter Bo Poulsen   Pfizer Denmark ApS, Lautrupvang 8,  DK-2750 Ballerup, Denmark   T el +45 2920 3211   Fax +45 4420 1114   email peterbo.poulsen@pfizer.co mObjective:  The aim of this study was to provide evidence regarding the real-life efficacy of  pregabalin in the treatment of peripheral neuropathic pain (NeP) in Denmark.",Non-OADS,/arxiv_data1/oa_pdf/38/93/jpr-9-293.PMC4881924.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/38/93/jpr-9-293.PMC4881924.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/93/jpr-9-293.PMC4881924.pdf
Available  from: http://www.whocc.no/atc_ddd_index/?code =N03AX1 6.,OADS,/arxiv_data1/oa_pdf/38/93/jpr-9-293.PMC4881924.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/fb/bctt-8-093.PMC4881925.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Triple-negative breast cancer: treatment  challenges and solutions Joëlle Collignon1 Laurence Lousberg1 Hélène Schroeder1 Guy Jerusalem1,2 1Medical Oncology Department,   CHU Sart Tilman Liege, Domaine  Universitaire du Sart Tilman, Liege,   Belgium; 2University of Liege, Liege,   Belgium Correspondence: Guy Jerusalem   Medical Oncology, Domaine Universitaire  du Sart Tilman, Bâtiment B35, Liège 4000,  Belgium   T el +32 4 366 7111   Email g.jerusalem@chu.ulg.ac.b eAbstract:  Triple-negative breast cancers (TNBCs) are defined by the absence of estrogen  and progesterone receptors and the absence of HER2 overexpression.",Non-OADS,/arxiv_data1/oa_pdf/1d/fb/bctt-8-093.PMC4881925.pdf
Available from: http://www.abstracts2view.com/ sabcs14/view.php?nu=SABCS13L_78 9.,Non-OADS,/arxiv_data1/oa_pdf/1d/fb/bctt-8-093.PMC4881925.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02125344 .,Non-OADS,/arxiv_data1/oa_pdf/1d/fb/bctt-8-093.PMC4881925.pdf
Available from: http://www.abstracts2view.com/sabcs15/view.,Non-OADS,/arxiv_data1/oa_pdf/1d/fb/bctt-8-093.PMC4881925.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/1d/fb/bctt-8-093.PMC4881925.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7b/2a/amep-7-293.PMC4881926.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7b/2a/amep-7-293.PMC4881926.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 293–300Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 293 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S103083Bedside echo for chest pain: an algorithm for  education and assessment Richard Amini Lori A Stolz Jeffrey Z Kartchner Matthew ThompsonNicholas SteaNicolaus Hawbaker Raj Joshi Srikar Adhikari Department of Emergency Medicine,   University of Arizona Medical Center,  T ucson, AZ, USABackground: Goal-directed ultrasound protocols have been developed to facilitate efficiency,  throughput, and patient care.",Non-OADS,/arxiv_data1/oa_pdf/7b/2a/amep-7-293.PMC4881926.pdf
"9–11 As a result, majority of the EM  residency programs now integrate ultrasound training into the resident curriculum.12–14 Correspondence: Richard Amini Department of Emergency Medicine, University of Arizona Medical Center, PO Box 245057, Tucson, AZ 85724-5057, USATel +1 520 626 9604Fax +1 520 626 2480Email richardamini@gmail.comJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Amini et alRunning head recto: Bedside echo algorithm for chest painDOI: http://dx.doi.org/10.2147/AMEP .S103083",Non-OADS,/arxiv_data1/oa_pdf/7b/2a/amep-7-293.PMC4881926.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/7b/2a/amep-7-293.PMC4881926.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 300 Amini et al 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/2a/amep-7-293.PMC4881926.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/a2/ppa-10-879.PMC4881928.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 879–885Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  879OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8661 2Anxiety and depression correlate with disease  and quality-of-life parameters in chinese patients  with ankylosing spondylitis Xujuan Xu1,* Biyu shen2,3,* Aixian Zhang4 Jingwei liu3 Zhanyun Da4 hong liu4 Zhifeng gu4 1Department of n ursing, Affiliated  hospital of nantong University,   2school of nursing, nantong  University, 3Department of n ursing,   The second Affiliated hospital of  nantong University, 4Department of  rheumatology, Affiliated hospital of  nantong University, nantong, People’s  republic of china *These authors contributed equally  to this workAim:  To evaluate the relationship between mental and physical health in Chinese patients with  ankylosing spondylitis (AS) and to identify the predictors of psychological status.",Non-OADS,/arxiv_data1/oa_pdf/21/a2/ppa-10-879.PMC4881928.pdf
"Studies in Europe and the US were the first to demonstrate that psy - chological distress (characterized by depressive and anxious symptoms) is common  in patients with chronic musculoskeletal pain.7–9 In the UK, impaired quality of life  (QoL) and functional disability were found to be among the most powerful predictors  of mood disturbances.1 It was reported that patients with AS are prone to anxiety or  depression in Turkey and have a deteriorated QoL in Tunisia.3 Additionally, impaired correspondence: Zhifeng gu Department of Rheumatology, Affiliated  hospital of nantong University, 20 Xisi  road, nantong 226001, People’s republic  of china Tel/fax +86 513 8116 8512 email guzhifeng@126.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Xu et al Running head recto: Psychological status in patients with AS DOI: http://dx.doi.org/10.2147/PPA.S86612",Non-OADS,/arxiv_data1/oa_pdf/21/a2/ppa-10-879.PMC4881928.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/21/a2/ppa-10-879.PMC4881928.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/b4/ott-9-3017.PMC4881929.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3017–3023OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3017Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9691 0Prognostic performance of lymphocyte-to- monocyte ratio in diffuse large B-cell lymphoma:  an updated meta-analysis of eleven reports hui-ling sun1,* Yu-Qin Pan1,* Bang-shun he1 Zhen-lin n ie2 Kang lin1 hong-Xin Peng1,3 William c cho4 shu-Kui Wang1 1central laboratory, 2laboratory  Medicine, nanjing First hospital,   nanjing Medical University, 3Medical  college, southeast University, nanjing,   4Department of clinical Oncology,   Queen elizabeth hospital, hong Kong,   People’s republic of china *These authors contributed equally  to this workPurpose:  The findings on the prognostic value of lymphocyte-to-monocyte ratio (LMR) in  diffuse large B-cell lymphoma (DLBCL) are inconsistent.",Non-OADS,/arxiv_data1/oa_pdf/3e/b4/ott-9-3017.PMC4881929.pdf
"Systemic immune suppression is susceptible to the development of lymphoma.3  Emerging evidence has shown a close association between the host immune status and  lymphoma biology, indicating that the clinical outcomes of lymphoma are associated  with tumor inflammation and immunology.4 Tumor inflammation and immunology  have been extensively identified to be involved in tumor biologic behaviors.5,6 Systemic  inflammatory markers have also been reported to predict the survival outcomes in  various solid cancers, such as C-reactive protein, neutrophil-to-lymphocyte ratio,  and platelet-to-lymphocyte ratio.7–9 Considering the cost and technical limitations for  clinical application, increasing studies have focused on seeking a surrogate biomarker  representing the host immune status in peripheral blood that can serve as a prognostic correspondence: shu-Kui Wang central laboratory, nanjing First  hospital, nanjing Medical University,  68 changle road, nanjing 210006,  People’s republic of china email shukwang@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Sun et al Running head recto: Lymphocyte-to-monocyte ratio and diffuse large B-cell lymphoma DOI: http://dx.doi.org/10.2147/OTT.S96910",Non-OADS,/arxiv_data1/oa_pdf/3e/b4/ott-9-3017.PMC4881929.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/b4/ott-9-3017.PMC4881929.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/b4/ott-9-3017.PMC4881929.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/ott-9-3009.PMC4881930.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3009–3016OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3009Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10408 1Targeting gastrointestinal stromal tumors: the role  of regorafenib Brett Schroeder1 Zula Li2,3 Lee D Cranmer2,3 Robin L Jones4 Seth M Pollack2,3 1College of Human Medicine, Michigan  State University, Grand Rapids, M i,   2Division of Medical Oncology,   University of washington, 3Clinical  Research Division, Fred Hutchinson  Cancer Research Center, Seattle, wA,   USA; 4Royal Marsden Hospital,   institute of Cancer Research,   London,  UKAbstract:  Gastrointestinal stromal tumor (GIST) is a devastating disease in the metastatic  setting, but its natural history has been dramatically altered by the development of small molecule  tyrosine kinase inhibitors, most notably imatinib.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/ott-9-3009.PMC4881930.pdf
"A key observation in GIST diagnosis and therapy was the central role  of mitogen receptor and GIST marker, c-Kit; gain-of-function of this receptor is crucial  for tumor growth in most cases of GISTs.6 Overexpression of c-Kit protein is detected  immunohistochemically in the majority of GISTs, which is a key diagnostic finding.Correspondence: Seth M Pollack Fred Hutchinson Cancer Research  Center, 1100 Fairview Ave N, Seattle,  wA 98109, USA Tel +1 206 667 6629 Fax +1 206 667 7983 email spollack@fredhutch.or g Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Schroeder et al Running head recto: Regorafenib for GIST DOI: http://dx.doi.org/10.2147/OTT.S104081",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/ott-9-3009.PMC4881930.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/ott-9-3009.PMC4881930.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/aa/ott-9-3009.PMC4881930.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/ed/rjw067.PMC4881932.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/3e/main.PMC4881987.pdf
1These authors contributed equally to the manuscript http://dx.doi.org/10.1016/j.atg.2014.04.001 2212-0661/© 2014 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/aa/3e/main.PMC4881987.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/3e/main.PMC4881987.pdf
"Large networks such as the Public Population Project in Geno- mics and Society (P3G) (http://p3g.org/ ) and Biobanking and Biomolec- ular Resources Research Infrastructure (BBMRI) ( http://bbmri.eu/ )a r e changing the landscape of international collaboration in biobanking, harmonizing regulatory legislation and thus facilitating the use of biobanks in research ( Wichmann et al., 2011 ).",Non-OADS,/arxiv_data1/oa_pdf/aa/3e/main.PMC4881987.pdf
"Promising nation-wide models have also emerged, including the United Kingdom Biobank (http://www.ukbiobank.ac.uk/ ), the Swedish National Biobank pro- gramme (now the Swedish arm of BBMRI, http://www.bbmri.se/ ), the Iceland Biobank, and others.",Non-OADS,/arxiv_data1/oa_pdf/aa/3e/main.PMC4881987.pdf
Brussels http://euapm.eu/wp-content/uploads/2012/07/EAPM-RE- PORT-on-Innovation-and-Patient-Access-to-Personalised-Medicine.pdf .,Non-OADS,/arxiv_data1/oa_pdf/aa/3e/main.PMC4881987.pdf
"Biobanks and data sharing are a so- cial enterprise that can and should undergird as well as sustain the viability of quality healthcare for all, including –as we have seen –Applied & Translational Genomics 3 (2014) 21 –22 http://dx.doi.org/10.1016/j.atg.2014.04.002 2212-0661/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fd/eb/main.PMC4882006.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/eb/main.PMC4882006.pdf
"Time Magazine, viewed 12 October 2013, http://www.time.com/time/specials/packages/article/ 0,28804,1884779_1884782_1884766,00.hml .",Non-OADS,/arxiv_data1/oa_pdf/fd/eb/main.PMC4882006.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/93/main.PMC4882025.pdf
: +39 080 555561 0; fax: +39 080 555560. http://dx.doi.org/10.1016/j.atg.2014.04.003 2212-0661/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/93/main.PMC4882025.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/93/main.PMC4882025.pdf
(Webpage accessed on September 10th 2013) http://www.cdc.gov/genomics/public/ .,OADS,/arxiv_data1/oa_pdf/b3/93/main.PMC4882025.pdf
(Webpage accessed on 11 Sept. 2013) http://www.geneticalliance.,Non-OADS,/arxiv_data1/oa_pdf/b3/93/main.PMC4882025.pdf
"NIH Of ﬁce of rare diseases research, http://rarediseases.info.nih.gov/research/pages/43/ global-rare-disease-patient-registry-and-data-repository.",Non-OADS,/arxiv_data1/oa_pdf/b3/93/main.PMC4882025.pdf
(Webpage accessed on September 11th 2013) http://www.orpha.net/ consor/cgi-bin/Education_AboutRareDisease.php .,Non-OADS,/arxiv_data1/oa_pdf/b3/93/main.PMC4882025.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
"- Mutual respect: The development and sustainability of P3G is based on responsi- bility, collaboration, co-operation, trust and mutual respect for others, which http://dx.doi.org/10.1016/j.atg.2014.04.004 2212-0661/© 2014 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
"As P3G embarks on col- laborations with a wider range of projects, including the nascent Global Alliance for Genomics and Health ( http://www.humanvariomeproject.org/index.php/news/237-a-global-alliance-to-enable-responsible- sharing-of-genomic-and-clinical-data —accessed 17 November 2013), the consortium and its secretariat continue to be an enabler and provid- er of services at the very heart of international genetic research.",Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
http://dx.doi.org/ 10.1038/ng.831 .,Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
http://dx.doi.org/10.1093/ije/dyr106 .,OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
http://dx.doi.org/ 10.1159/000309852 .,Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
http://dx.doi.org/10.1038/ejhg.2012.96 .,OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
http://dx.doi.org/10.1126/science.1218015 .,Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
http://dx.doi.org/10.1038/ejhg.2008.55 .,OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
"3 (7), 46. http://dx.doi.org/10.1186/gm262 .",Non-OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
http://dx.doi.org/10.1038/ ejhg.2012.152 .,OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
"22, 3 –5.http://dx.doi.org/10.1038/ejhg.2013.176 .",OADS,/arxiv_data1/oa_pdf/3a/0f/main.PMC4882047.pdf
"It typically supports a discrete, specified, and circum- scribed project of up to 5 years duration, to be performed by applicants in an area representing their specific interests and competencies, based on the mission of the NIH (see http://grants.nih.gov/ grants/funding/r01.htm).",Non-OADS,/arxiv_data1/oa_pdf/12/16/10.1177_1098214015582049.PMC4882120.pdf
"In 1997, innovation and four other core review criteria were specified for reviewers to evaluate and rely on when determining their score for the overall impact of the applications (see Table 1, from NIH policy announcement number NOT-95-10 at http://grants.nih.gov/grants/guide/notice-files/ not97-010.html).",Non-OADS,/arxiv_data1/oa_pdf/12/16/10.1177_1098214015582049.PMC4882120.pdf
overall impact score (see NOT-OD-09-025 at http://grants.nih.gov/grants/guide/notice-files/not-od- 09-025.html).,Non-OADS,/arxiv_data1/oa_pdf/12/16/10.1177_1098214015582049.PMC4882120.pdf
"Some analyses have been posted on NIH blogs (e.g., see http://nexus.od.nih.gov/all/2011/03/08/overall-impact- and-criterion-scores/ and https://loop.nigms.nih.gov/2010/07/more-on-criterion-scores/) and those analyses suggest, at least to some, that reviewers may still base their overall impact scores largely on their assessment of the research methodology (i.e., the approach criterion), with little if any con- sideration for how innovative the projects are.",Non-OADS,/arxiv_data1/oa_pdf/12/16/10.1177_1098214015582049.PMC4882120.pdf
"These results are consistent with previous reports, http://nexus.od.nih.gov/all/2011/03/08/overall-impact-and-criterion-scores/.Table 3.",OADS,/arxiv_data1/oa_pdf/12/16/10.1177_1098214015582049.PMC4882120.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/43/95/ndt-12-1243.PMC4882152.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1243–1250Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1243OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10475 6a functional M ri study of altered spontaneous brain  activity pattern in patients with  congenital comitant  strabismus using amplitude of low-frequency  fluctuation gang Tan,1,2,* Xin huang,1,3,*  Ying Zhang,1 an-hua Wu,2  Yu-lin Zhong,1 Kai Wu,2  Fu-Qing Zhou,4 Yi shao1 1Department of Ophthalmology,   The First affiliated hospital of  Nanchang University, Jiangxi Province  clinical Ophthalmology institute  and Oculopathy research centre,   Nanchang, Jiangxi, 2Department of  Ophthalmology, The First affiliated  hospital of University of south china,   hengyang, hunan, 3Department of  Ophthalmology, The First People’s  hospital of Jiujiang city, Jiujiang,   4Department of radiology, The First  affiliated hospital of Nanchang  University, Jiangxi Province Medical  imaging research institute, Nanchang,   Jiangxi, People’s republic of china *These authors contributed equally  to this workObjective:  The aim of this study was to use amplitude of low-frequency fluctuation (ALFF)  to investigate local features of spontaneous brain activity in patients with congenital comitant  strabismus and clarify their relationship with emotional and psychosocial problems.",Non-OADS,/arxiv_data1/oa_pdf/43/95/ndt-12-1243.PMC4882152.pdf
"In addition to functional limitations (restriction in visual field and  stereopsis), strabismic patients may suffer from significant psychosocial problems.2  It was worthy of attention that the strabismus had posed great pressures on patients  in all age groups.3correspondence: Yi shao Department of Ophthalmology, The  First Affiliated Hospital of Nanchang  University, No 17, Yongwaizheng street,  Donghu District, Nanchang 330006,  Jiangxi, People’s republic of china Tel +86 791 8869 2520 email freebee99@163.co m  Fu-Qing Zhou Department of radiology, The First  Affiliated Hospital of Nanchang  University, No 17, Yongwaizheng street,  Donghu District, Nanchang 330006,  Jiangxi, People’s republic of china Tel +86 791 8869 5132 email f q.chou@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Tan et al Running head recto: Altered spontaneous brain activity pattern in comitant strabismus DOI: http://dx.doi.org/10.2147/NDT.S104756",Non-OADS,/arxiv_data1/oa_pdf/43/95/ndt-12-1243.PMC4882152.pdf
"The rest of the data preprocessing was performed by  DPARSFA ( http://rfmri.org/DPARS F) software, including  Digital Imaging Communications in Medicine form transfor - mation, slice timing, head-motion correction, spatial normal - ization, and smooth with a Gaussian kernel of 6 ×6×6 mm3  full-width at half-maximum.",OADS,/arxiv_data1/oa_pdf/43/95/ndt-12-1243.PMC4882152.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/43/95/ndt-12-1243.PMC4882152.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/95/ndt-12-1243.PMC4882152.pdf
Graphical Abstract This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/45/nihms650295.PMC4882153.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, one table, and one movie and can be found  with this article online at http://dx.doi.org/10.1016/j.celrep.2014.08.049 .",OADS,/arxiv_data1/oa_pdf/6f/45/nihms650295.PMC4882153.pdf
This is an o pen access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/ac/main.PMC4882191.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.05.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/28/ac/main.PMC4882191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 159 e162,Non-OADS,/arxiv_data1/oa_pdf/28/ac/main.PMC4882191.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.02.006 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/57/db/main.PMC4882192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 29 e31,Non-OADS,/arxiv_data1/oa_pdf/57/db/main.PMC4882192.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.02.004 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/15/13/main.PMC4882193.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 8 e11,Non-OADS,/arxiv_data1/oa_pdf/15/13/main.PMC4882193.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.02.003 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/50/92/main.PMC4882194.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 1 e7,Non-OADS,/arxiv_data1/oa_pdf/50/92/main.PMC4882194.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.06.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/f1/5e/main.PMC4882195.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 168 e171,Non-OADS,/arxiv_data1/oa_pdf/f1/5e/main.PMC4882195.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.11.003 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/81/77/main.PMC4882196.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 43 e44,Non-OADS,/arxiv_data1/oa_pdf/81/77/main.PMC4882196.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.07.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/4b/8f/main.PMC4882197.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 177 e178,Non-OADS,/arxiv_data1/oa_pdf/4b/8f/main.PMC4882197.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/ea/main.PMC4882198.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.12.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/bf/ea/main.PMC4882198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 38 e40,Non-OADS,/arxiv_data1/oa_pdf/bf/ea/main.PMC4882198.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.02.005 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/6c/cf/main.PMC4882199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 22 e25,Non-OADS,/arxiv_data1/oa_pdf/6c/cf/main.PMC4882199.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.11.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/04/75/main.PMC4882200.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 35 e37,Non-OADS,/arxiv_data1/oa_pdf/04/75/main.PMC4882200.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.10.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/b6/b2/main.PMC4882201.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 26 e28,Non-OADS,/arxiv_data1/oa_pdf/b6/b2/main.PMC4882201.pdf
2013 Oct 29;3:49. http://dx.doi.org/10.4103/2156-7514.120805 .,Non-OADS,/arxiv_data1/oa_pdf/b6/b2/main.PMC4882201.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.03.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/25/75/main.PMC4882202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 192 e193,Non-OADS,/arxiv_data1/oa_pdf/25/75/main.PMC4882202.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.02.007 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/55/78/main.PMC4882203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 45 e46,Non-OADS,/arxiv_data1/oa_pdf/55/78/main.PMC4882203.pdf
This is an o pen access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/e8/main.PMC4882204.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.09.003 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/c3/e8/main.PMC4882204.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 185 e186,Non-OADS,/arxiv_data1/oa_pdf/c3/e8/main.PMC4882204.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.10.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/76/43/main.PMC4882205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 17 e21,Non-OADS,/arxiv_data1/oa_pdf/76/43/main.PMC4882205.pdf
http://emedicine.medscape.com/article/154336 (achieved at 05.01.2012).,OADS,/arxiv_data1/oa_pdf/76/43/main.PMC4882205.pdf
This is an o pen access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/39/main.PMC4882206.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.09.004 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/69/39/main.PMC4882206.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 187 e189,Non-OADS,/arxiv_data1/oa_pdf/69/39/main.PMC4882206.pdf
This is an o pen access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/20/main.PMC4882207.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.07.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/60/20/main.PMC4882207.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 179 e181,Non-OADS,/arxiv_data1/oa_pdf/60/20/main.PMC4882207.pdf
This is an o pen access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/01/main.PMC4882208.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.02.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/e9/01/main.PMC4882208.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 172 e176,Non-OADS,/arxiv_data1/oa_pdf/e9/01/main.PMC4882208.pdf
At http://www.who.int/csr/don/ 2009_09_25/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/e9/01/main.PMC4882208.pdf
"46. hudered killed in hajj stampedes, at http://www.google.com/url?q ¼http%3A% 2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fmiddle_east%2F3448779.",Non-OADS,/arxiv_data1/oa_pdf/e9/01/main.PMC4882208.pdf
47. incidents during hajj available at: http://www.google.com/url?q ¼http%3A%2F% 2Fen.wikipedia.org%2Fwiki%2FIncidents_during_the_Hajj&sa¼D&sntz¼1&usg¼AFQjCNHjJlo_Li-Nsxg5FjIqMAG10omt_ghttp://en.,Non-OADS,/arxiv_data1/oa_pdf/e9/01/main.PMC4882208.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.08.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/29/b8/main.PMC4882209.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 12 e16,Non-OADS,/arxiv_data1/oa_pdf/29/b8/main.PMC4882209.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.06.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/b8/cc/main.PMC4882210.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 163 e167,Non-OADS,/arxiv_data1/oa_pdf/b8/cc/main.PMC4882210.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2015.01.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/8f/ad/main.PMC4882211.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 190 e191,Non-OADS,/arxiv_data1/oa_pdf/8f/ad/main.PMC4882211.pdf
Peer review under responsibility of The Emergency Medicine Association of Turkey HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.02.008 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/ec/77/main.PMC4882212.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 151 e154,Non-OADS,/arxiv_data1/oa_pdf/ec/77/main.PMC4882212.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.02.009 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/e2/8b/main.PMC4882213.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 155 e158,Non-OADS,/arxiv_data1/oa_pdf/e2/8b/main.PMC4882213.pdf
trjemergmed.com and Journal of Academic Emergency Medicine: http://www.akademikaciltip.com ).,Non-OADS,/arxiv_data1/oa_pdf/e2/8b/main.PMC4882213.pdf
Available at: http://www.ulakbim.gov.tr/cabim/yayin/tbyg_1981_2007/ektablo2.,Non-OADS,/arxiv_data1/oa_pdf/e2/8b/main.PMC4882213.pdf
HOSTED BY Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.09.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/3c/b8/main.PMC4882214.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 15 (2015) 182 e184,Non-OADS,/arxiv_data1/oa_pdf/3c/b8/main.PMC4882214.pdf
UpToDate Web site http://www.uptodate.com/contents/clinical-features- diagnosis-and-treatment-of-methemoglobinemia ; Accessed 12.02.14.,Non-OADS,/arxiv_data1/oa_pdf/3c/b8/main.PMC4882214.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.11.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/60/f3/main.PMC4882215.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 41 e42,Non-OADS,/arxiv_data1/oa_pdf/60/f3/main.PMC4882215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/b5/main.PMC4882216.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2014.09.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/3b/b5/main.PMC4882216.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 32 e34,Non-OADS,/arxiv_data1/oa_pdf/3b/b5/main.PMC4882216.pdf
O Acknowledgments Raw proteomics study data set available at http://crggh.nih.gov/resources.cfm under HUFS.,OADS,/arxiv_data1/oa_pdf/62/8e/OBY-24-1257.PMC4882259.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2014-308430).,OADS,/arxiv_data1/oa_pdf/1a/6e/gutjnl-2014-308430.PMC4882277.pdf
"1Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA 2Agency for Science Technology and Research, Singapore, Singapore 3Department of Bioengineering and Therapeutic Sciences,University of California San Francisco, San Francisco, California, USA 4Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA Correspondence to Dr Guisheng Song, Division ofGastroenterology, Hepatology and Nutrition, Department of Medicine, University ofMinnesota Medical School,MMC 36, VFW Cancer Research Center, V354, 406 Harvard Street SE,Minneapolis, MN 55455, USA;gsong@umn.edu Received 19 September 2014 Revised 12 July 2015Accepted 14 July 2015Published Online First 17 August 2015 ▸http://dx.doi.org/10.1136/ gutjnl-2015-310044 To cite: Wu H, Ng R, Chen X, et al.Gut 2016; 65:1850 –1860.ABSTRACT Background Non-alcoholic fatty liver disease (NAFLD) is a major risk factor for hepatocellular carcinoma (HCC).However, the mechanistic pathways that link bothdisorders are essentially unknown.Objective Our study was designed to investigate the role of microRNA-21 in the pathogenesis of NAFLD andits potential involvement in HCC.Methods Wildtype mice maintained on a high fat diet (HFD) received tail vein injections of microRNA-21-anti-sense oligonucleotide (ASO) or miR-21 mismatched ASOfor 4 or 8 weeks.",Non-OADS,/arxiv_data1/oa_pdf/1a/6e/gutjnl-2014-308430.PMC4882277.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Yang JD, Roberts LR.",Non-OADS,/arxiv_data1/oa_pdf/1a/6e/gutjnl-2014-308430.PMC4882277.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ba/81/12325_2016_Article_337.PMC4882346.pdf
The Cochrane Collaboration; 2011. http://www.handbook.,OADS,/arxiv_data1/oa_pdf/ba/81/12325_2016_Article_337.PMC4882346.pdf
http://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf .,Non-OADS,/arxiv_data1/oa_pdf/ba/81/12325_2016_Article_337.PMC4882346.pdf
Keywords: Hepatocellular carcinoma (HCC); Oncology; Radioembolization; Transarterial radioembolization (TARE); Yttrium-90 (Y90)Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/9B84 F06014B881BF .,Non-OADS,/arxiv_data1/oa_pdf/c7/5f/12325_2016_Article_324.PMC4882351.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c7/5f/12325_2016_Article_324.PMC4882351.pdf
http://www.therasphere.com/ physicians-package-insert/TS_PackageInsert_USA_v12.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c7/5f/12325_2016_Article_324.PMC4882351.pdf
"Methods : Treatment-naive patients with MPC (N=861) received either nab-P 125 mg/ m2?Gem 1000 mg/m2on days 1, 8, and 15 every 4 weeks or Gem 1000 mg/m2weekly for the ﬁrst 7 of 8 weeks (cycle 1) and then on days 1, 8, and 15 every 4 weeks (cycle C2).Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/3E84 F06021D67FC0 .",Non-OADS,/arxiv_data1/oa_pdf/aa/9a/12325_2016_Article_327.PMC4882352.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/aa/9a/12325_2016_Article_327.PMC4882352.pdf
Available at: http://www.cancer.ca/ */media/ cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20stat istics/Canadian-Cancer- Statistics-2015-EN.pdf .,Non-OADS,/arxiv_data1/oa_pdf/aa/9a/12325_2016_Article_327.PMC4882352.pdf
Available at: http://www.cancer.org/ acs/groups/content/@editorial/documents/document/acspc-044552.pdf .,Non-OADS,/arxiv_data1/oa_pdf/aa/9a/12325_2016_Article_327.PMC4882352.pdf
Available at: http://www.pancreaticcancercanada.ca/site/PageServer?pagename=facingpan creaticcancer_facts .,Non-OADS,/arxiv_data1/oa_pdf/aa/9a/12325_2016_Article_327.PMC4882352.pdf
Available at: https://www.cadth.ca/sites/default/ﬁles/pcodr/pcodr- abraxane-mpc-fn-egr.pdf .,Non-OADS,/arxiv_data1/oa_pdf/aa/9a/12325_2016_Article_327.PMC4882352.pdf
"Conclusion : The use of FP/FORM as an alternative to FP/SAL can result in cost savings for the NHS when assessing drug,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8784F0600E48598D .",Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriatecredit to the original author(s) and the source, p r o v i d eal i n kt ot h eC r e a t i v eC o m m o n s license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
Available from: http://www.asthma.org.uk/asthma-facts-and-statist ics.,Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
Dispensing factsheet: using the drug tariff.Available from: http://psnc.org.uk/wp-content/ uploads/2013/07/CPN-Factsheet-Jan-15-for-website.,Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
Available from: http://www.pssru.ac.uk/project- pages/unit-costs/2014/ .,Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
Available from: http://www.nhscc.org/ccgs/ .,Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
Available from: http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
"Available from: http://centreformedicinesoptimisation.co.uk/ﬁles/ Flutiform%20update%20VS%202014_ﬁnal.pdf .D e c , 2015.22.",Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
Available from:http://www.scottishmedicines.org.uk/SMC_Advice/ Advice/736_11_ﬂuticasone_formoterol_mdi_inhaler _Flutiform/ﬂuticasone_formoterol_Flutiform .,Non-OADS,/arxiv_data1/oa_pdf/4b/9c/12325_2016_Article_317.PMC4882365.pdf
Funding : Boehringer Ingelheim.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ E984F060256965B2 .,Non-OADS,/arxiv_data1/oa_pdf/15/9f/12325_2016_Article_322.PMC4882367.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/15/9f/12325_2016_Article_322.PMC4882367.pdf
Available from: http://www.medicines.org.uk/emc/medicine/ 10039/SPC/Spiriva ?18?microgram ?inhalation ?,Non-OADS,/arxiv_data1/oa_pdf/15/9f/12325_2016_Article_322.PMC4882367.pdf
Available from: http://www.medicines.org.uk/emc/ medicine/20134/SPC .,Non-OADS,/arxiv_data1/oa_pdf/15/9f/12325_2016_Article_322.PMC4882367.pdf
Keywords: Bariatric surgery; Epworth Sleepiness Scale; Laparoscopic sleeveEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/3A84 F06018B1FF80 .,Non-OADS,/arxiv_data1/oa_pdf/88/34/12325_2016_Article_323.PMC4882368.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/88/34/12325_2016_Article_323.PMC4882368.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bc/1a/12325_2016_Article_332.PMC4882369.pdf
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/2D84 F06040DA120C .,Non-OADS,/arxiv_data1/oa_pdf/40/33/12325_2016_Article_326.PMC4882374.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/40/33/12325_2016_Article_326.PMC4882374.pdf
http://av.conferencearchives.com/pdfs/100502/ 09.08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/1f/PWKI-12-27388.PMC4882381.pdf
http://www.sha-conferences.com/files/presentation2011/   090005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/1f/PWKI-12-27388.PMC4882381.pdf
http://women.texaschil-drens.org/Our-Services/Fetal-Center/Balloon-Atrial-Septosto- my-for-H LHS/.,Non-OADS,/arxiv_data1/oa_pdf/47/1f/PWKI-12-27388.PMC4882381.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowReview Article An aggressive multidisciplinary approach reduces mortality in  rhinocerebral mucormycosis Sheri K. Palejwala, Tirdad T .",Non-OADS,/arxiv_data1/oa_pdf/92/48/SNI-7-61.PMC4882964.pdf
"Surg Neurol Int 2016;7:61. http://surgicalneurologyint.com/An-aggressive-multidisciplinary-approach-reduces- mortality-in-rhinocerebral-mucormycosis/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/92/48/SNI-7-61.PMC4882964.pdf
"Surgical Neurology International 2016, 7:61  http://www.surgicalneurologyint.com/content/7/1/61that are inhaled and access the central nervous system  (CNS) via the respiratory tract.",Non-OADS,/arxiv_data1/oa_pdf/92/48/SNI-7-61.PMC4882964.pdf
"Surgical Neurology International 2016, 7:61  http://www.surgicalneurologyint.com/content/7/1/61with some degree of headache, facial and orbital pain,  with ophthalmologic symptoms ranging from pain, ptosis,  and proptosis to ophthalmoplegia and blindness.",Non-OADS,/arxiv_data1/oa_pdf/92/48/SNI-7-61.PMC4882964.pdf
"Surgical Neurology International 2016, 7:61  http://www.surgicalneurologyint.com/content/7/1/61commenced rapidly with intravenous amphotericin B.",Non-OADS,/arxiv_data1/oa_pdf/92/48/SNI-7-61.PMC4882964.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Spontaneous shrinkage of vestibular schwannoma Rossana Romani, Jonathan Pollock Department of Neurosurgery, Queen’s Hospital, Essex Neuroscience Centre, Romford, London, UK E-mail: *Rossana Romani - romanirossana@yahoo.it; Jonathan Pollock - jonathan.pollock@bhrhospitals.nhs.uk   *Corresponding author Received: 02 March 16  Accepted: 10 April 16  Published: 19 May 16 Abstract Background:  “Watch, wait, and rescan” (WWR) has an established place  as a successful management option for a significant proportion of vestibular  schwannomas (VS) as an alternative to microsurgical removal or stereotactic  radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/5f/99/SNI-7-59.PMC4882965.pdf
"Surg Neurol Int 2016;7:59. http://surgicalneurologyint.com/Spontaneous-shrinkage-of-vestibular-schwannoma/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/5f/99/SNI-7-59.PMC4882965.pdf
"Surgical Neurology International 2016, 7:59  http://www.surgicalneurologyint.com/content/7/1/59continuously, followed by stagnation or even shrinkage.",Non-OADS,/arxiv_data1/oa_pdf/5f/99/SNI-7-59.PMC4882965.pdf
"Surgical Neurology International 2016, 7:59  http://www.surgicalneurologyint.com/content/7/1/59or stereotactic radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/5f/99/SNI-7-59.PMC4882965.pdf
"Surgical Neurology International 2016, 7:59  http://www.surgicalneurologyint.com/content/7/1/59Prospective multicentre studies with a large number of  patients such as the UK vestibular schwannoma database  will be a valuable future aid in identifying predictive  factors for tumor shrinkage.",Non-OADS,/arxiv_data1/oa_pdf/5f/99/SNI-7-59.PMC4882965.pdf
"Surgical Neurology International 2016, 7:59  http://www.surgicalneurologyint.com/content/7/1/593.",Non-OADS,/arxiv_data1/oa_pdf/5f/99/SNI-7-59.PMC4882965.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowErratum Erratum: Are there a guidelines for implantable spinal cord  stimulator therapy in patients using chronic anticoagulation  therapy?",Non-OADS,/arxiv_data1/oa_pdf/8d/da/SNI-7-57.PMC4882966.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75 East and North Africa regions.",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75 compared PAF of each outcome of high FPG for both  sexes by age groups and province in 2005 and 2011.",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75 Kohgiluyeh and Boyer-Ahmad, respectively.",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75 Almost, in half of the provinces, attributed deaths to  CKD were higher in females than in males.",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75 central region of the country.",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75Table 1: The population attributable fractions of high fasting plasma glucose on ischemic heart disease, stroke, and chronic ki dney diseases in males by age  in 2011 for population 25–64 years The PAFs of high FPG Provinces Ischemic heart disease Stroke Kidney disease 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 Iran 0.08 0.08 0.17 0.17 0.33 0.36 0.38 0.24 0.07 0.07 0.15 0.15 0.29 0.32 0.33 0.32 0.07 0.07 0.15 0.15 0.25 0.26 0.29 0.33 Alborz 0.11 0.20 0.08 0.30 0.03 0.34 0.56 0.16 0.10 0.17 0.07 0.27 0.03 0.30 0.48 0.22 0.10 0.16 0.07 0.24 0.03 0.26 0.39 0.23 Ardabil 0.03 0.11 0.09 0.05 0.10 0.04 0.25 0.00 0.03 0.10 0.07 0.05 0.08 0.03 0.22 0.00 0.03 0.10 0.07 0.04 0.08 0.04 0.20 0.00Azerbaijan_East 0.06 0.02 0.06 0.20 0.18 0.45 0.37 0.30 0.06 0.02 0.05 0.17 0.15 0.41 0.32 0.40 0.05 0.02 0.05 0.17 0.15 0.33 0.30 0.38Azerbaijan_West 0.08 0.13 0.46 0.22 0.20 0.10 0.20 0.42 0.07 0.11 0.40 0.19 0.18 0.08 0.17 0.54 0.07 0.10 0.35 0.19 0.16 0.08 0.17 0.43Bushehr 0.13 0.00 0.01 0.00 0.33 0.28 0.71 0.15 0.12 0.00 0.00 0.00 0.29 0.25 0.61 0.20 0.12 0.00 0.01 0.00 0.22 0.23 0.47 0.22ChaharMahal  and Bakhtiari0.01 0.02 0.10 0.00 0.18 0.27 0.13 0.22 0.01 0.02 0.09 0.00 0.16 0.23 0.12 0.30 0.01 0.02 0.08 0.00 0.15 0.21 0.12 0.30 Fars 0.09 0.18 0.40 0.24 0.19 0.19 0.36 0.23 0.07 0.16 0.38 0.21 0.17 0.16 0.32 0.31 0.08 0.16 0.32 0.19 0.16 0.16 0.29 0.30 Gilan 0.04 0.13 0.31 0.02 0.06 0.03 0.78 0.10 0.04 0.12 0.26 0.02 0.05 0.03 0.68 0.14 0.04 0.11 0.23 0.02 0.05 0.03 0.50 0.17Golestan 0.05 0.18 0.31 0.16 0.64 0.56 0.31 0.34 0.04 0.15 0.28 0.14 0.57 0.48 0.26 0.45 0.04 0.14 0.26 0.13 0.43 0.39 0.24 0.38Hamadan 0.04 0.00 0.20 0.06 0.31 0.35 0.45 0.04 0.00 0.17 0.05 0.27 0.30 0.39 0.04 0.00 0.17 0.06 0.25 0.27 0.34Hormozgan 0.15 0.08 0.05 0.02 0.02 0.39 0.35 0.20 0.13 0.07 0.04 0.02 0.01 0.34 0.31 0.28 0.13 0.07 0.04 0.02 0.02 0.29 0.27 0.28 Ilam 0.09 0.11 0.23 0.27 0.33 0.14 0.20 0.10 0.08 0.10 0.21 0.24 0.29 0.12 0.17 0.13 0.08 0.11 0.19 0.22 0.26 0.12 0.16 0.15 Isfahan 0.08 0.23 0.34 0.38 0.04 0.46 0.83 0.26 0.07 0.20 0.31 0.33 0.03 0.40 0.71 0.36 0.07 0.18 0.27 0.30 0.03 0.35 0.54 0.35Kerman 0.05 0.04 0.00 0.00 0.04 0.02 0.78 0.04 0.04 0.00 0.00 0.03 0.02 0.68 0.04 0.04 0.00 0.00 0.03 0.02 0.51Kermanshah 0.17 0.32 0.14 0.32 0.41 0.22 0.26 0.17 0.15 0.28 0.13 0.28 0.35 0.20 0.22 0.23 0.14 0.26 0.12 0.26 0.31 0.19 0.21 0.26Khorasan_North 0.05 0.15 0.17 0.12 0.12 0.03 0.46 0.08 0.04 0.13 0.15 0.11 0.11 0.02 0.41 0.12 0.05 0.12 0.14 0.10 0.10 0.02 0.33 0.14Khorasan_Razavi 0.04 0.09 0.08 0.33 0.19 0.49 0.40 0.34 0.03 0.07 0.07 0.28 0.17 0.43 0.33 0.45 0.03 0.08 0.07 0.24 0.16 0.37 0.30 0.42 Khorasan_South 0.06 0.07 0.15 0.24 0.11 0.10 0.31 0.10 0.05 0.06 0.12 0.20 0.09 0.08 0.28 0.14 0.05 0.06 0.12 0.19 0.10 0.08 0.24 0.14 Khuzestan 0.02 0.06 0.23 0.13 0.11 0.41 0.59 0.13 0.02 0.05 0.21 0.11 0.09 0.36 0.51 0.18 0.02 0.05 0.19 0.11 0.09 0.31 0.41 0.19Kohgiluyeh and  Boyerahmad0.11 0.01 0.01 0.11 0.29 0.14 0.16 0.02 0.10 0.01 0.01 0.10 0.26 0.12 0.13 0.03 0.09 0.01 0.01 0.09 0.21 0.12 0.13 0.04 Kurdistan 0.20 0.00 0.20 0.25 0.15 0.25 0.29 0.25 0.18 0.00 0.16 0.22 0.13 0.22 0.25 0.34 0.18 0.00 0.17 0.20 0.13 0.20 0.23 0.34 Lorestan 0.04 0.07 0.09 0.17 0.15 0.31 0.61 0.18 0.04 0.06 0.08 0.14 0.14 0.27 0.53 0.25 0.04 0.06 0.07 0.15 0.12 0.23 0.42 0.25 Markazi 0.01 0.08 0.06 0.12 0.13 0.87 0.40 0.10 0.01 0.07 0.05 0.11 0.11 0.78 0.34 0.14 0.01 0.07 0.05 0.11 0.11 0.54 0.30 0.17 Mazandaran 0.07 0.20 0.27 0.18 0.75 0.52 0.41 0.56 0.06 0.18 0.24 0.16 0.65 0.46 0.36 0.69 0.06 0.16 0.22 0.16 0.50 0.37 0.31 0.53Qazvin 0.19 0.13 0.33 0.19 0.84 0.23 0.25 0.57 0.16 0.11 0.29 0.17 0.74 0.20 0.22 0.72 0.15 0.11 0.27 0.16 0.53 0.19 0.21 0.58Qom 0.20 0.05 0.17 0.04 0.61 0.56 0.31 0.33 0.17 0.05 0.15 0.03 0.53 0.47 0.27 0.45 0.17 0.05 0.15 0.03 0.44 0.39 0.23 0.41Semnan 0.16 0.24 0.42 0.16 0.16 0.24 0.20 0.33 0.14 0.21 0.37 0.14 0.14 0.21 0.17 0.43 0.14 0.19 0.32 0.13 0.14 0.20 0.16 0.40Sistan and  Baluchistan0.12 0.01 0.11 0.37 0.00 0.18 0.11 0.09 0.10 0.01 0.09 0.32 0.00 0.16 0.10 0.13 0.10 0.01 0.09 0.27 0.00 0.16 0.10 0.15 Tehran 0.20 0.06 0.13 0.11 0.36 0.33 0.44 0.24 0.17 0.05 0.11 0.10 0.32 0.29 0.37 0.32 0.16 0.05 0.11 0.09 0.27 0.26 0.33 0.32 Yazd 0.14 0.20 0.40 0.65 0.31 0.90 0.57 0.19 0.12 0.17 0.35 0.55 0.27 0.82 0.49 0.26 0.11 0.17 0.31 0.44 0.23 0.58 0.42 0.28Zanjan 0.03 0.01 0.00 0.08 0.88 0.01 0.01 0.05 0.03 0.01 0.00 0.07 0.78 0.01 0.01 0.07 0.03 0.01 0.00 0.07 0.56 0.01 0.01 0.08 FPG=Fasting plasma glucose, PAF=Population attributable fraction",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75Table 2: The population attributable fractions of high fasting plasma glucose on ischemic heart disease, stroke, and chronic ki dney diseases in females by age in  2011 for population 25–64 years The PAFs of high FPG Provinces IHD Stroke Kidney disease 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 Iran 0.09 0.1 0.2 0.24 0.33 0.47 0.48 0.29 0.07 0.09 0.17 0.22 0.29 0.40 0.41 0.40 0.07 0.08 0.16 0.18 0.26 0.33 0.35 0.36 Alborz 0.10 0.18 0.67 0.05 0.28 0.40 0.52 0.17 0.09 0.15 0.62 0.05 0.25 0.33 0.44 0.23 0.09 0.14 0.47 0.04 0.23 0.29 0.34 0.26Ardabil 0.11 0.03 0.03 0.16 0.28 0.82 0.05 0.36 0.09 0.03 0.03 0.13 0.25 0.71 0.05 0.48 0.09 0.03 0.03 0.14 0.22 0.51 0.05 0.43Azerbaijan_East 0.14 0.13 0.16 0.06 0.49 0.36 0.60 0.19 0.12 0.12 0.14 0.05 0.43 0.32 0.51 0.26 0.11 0.12 0.13 0.05 0.35 0.28 0.41 0.29Azerbaijan_West 0.01 0.03 0.15 0.14 0.52 0.34 0.53 0.39 0.01 0.02 0.12 0.13 0.44 0.29 0.47 0.52 0.01 0.02 0.11 0.13 0.37 0.25 0.36 0.45Bushehr 0.13 0.01 0.00 0.47 0.02 0.62 0.52 0.66 0.11 0.01 0.00 0.40 0.02 0.54 0.46 0.78 0.11 0.01 0.00 0.32 0.02 0.40 0.36 0.57 ChaharMahal  and Bakhtiari0.02 0.01 0.01 0.18 0.03 0.70 0.29 0.04 0.02 0.01 0.01 0.16 0.02 0.61 0.25 0.06 0.02 0.01 0.01 0.15 0.03 0.45 0.23 0.07 Fars 0.12 0.14 0.17 0.12 0.60 0.50 0.48 0.29 0.10 0.13 0.15 0.11 0.52 0.43 0.42 0.40 0.11 0.12 0.15 0.11 0.39 0.34 0.35 0.38 Gilan 0.03 0.04 0.16 0.53 0.20 0.19 0.68 0.21 0.03 0.04 0.14 0.45 0.17 0.16 0.59 0.28 0.03 0.04 0.13 0.37 0.17 0.16 0.44 0.28Golestan 0.01 0.02 0.15 0.35 0.04 0.47 0.20 0.17 0.01 0.02 0.13 0.30 0.03 0.41 0.18 0.24 0.01 0.02 0.12 0.25 0.03 0.32 0.18 0.25Hamadan 0.04 0.13 0.22 0.24 0.23 0.35 0.54 0.23 0.05 0.11 0.20 0.21 0.20 0.31 0.46 0.20 0.06 0.12 0.17 0.19 0.20 0.26 0.38 0.20 Hormozgan 0.01 0.15 0.15 0.25 0.21 0.61 0.24 0.25 0.00 0.13 0.13 0.21 0.19 0.52 0.21 0.33 0.00 0.11 0.13 0.19 0.17 0.41 0.19 0.31 Ilam 0.04 0.01 0.15 0.04 0.49 0.47 0.08 0.25 0.04 0.01 0.13 0.04 0.42 0.41 0.06 0.34 0.04 0.01 0.12 0.04 0.35 0.34 0.06 0.35Isfahan 0.14 0.35 0.13 0.21 0.49 0.46 0.45 0.33 0.13 0.31 0.11 0.19 0.42 0.40 0.38 0.44 0.12 0.28 0.11 0.18 0.35 0.32 0.32 0.41Kerman 0.00 0.00 0.00 0.22 0.07 0.23 0.41 0.45 0.00 0.00 0.00 0.20 0.06 0.20 0.36 0.39 0.00 0.00 0.00 0.19 0.06 0.18 0.30 0.32Kermanshah 0.31 0.24 0.26 0.18 0.52 0.48 0.40 0.33 0.27 0.21 0.23 0.15 0.45 0.42 0.34 0.44 0.25 0.19 0.21 0.14 0.36 0.31 0.30 0.37Khorasan_North 0.08 0.02 0.03 0.69 0.15 0.18 0.16 0.45 0.07 0.02 0.03 0.61 0.13 0.15 0.14 0.57 0.07 0.02 0.03 0.43 0.13 0.15 0.13 0.42 Khorasan_Razavi 0.05 0.06 0.04 0.06 0.60 0.29 0.30 0.36 0.04 0.06 0.04 0.05 0.52 0.25 0.27 0.47 0.04 0.05 0.04 0.05 0.43 0.23 0.25 0.43 Khorasan_South 0.04 0.14 0.06 0.07 0.33 0.28 0.16 0.16 0.03 0.12 0.05 0.06 0.28 0.24 0.14 0.22 0.03 0.12 0.05 0.06 0.25 0.22 0.13 0.24Khuzestan 0.03 0.06 0.38 0.22 0.59 0.53 0.34 0.31 0.03 0.05 0.34 0.19 0.52 0.45 0.30 0.41 0.03 0.05 0.30 0.18 0.39 0.37 0.25 0.38Kohgiluyeh and  Boyerahmad0.02 0.05 0.14 0.00 0.31 0.02 0.16 0.02 0.02 0.05 0.12 0.00 0.28 0.02 0.15 0.03 0.02 0.05 0.12 0.00 0.23 0.02 0.13 0.04 Kurdistan 0.04 0.14 0.16 0.19 0.08 0.24 0.38 0.17 0.04 0.12 0.14 0.17 0.07 0.21 0.33 0.23 0.04 0.12 0.14 0.16 0.06 0.18 0.29 0.25 Lorestan 0.02 0.10 0.59 0.07 0.15 0.21 0.55 0.05 0.02 0.08 0.54 0.06 0.13 0.19 0.47 0.07 0.02 0.07 0.44 0.06 0.13 0.17 0.38 0.08 Markazi 0.18 0.03 0.11 0.16 0.39 0.51 0.66 0.29 0.16 0.02 0.10 0.14 0.34 0.43 0.58 0.39 0.15 0.02 0.10 0.13 0.31 0.36 0.45 0.37Mazandaran 0.26 0.22 0.31 0.58 0.74 0.70 0.80 0.50 0.23 0.19 0.27 0.50 0.64 0.60 0.68 0.64 0.22 0.18 0.26 0.43 0.47 0.47 0.52 0.51Qazvin 0.12 0.12 0.21 0.58 0.16 0.58 0.88 0.18 0.10 0.10 0.18 0.50 0.14 0.51 0.76 0.24 0.10 0.10 0.17 0.38 0.13 0.41 0.56 0.24Qom 0.11 0.14 0.15 0.33 0.40 0.47 0.43 0.17 0.10 0.12 0.13 0.29 0.34 0.41 0.37 0.24 0.08 0.12 0.13 0.26 0.29 0.35 0.35 0.25Semnan 0.32 0.15 0.07 0.04 0.59 0.42 0.51 0.43 0.28 0.13 0.06 0.03 0.52 0.37 0.44 0.55 0.26 0.13 0.06 0.03 0.40 0.33 0.38 0.44 Sistan and  Baluchistan0.02 0.05 0.25 0.27 0.13 0.18 0.15 0.41 0.02 0.04 0.22 0.24 0.10 0.16 0.13 0.53 0.01 0.04 0.21 0.23 0.10 0.15 0.12 0.44 Tehran 0.06 0.16 0.39 0.20 0.46 0.43 0.35 0.24 0.05 0.14 0.35 0.18 0.39 0.37 0.30 0.33 0.05 0.13 0.31 0.17 0.34 0.32 0.28 0.35 Yazd 0.38 0.46 0.43 0.31 0.27 0.84 0.86 0.37 0.34 0.42 0.38 0.28 0.23 0.73 0.76 0.49 0.30 0.33 0.33 0.25 0.21 0.53 0.56 0.43Zanjan 0.01 0.01 0.03 0.12 0.00 0.54 0.44 0.31 0.01 0.01 0.03 0.10 0.00 0.46 0.38 0.42 0.01 0.01 0.03 0.10 0.00 0.38 0.35 0.38 FPG=Fasting plasma glucose, IHD: Ischemic heart disease, PAF=Population attributable fraction",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75 minimum risk level lead to a considerable reduction in  cardiovascular disease’s disability-adjusted life years (6.8% in females and 3.1% in males).",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
Available from: http://www.vizhub.healthdata.,Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:75 http://www.ijpvmjournal.net/content/7/1/75 fractions to quantify the health burden of obesity.",Non-OADS,/arxiv_data1/oa_pdf/23/11/IJPVM-7-75.PMC4882967.pdf
"International Journal of Preventive Medicine 2016, 7:77 http://www.ijpvmjournal.net/content/7/1/77METHODS Study design This was a double‑blind random clinical trial with control  group (placebo).",Non-OADS,/arxiv_data1/oa_pdf/26/65/IJPVM-7-77.PMC4882968.pdf
"International Journal of Preventive Medicine 2016, 7:77 http://www.ijpvmjournal.net/content/7/1/77regarding the treatment groups.",Non-OADS,/arxiv_data1/oa_pdf/26/65/IJPVM-7-77.PMC4882968.pdf
"International Journal of Preventive Medicine 2016, 7:77 http://www.ijpvmjournal.net/content/7/1/77Therefore, particular attention has been paid to the rich  sources of omega‑3 for the treatment of many diseases,  especially mental illnesses in the recent years.",Non-OADS,/arxiv_data1/oa_pdf/26/65/IJPVM-7-77.PMC4882968.pdf
"International Journal of Preventive Medicine 2016, 7:77 http://www.ijpvmjournal.net/content/7/1/77evaluated by the Y oung Mania Rating Scale weekly, so in  future studies, patients should be evaluated on a weekly  basis.",Non-OADS,/arxiv_data1/oa_pdf/26/65/IJPVM-7-77.PMC4882968.pdf
"International Journal of Preventive Medicine 2016, 7:74 http://www.ijpvmjournal.net/content/7/1/74the elderly in Iran.",Non-OADS,/arxiv_data1/oa_pdf/c2/3c/IJPVM-7-74.PMC4882969.pdf
"International Journal of Preventive Medicine 2016, 7:74 http://www.ijpvmjournal.net/content/7/1/74Therefore, we avoid the repetition of the translating  process, and we used it with the consent of the authors.",Non-OADS,/arxiv_data1/oa_pdf/c2/3c/IJPVM-7-74.PMC4882969.pdf
"International Journal of Preventive Medicine 2016, 7:74 http://www.ijpvmjournal.net/content/7/1/74HPLP‑II was measured as 0.78.",Non-OADS,/arxiv_data1/oa_pdf/c2/3c/IJPVM-7-74.PMC4882969.pdf
"International Journal of Preventive Medicine 2016, 7:74 http://www.ijpvmjournal.net/content/7/1/74health responsibility, self‑efficacy, and ability to judge  and decide.",Non-OADS,/arxiv_data1/oa_pdf/c2/3c/IJPVM-7-74.PMC4882969.pdf
"International Journal of Preventive Medicine 2016, 7:74 http://www.ijpvmjournal.net/content/7/1/745.",Non-OADS,/arxiv_data1/oa_pdf/c2/3c/IJPVM-7-74.PMC4882969.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comI slew the fire breathing, hideous, CA headed dragon  a quarter‑century ago in a no holds barred contest to  the death.",Non-OADS,/arxiv_data1/oa_pdf/81/98/SNI-7-60.PMC4882970.pdf
Surg Neurol Int  2016;7:60. http://surgicalneurologyint.com/I-slew-the-beast!/,Non-OADS,/arxiv_data1/oa_pdf/81/98/SNI-7-60.PMC4882970.pdf
"Surgical Neurology International 2016, 7:60  http://www.surgicalneurologyint.com/content/7/1/60chemotherapy in case a few of its errant scales had been  left floating around inside me.",Non-OADS,/arxiv_data1/oa_pdf/81/98/SNI-7-60.PMC4882970.pdf
"Surgical Neurology International 2016, 7:60  http://www.surgicalneurologyint.com/content/7/1/60he acknowledged my infirmity?",Non-OADS,/arxiv_data1/oa_pdf/81/98/SNI-7-60.PMC4882970.pdf
Available  from: http://www.wsj.com/articles/SB87038394787908500.,Non-OADS,/arxiv_data1/oa_pdf/81/98/SNI-7-60.PMC4882970.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowErratum Erratum: A rare intracranial tumor consisting of malignant  anaplastic and papillary meningioma subtypes In the article titled, “ A rare intracranial tumor consisting of malignant anaplastic and papillary meningioma subtypes”  published in page 21, issue 1, vol.",Non-OADS,/arxiv_data1/oa_pdf/57/02/SNI-7-58.PMC4882971.pdf
"International Journal of Preventive Medicine 2016, 7:76 http://www.ijpvmjournal.net/content/7/1/76nucleophilic and lipophilic agent and due to this property,  it can diffuse through the body and can change DNA  structure.",Non-OADS,/arxiv_data1/oa_pdf/a9/8d/IJPVM-7-76.PMC4882972.pdf
"International Journal of Preventive Medicine 2016, 7:76 http://www.ijpvmjournal.net/content/7/1/76Lung cancers Hosseini‑khalili et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/8d/IJPVM-7-76.PMC4882972.pdf
"International Journal of Preventive Medicine 2016, 7:76 http://www.ijpvmjournal.net/content/7/1/76results should be cautiously interpreted due to some  confounding factors within their study.",Non-OADS,/arxiv_data1/oa_pdf/a9/8d/IJPVM-7-76.PMC4882972.pdf
Available from: https://www.google.com/ patents/.,Non-OADS,/arxiv_data1/oa_pdf/a9/8d/IJPVM-7-76.PMC4882972.pdf
Available	 from:		http://www.inchem.org/documents/.,OADS,/arxiv_data1/oa_pdf/a9/8d/IJPVM-7-76.PMC4882972.pdf
"International Journal of Preventive Medicine 2016, 7:76 http://www.ijpvmjournal.net/content/7/1/76malignancies and aplastic anemia following exposure to mustard gas.",Non-OADS,/arxiv_data1/oa_pdf/a9/8d/IJPVM-7-76.PMC4882972.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/80/main.PMC4883047.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.02.001 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/80/main.PMC4883047.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/70/main.PMC4883053.pdf
It  is  of  note  that  mam- mogram  or  ultrasound  study  do  not  present  proper  pathological http://dx.doi.org/10.1016/j.ijscr.2016.02.003 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/70/main.PMC4883053.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/70/main.PMC4883053.pdf
"2011  (2011),  http://dx.doi.org/10.1155/ 2011/517047 ,  517047.",Non-OADS,/arxiv_data1/oa_pdf/3e/70/main.PMC4883053.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/9d/main.PMC4883054.pdf
With  their  mutation  frequency  and  extent  of http://dx.doi.org/10.1016/j.ijscr.2016.02.004 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/fc/9d/main.PMC4883054.pdf
"[33]  NCCN  (National  Comprehensive  Cancer  Network),  Breast  Cancer  Guidelines http://www.nccn.org .",Non-OADS,/arxiv_data1/oa_pdf/fc/9d/main.PMC4883054.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4883056.pdf
"The  ultrasound  showed  a  hypoechoic,  het- erogeneous,  irregular  and  poorly  limited  mass  17  mm,  located  at http://dx.doi.org/10.1016/j.ijscr.2016.02.005 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/main.PMC4883056.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/db/main.PMC4883057.pdf
The  endobronchial  biopsies  showed  ﬁbrinoid  material  and  micro- calciﬁcations in the contest  of  a  nonspeciﬁc  granulation  tissue  but http://dx.doi.org/10.1016/j.ijscr.2016.02.006 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/ad/db/main.PMC4883057.pdf
Available from: http://www.ibge.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/80/fd/PM-12-195.PMC4883078.pdf
Available from: http://www.anvisa.gov.br/hotsite/genericos/legis/ resolucoes/2003/899_03re_e.pdf.,OADS,/arxiv_data1/oa_pdf/05/cf/PM-12-285.PMC4883093.pdf
Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/Scientific_guideline/2011/09/WC500113209.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/cf/PM-12-285.PMC4883093.pdf
Available at: http://www.hc-sc.gc.ca/ dhp-mps/medeff/advisories-avis/review-examen/serotonin-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/62/88/40801_2014_Article_4.PMC4883185.pdf
Available at: http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM342225.pdf .,Non-OADS,/arxiv_data1/oa_pdf/62/88/40801_2014_Article_4.PMC4883185.pdf
Seri- ousness of ADRs was deﬁned in accordance with the ICHE2A guideline ( http://www.ich.org/ﬁleadmin/Public_Web_ Site/ICH_Products/Guidelin es/Efﬁcacy/E2A/Step4/E2A_ Guideline.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/a8/17/40801_2014_Article_5.PMC4883186.pdf
Information on case reports of possible adverse drug reactions [in Japanese].http://www.info.pmda.go.jp/fsearchnew/jsp/menu_fukusayou_ base.jsp .,Non-OADS,/arxiv_data1/oa_pdf/a8/17/40801_2014_Article_5.PMC4883186.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/63/0e/40801_2015_Article_21.PMC4883189.pdf
2014. http://www.cvs.com/drug/qsymia/oral- capsule-extended-release/15-92mg .,Non-OADS,/arxiv_data1/oa_pdf/63/0e/40801_2015_Article_21.PMC4883189.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/68/f2/40801_2015_Article_22.PMC4883190.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ce/3b/40801_2015_Article_23.PMC4883191.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/01/1f/40801_2015_Article_24.PMC4883192.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/de/14/40801_2015_Article_25.PMC4883193.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: https://www.health.govt.nz/system/ﬁles/documents/pages/ controlled-drugs-prescribing-v1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
New Zealand: Statistics New Zealand; 2013 [cited 2014 30 Mar].Available from: http://www.stats.govt.nz/Census/2013 .,OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: http://www.stats.govt.nz/browse_for_stats/population/ estimates_and_projections/NationalPopulationEstimates_HOTPJun09qtr/Commentary .,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Avail- able from: http://www.bpac.org.nz/BPJ/2008/February/pain.aspx .,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: http://www.health.govt.nz/publ ication/tatau-kahukura-maori- health-chart-book-2010-2nd-edition .,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Availablefrom: http://www.saferx.co.nz/full/triplewhammy.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: http://www.bpac.org.nz/ bpj/2013/october/nsaids.aspx .,OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: http://www.legislation.govt.nz/act/public/ 1975/0116/latest/DLM436576.html .,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: http://www.health.govt.nz/new-zealand- health-system/overview-health-system/funding .,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
Available from: http://www.nzf.org.,Non-OADS,/arxiv_data1/oa_pdf/4e/97/40801_2015_Article_26.PMC4883194.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/b2/28/40801_2015_Article_27.PMC4883195.pdf
Avail- able at: http://www.who.int/mediacentre/factsheets/fs312/en/ (2014).,Non-OADS,/arxiv_data1/oa_pdf/b2/28/40801_2015_Article_27.PMC4883195.pdf
London: Royal College of Physicians (UK); 2010. http://www.ncbi.nlm.nih.gov/ books/NBK116530/ .,Non-OADS,/arxiv_data1/oa_pdf/1a/85/40801_2014_Article_6.PMC4883196.pdf
2011. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/e0/6a/40801_2015_Article_11.PMC4883198.pdf
2012. http://www.has-sante.fr/portail/jcms/r_1439689/fr/ contraceptifs-oraux-estroprogestatifs-preferez-les-pilules-de-1re- ou-2e-generation-ﬁche-bum .,Non-OADS,/arxiv_data1/oa_pdf/e0/6a/40801_2015_Article_11.PMC4883198.pdf
2004. http://www.choisirsacontraception.fr/pdf/contraception_ recommandations_has.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e0/6a/40801_2015_Article_11.PMC4883198.pdf
http://www.xpr-so.com/pages/Public/Accueil.aspx .,Non-OADS,/arxiv_data1/oa_pdf/e0/6a/40801_2015_Article_11.PMC4883198.pdf
Available at: http://www.fda.gov/Drugs/Drug Safety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053171.htm .,Non-OADS,/arxiv_data1/oa_pdf/27/c7/40801_2015_Article_13.PMC4883200.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm 124830.htm .,Non-OADS,/arxiv_data1/oa_pdf/27/c7/40801_2015_Article_13.PMC4883200.pdf
2010 Available at: http://www.medpac.gov/documents/Jun10DataBook EntireReport.pdf .,OADS,/arxiv_data1/oa_pdf/27/c7/40801_2015_Article_13.PMC4883200.pdf
Available at:http://www.cms.hhs.gov/IdentiﬁableDataFiles/02_StandardAnaly ticalFiles.asp .,OADS,/arxiv_data1/oa_pdf/27/c7/40801_2015_Article_13.PMC4883200.pdf
Available at: http://www.resdac.umn.edu/ Available_CMS_Data.asp .,OADS,/arxiv_data1/oa_pdf/27/c7/40801_2015_Article_13.PMC4883200.pdf
Available at:http://www2.sas.com/proceedings/sugi26/p214-26.pdf .A c c e s s e d3 Dec 2010.,Non-OADS,/arxiv_data1/oa_pdf/27/c7/40801_2015_Article_13.PMC4883200.pdf
Available at: http://www.nesug.org/ proceedings/nesug07/sa/sa01.pdf .,Non-OADS,/arxiv_data1/oa_pdf/27/c7/40801_2015_Article_13.PMC4883200.pdf
Available from http://www.deutsche-diabetes- gesellschaft.de/leitlinien/englische-versionen.html .,Non-OADS,/arxiv_data1/oa_pdf/d9/76/40801_2015_Article_14.PMC4883201.pdf
Available fromhttp://www.aok.de/bayern/gesundheit/behandlung-programme-fuer-chronisch-kranke-aok-curaplan-englisch-245265.php .A c - cessed 16 Dec 2014.,Non-OADS,/arxiv_data1/oa_pdf/d9/76/40801_2015_Article_14.PMC4883201.pdf
The ‘‘Rabat Declaration for Pharmacovigilance in the Eastern Mediterranean Region and Arab Countries’’ canbe found under the following link: http://www.capm.ma/ Doc/Workshop/RAPV_2014_Communique_Final_Ag.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ee/6e/40801_2015_Article_15.PMC4883202.pdf
http://www.deloitte.com/assets/Dcom-United States/Local%20Assets/Docume nts/us_lshc_WhatPayersWant_ 091109.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5e/36/40801_2015_Article_18.PMC4883205.pdf
http://www.managedcaremag.,Non-OADS,/arxiv_data1/oa_pdf/5e/36/40801_2015_Article_18.PMC4883205.pdf
2011. http://www.bls.gov/cpi/cpid12av.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5e/36/40801_2015_Article_18.PMC4883205.pdf
http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/44/7a/40801_2015_Article_8.PMC4883207.pdf
http://novascotia.ca/dhw/nspbcp/docs/IVIG- SCIG-Utilization-Atlantic-Provinces-FY-2009-10.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b5/32/40801_2015_Article_9.PMC4883208.pdf
March 2009. http://transfusionontario.org/en/cmdownloads/categories/ reports/ .,Non-OADS,/arxiv_data1/oa_pdf/b5/32/40801_2015_Article_9.PMC4883208.pdf
The TGA maintains the Database of Adverse Event Notiﬁcations (DAEN: http://www.tga.gov.au/daen/daen- entry.aspx ).,OADS,/arxiv_data1/oa_pdf/09/c8/40801_2015_Article_28.PMC4883210.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.202 S. A. Hollingworth et al.",Non-OADS,/arxiv_data1/oa_pdf/09/c8/40801_2015_Article_28.PMC4883210.pdf
2007. http://www.fdagov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm051285htm .,Non-OADS,/arxiv_data1/oa_pdf/09/c8/40801_2015_Article_28.PMC4883210.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/98/4f/40801_2015_Article_29.PMC4883211.pdf
MEPs 2014. http://europarl.europa.eu/ .,Non-OADS,/arxiv_data1/oa_pdf/98/4f/40801_2015_Article_29.PMC4883211.pdf
ATC/DDD index 2014. http://www.whocc.no/atcddd/ .,OADS,/arxiv_data1/oa_pdf/98/4f/40801_2015_Article_29.PMC4883211.pdf
Base des me ´dicaments et informations tari- faires 2014. http://www.codage.ext.cnamts.fr/codif/bdm_it/index.,Non-OADS,/arxiv_data1/oa_pdf/98/4f/40801_2015_Article_29.PMC4883211.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e2/9f/40801_2015_Article_30.PMC4883212.pdf
A national clinical guideline 123.Edinburgh: SIGN; 2011. http://www.sign.ac.uk/pdf/sign123.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/9f/40801_2015_Article_30.PMC4883212.pdf
London: NICE; 2010. http://www.nice.org.uk/ nicemedia/pdf/TA130guidance.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/9f/40801_2015_Article_30.PMC4883212.pdf
http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/landing/epar_search.jsp&mid=WC0b01ac05800 1d124 .,Non-OADS,/arxiv_data1/oa_pdf/e2/9f/40801_2015_Article_30.PMC4883212.pdf
http://ec.europa.eu/social/main.jsp?catId=858 .,Non-OADS,/arxiv_data1/oa_pdf/e2/9f/40801_2015_Article_30.PMC4883212.pdf
Combinaison simultane ´e des re ´sultats releve ´s dans les essais randomise ´s et les e ´tudes observationnelles avec groupe contro ˆle.http://www.rees-france.com/article.php3?id_article=744 &var_recherche=polyarthrite .,Non-OADS,/arxiv_data1/oa_pdf/e2/9f/40801_2015_Article_30.PMC4883212.pdf
Paris:HCSP; 2012. p. 56. http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine ?clefr=258 .,Non-OADS,/arxiv_data1/oa_pdf/e2/9f/40801_2015_Article_30.PMC4883212.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/40801_2015_Article_31.PMC4883213.pdf
Available at: http://www.uea.ac.uk/mac/comm/media/ press/2011/June/Anticholinergics ?study ?drug?list.,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/40801_2015_Article_31.PMC4883213.pdf
Available at: http://graphpad.com/quickcalcs/ contingency1/ .,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/40801_2015_Article_31.PMC4883213.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4f/9d/40801_2015_Article_33.PMC4883215.pdf
Available from: http://www.heartfoundation.org.au .,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/40801_2015_Article_33.PMC4883215.pdf
Available from: http://www.nice.org.uk/ guidance/cg127 .,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/40801_2015_Article_33.PMC4883215.pdf
"Open Access This article is distributed under the terms of the Crea- tive Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium,provided you give appropriate credit to the original author(s) and thesource, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/62/cc/40801_2015_Article_34.PMC4883216.pdf
2014. http://www.jspe.jp/mt- static/FileUpload/ﬁles/JSPE_DB_TF_E.pdf .,OADS,/arxiv_data1/oa_pdf/62/cc/40801_2015_Article_34.PMC4883216.pdf
2002. http://www.niph.go.jp/wadai/ ekigakurinri/guidelines.pdf .,Non-OADS,/arxiv_data1/oa_pdf/62/cc/40801_2015_Article_34.PMC4883216.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3e/f4/40801_2015_Article_35.PMC4883217.pdf
"1 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6b/4c/40801_2015_Article_36.PMC4883218.pdf
Available from: http://www.whocc.no/ atc_ddd_methodology/who_collaborating_centre/ .,OADS,/arxiv_data1/oa_pdf/6b/4c/40801_2015_Article_36.PMC4883218.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Prevnar 13 Childhood Immunization Program 317",Non-OADS,/arxiv_data1/oa_pdf/ef/c5/40801_2015_Article_37.PMC4883219.pdf
"panic disorder, OCDBulimia nervosaPremenstrual dysphoric disorder18 (8.1) 10–40 mg per day Desvenlafaxine Major depression: 200 mg per day4 (1.8) 50–100 mg mornings Duloxetine Depression: 60 mg per dayGeneralised anxiety disorder: 120 mg per dayDiabetic neuropathy: 60 mg per day6 (2.7) 30–120 mg per day Escitalopram (20 mg per day for all) Major depression Generalised anxiety disorder Social phobiaOCD21 (9.5) 10–20 mg per day usually mornings Fluoxetine Major depression: 60 mgOCD: 80 mgPremenstrual dysphoric disorder: 20 mg2 (0.9) 20 mg morning Fluvoxamine Major depression: 300 mgOCD: 300 mg per day2 (0.9) 100–200 mg at night Mirtazapine Major depression: 60 mg per day17 (7.7) 10–45 mg per day Paroxetine Depression: 50 mgGeneralised anxiety disorder: 20 mgOCD/panic disorder: 50 mg per day6 (2.7) 20 mg per day Sertraline Depression: 200 mg per dayOCD: 200 mg per dayPanic disorder: 50 mg per day28 (12.7) 50–100 mg per day Venlafaxine Major depression: 225 mgGeneralised anxiety disorder: 225 mgPanic disorder: 225 mgSocial phobia: 225 mg9 (4.1) 75–300 mg per day Using two or more antidepressants 5 (2.3) Source: Australian Medicines Handbook 2015, http://www.amh.net.au OCD obsessive compulsive disorder292 D. Goeman et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/7a/40801_2015_Article_38.PMC4883220.pdf
"3.6 Antidepressants A total of 103 persons had been prescribed antidepres- sant(s); 38 of them had a diagnosis of depressionTable 2 Antipsychotics, indication for use and recommended dosage, number of clients using antipsychotic medicines and prescribed dose Antipsychotic, indication and recommended maximum dosage n=39 (17.6 %) Prescribed dose as documented in health record (range) Haloperidol Acute and chronic psychosis: 1–5 mg, 2–3 times per dayAcute mania in bipolar: 5–10 mg, 2 hourly when requiredNot recommended for BPSDLong-acting injection: 50–300 mg every 4 weeksIn elderly, use low doses: 0.5–10 mg/dayn=4 (1.8) 0.5 mg per day Olanzapine Schizophrenia: 20 mg per day Bipolar: 20 mg per dayBPSD: no listingn=5 (2.3) 1.25–2.5 mg at night ( n=4) 15 mg morning ( n=1) Paliperidone Schizophrenia: 25–150 mg once a monthBPSD: no listingn=1 (0.5) 75 mg monthly Pericyazine Schizophrenia: 30 mg per dayNot recommended for BPSDn=2 (0.9) 10 mg at night ( n=1) 2.5 mg three times per day (n=1) Quetiapine Schizophrenia: 800 mg per dayBipolar: 800 mg per dayGeneral anxiety disorder: 150 mg per dayAdjunct in depression: 300 mg per dayNot recommend for BPSDn=9 (4.1) 25 mg–600 mg per day Risperidone Schizophrenia and related psychoses: 4–6 mg per dayBipolar disorder: 2–6 mg/dayBPSD: 0.25–2 mg per day after non-drug strategies have been unsuccessfulConduct and other disruptive behaviour disorders in people with sub-average intellectual functioning or mental retardation: 0.5–1.5 mg (lower doses if \50 kg Behavioural disorders in autism: 0.5–2.5 mg per dayn=18 (8.1) 0.5 mg ( n=12) 0.5 mg as needed ( n=1) 1m g( n=3) 3m g( n=1) 5m g( n=1) Prescribed more than one antipsychotic n=0 Source: Australian Medicines Handbook 2015, http://www.amh.net.au BPSD Behavioural and psychological symptoms of dementiaPsychotropic Medicines Use in Dementia 293",Non-OADS,/arxiv_data1/oa_pdf/4f/7a/40801_2015_Article_38.PMC4883220.pdf
"None of these ﬁve cases had a diagnosis of depression, insomnia or chronic neuropathic pain docu- mented in their records.Table 3 Benzodiazepines, indication for use and recommended dosage, number of clients using Benzodiazepines and prescribed dose range Benzodiazepines Indication and recommended dosagen=69 (31.2 %) Prescribed dose as documented in person’s health record (range) Alprazolam Anxiety/panic disorder: 10 mg per day5 (2.3) 0.25–3 mg per day Clonazepam Epilepsy: 8 mg per day10 (4.5) 0.5–0.8 mg every 4 h 0.3–0.5 mg as needed2–30 mg as needed/at night Diazepam Anxiety: 30 mg per day Muscle spasm: 60 mg per day13 (5.9) 2–5 mg per day Nitrazepam Hypnotic: 10 mg per day2 (0.9) 5 mg per day Oxazepam Severe anxiety: 120 mg per dayHypnotic: 30 mg per day12 (5.4) 15–30 mg at night Temazepam Hypnotic: 20 mg per dayLower doses recommended in elderly25 (11.3) 10–20 mg at night/as needed Midazolam Palliative care: 2.5–5 mg hourly2 (0.9) 1–2 mg every 2–4 h ( n=1) 2 mg intravenously as needed ( n=1) Total 69 (31.2) Source: Australian Medicines Handbook 2015, http://www.amh.net.au Table 4 Number of clients using other psychotropic medicines Indication and recommended dosage n=23 (10.4 %) Prescribed dose as documented in health record (range) Memantine Moderate to severe AD: 20 mg once daily7 (3.2) 10–20 mg per day Carbamazepine Epilepsy: 2 g daily Bipolar disorder: 1.6 g dailyNeuralgia: 1.2 g daily4 (1.8) 100-300 mg twice a day Lithium Bipolar disorder: 2500 mg daily2 (0.9) 250 mg twice a day Sodium valproate Epilepsy: 2500 mg dailyBipolar disorder: 1000–2000 mg daily9 (4.1) 100–1200 mg per day Zolpidem Insomnia: 10 mg daily (conventional tablet), 12.5 mg daily (controlled-release tablet)1 (0.5) 10 mg at night Using two or more other psychotropic medicines 12 (5.4) Source: Australian Medicines Handbook 2015, http://www.amh.net.au ADAlzheimer’s disease294 D. Goeman et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/7a/40801_2015_Article_38.PMC4883220.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4f/7a/40801_2015_Article_38.PMC4883220.pdf
"Retrieved 20March 2009, from http://www.nps.org.au/__data/assets/pdf_ﬁle/ 0019/16921/ppr07.pdf .",OADS,/arxiv_data1/oa_pdf/4f/7a/40801_2015_Article_38.PMC4883220.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/53/c3/40801_2015_Article_39.PMC4883221.pdf
2013. http://www.truvenhealth.,Non-OADS,/arxiv_data1/oa_pdf/53/c3/40801_2015_Article_39.PMC4883221.pdf
"Washington, DC: US Bureau of Labor Statistics 2013. http://www.bls.gov/cpi/data.htm .",OADS,/arxiv_data1/oa_pdf/53/c3/40801_2015_Article_39.PMC4883221.pdf
"Conﬂict of interest The authors declare no conﬂict of interests related to this letter.Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/05/f2/40801_2015_Article_40.PMC4883222.pdf
Available from: http://www.nicedsu.org.,Non-OADS,/arxiv_data1/oa_pdf/05/f2/40801_2015_Article_40.PMC4883222.pdf
Available from: http://www.ncbi.nlm.nih.gov/ books/NBK126104/ .,Non-OADS,/arxiv_data1/oa_pdf/05/f2/40801_2015_Article_40.PMC4883222.pdf
"License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit tothe original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a2/4f/40744_2015_Article_15.PMC4883262.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.Rheumatol Ther (2015) 2:99–111 107",Non-OADS,/arxiv_data1/oa_pdf/f7/05/40744_2015_Article_16.PMC4883263.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/43/e6/40744_2015_Article_17.PMC4883264.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any150 Rheumatol Ther (2015) 2:141–151",Non-OADS,/arxiv_data1/oa_pdf/b4/6f/40744_2015_Article_18.PMC4883265.pdf
http://www.cms.,Non-OADS,/arxiv_data1/oa_pdf/b4/6f/40744_2015_Article_18.PMC4883265.pdf
http://www.cms.gov/ Medicare/Quality-Initiatives-Patient-Assessment-Ins truments/PQRS/Payment-Adjustment-Information.html .,Non-OADS,/arxiv_data1/oa_pdf/b4/6f/40744_2015_Article_18.PMC4883265.pdf
http://www.ahrq.gov/workingforquality/ about.htm .,Non-OADS,/arxiv_data1/oa_pdf/b4/6f/40744_2015_Article_18.PMC4883265.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e0/a0/40744_2015_Article_19.PMC4883266.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ee/0b/40744_2015_Article_21.PMC4883268.pdf
National Institute of Health and Care Excellence; 2009.Available from: http://www.nice.org.uk/guidance/ cg79/chapter/introduction .,Non-OADS,/arxiv_data1/oa_pdf/ee/0b/40744_2015_Article_21.PMC4883268.pdf
"2006, http://www.jeolusa.com/DesktopModules/Bring2mind/DMX/Download.",Non-OADS,/arxiv_data1/oa_pdf/ad/90/10.1177_2041731414557112.PMC4883592.pdf
"Color online-figures for A and B are available at http://www.jclinrheum.com.IMAGES JCR: Journal of Clinical Rheumatology Volume 22, Number 4, June 2016 www.jclinrheum.com 215",Non-OADS,/arxiv_data1/oa_pdf/b1/92/rhu-22-215.PMC4883639.pdf
Available at: http://www.contactlensjournal.com/art icle/S1367-0484%2814%2900165-9/ fulltext.,Non-OADS,/arxiv_data1/oa_pdf/51/76/opx-93-619.PMC4883641.pdf
Available at: http://www.opticianonline.net/defining-eye-enhancement/.,Non-OADS,/arxiv_data1/oa_pdf/51/76/opx-93-619.PMC4883641.pdf
Available at: http://cph.uiowa.edu/work safe/pubs/bulletin/Dec-2013.html.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
"Available at: http://www.cdc.gov/flu/news/updated-vaccine-effectiveness-2014-15.htm Published March 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
"Available at: http://www.cdc.gov/niosh/topics/flu/guidance.html Updated February 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://www.prnews- wire.com/news-releases/office-space-per-worker-will-drop-to-100-square- feet-or-below-for-many-companies-within-five-years-according-to-new- research-from-corenet-global-140702483.html.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://www.shrm.org/research/surveyfindings/docu- ments/kronos_us_executive_summary_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://ww2.cfo.com/health-benefits/2015/11/hike-health-care-costs-sinks- 20-year-low/.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://www.who.int/gpsc/ tools/faqs/system_change/en/.,OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://www.ihi.org/resources/ pages/tools/howtoguideimprovinghandhygiene.aspx.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://CRAN.R-project.org/package=lme4.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://www.cdc.gov/h1n1flu/pdf/handwashing.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
"Available at: http://www.cdc.gov/flu/ pdf/freeresources/updated/everyday_preventive_9-24.pdf Updated August 21, 2012.",Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: https://www.whi- tehouse.gov/sites/default/files/docs/national_action_plan_for_combatin- g_antibotic-resistant_bacteria.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://www.cdc.gov/drugresistance/ threat-report-2013.,OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
Available at: http://cris.cc.nih.- gov/pptemp/pt_care/pdfs/vre.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/7e/joem-58-e231.PMC4883643.pdf
"An overview of the outcome measures of the EPS, the items and response options, the reliability of the scales and the operationalization of the outcome measures can be found in the online only Appendix Table S1 (http://links.lww.com/JOM/A263).",OADS,/arxiv_data1/oa_pdf/2c/9d/joem-58-0575.PMC4883645.pdf
"The items used, their operationalization, and the reliability of both of these outcome measures are described in the online only Appendix Table S1 (http://links.lww.com/JOM/A263).",OADS,/arxiv_data1/oa_pdf/2c/9d/joem-58-0575.PMC4883645.pdf
"Report, January 2013. https://www.weforum.org/reports/work- place-wellness-alliance-making-right-investment-employee-health-and- power-metrics.",Non-OADS,/arxiv_data1/oa_pdf/2c/9d/joem-58-0575.PMC4883645.pdf
http://www.monitorarbeid.tno.nl/publicaties/ nea-2013.,Non-OADS,/arxiv_data1/oa_pdf/2c/9d/joem-58-0575.PMC4883645.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/a3/ott-9-3059.PMC4883802.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3059–3065OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3059Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9547 6URG4  expression is a novel prognostic factor for  the progression of nasopharyngeal carcinoma and  overall survival of patient guodong Yu1,* Qingxiang Meng2,* Tian Zhang1 chen Zeng1 Benfu he3 shanshan Zhang1 1enT and hn surgery Department,  affiliated hospital of guizhou  Medical University, guiyang, guizhou,  2Department of Otorhinolaryngology –  head and n eck surgery, guangzhou  First People’s hospital, guangzhou  Medical University, guangdong,  3Oncology Department,  Pla421 hospital, guangzhou,  People’s republic of china *These authors contributed equally to  this workAbstract:  URG4, a novel oncogene, is involved in the development and progression of various  tumors.",Non-OADS,/arxiv_data1/oa_pdf/59/a3/ott-9-3059.PMC4883802.pdf
"For example,  it is a natural product of hepatitis B × antigen (HB ×Ag), which participates in correspondence: guodong Yu enT and hn surgery Department,  Affiliated Hospital of Guizhou Medical  University, no 28 guiyi street, Yunyan  District, guiyang, guizhou 55004,  People’s republic of china Tel +86 851 8675 8678 Fax +86 851 8675 8678 email entyunose2015@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Yu et al Running head recto: URG4  as a novel prognostic factor for NPC DOI: http://dx.doi.org/10.2147/OTT.S95476",Non-OADS,/arxiv_data1/oa_pdf/59/a3/ott-9-3059.PMC4883802.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/59/a3/ott-9-3059.PMC4883802.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/a3/ott-9-3059.PMC4883802.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/2b/opth-10-929.PMC4883803.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 929–934Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  929Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10241 4Comparison of ab externo trabeculotomy in   primary open-angle glaucoma and uveitic  glaucoma: long-term outcomes antony William Martin s spitzer Deshka Doycheva spyridon Dimopoulos Martin alexander leitritz Bogomil Voykov Centre for Ophthalmology, University  hospital Tübingen, Tübingen, germanyBackground:  The aim of this study was to compare the long-term outcomes of ab externo  trabeculotomy in primary open-angle glaucoma (POAG) and uveitic glaucoma (UG).",Non-OADS,/arxiv_data1/oa_pdf/f3/2b/opth-10-929.PMC4883803.pdf
"First, is there a difference in the efficacy of surgical procedures in POAG Correspondence: Bogomil Voykov Centre for Ophthalmology, University  hospital Tübingen, schleichstraße 12-16,  72076 Tübingen, germany Tel +49 7071 298 3721 Fax +49 7071 29 5455 email bogomil.voykov@med.uni- tuebingen.d e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: William et al Running head recto: Ab externo trabeculotomy in POAG and UG DOI: http://dx.doi.org/10.2147/OPTH.S102414",Non-OADS,/arxiv_data1/oa_pdf/f3/2b/opth-10-929.PMC4883803.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/2b/opth-10-929.PMC4883803.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/2b/opth-10-929.PMC4883803.pdf
"dovepress.com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/e2/ijgm-9-147.PMC4883804.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Evaluation of immunological indices in HIV- infected patients with chronic hepatitis C in  Kazakhstan Nazgul Sarsekeyeva1,2 Bakhyt Kosherova3 1Department of Infectious Diseases  and Dermatovenerology, Karaganda  State Medical University, 2Karaganda  Regional Center for the AIDS  Prevention and Control, 3Rectorate of  Karaganda State Medical University,   Karaganda, Kazakhstan Correspondence: Nazgul Sarsekeyeva   Department of Infectious Diseases and  Dermatovenerology, Karaganda State  Medical University, 100019 Krivoguz str.",Non-OADS,/arxiv_data1/oa_pdf/98/e2/ijgm-9-147.PMC4883804.pdf
Available from: http://rcaids.kz/ ru/publications/page3796 /.,Non-OADS,/arxiv_data1/oa_pdf/98/e2/ijgm-9-147.PMC4883804.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.,OADS,/arxiv_data1/oa_pdf/98/e2/ijgm-9-147.PMC4883804.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/98/e2/ijgm-9-147.PMC4883804.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/e2/ijgm-9-147.PMC4883804.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/02/ott-9-3049.PMC4883805.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3049–3057OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3049Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10094 6Details of out-field regional recurrence after  involved-field irradiation with concurrent  chemotherapy for locally advanced esophageal  squamous cell carcinoma Xiaoli Zhang1,2 Jinming Yu1,2 Minghuan li2 hui Zhu2 1Department of Oncology, renmin  hospital of Wuhan University, Wuhan,   2Department of radiation Oncology,   shandong cancer hospital affiliated  to shandong University, shandong  academy of Medical sciences, Jinan,   People’s republic of chinaBackground:  The purpose of this study was to describe the patterns of out-field regional  recurrence after involved-field irradiation (IFI) in definitive concurrent chemoradiotherapy  (CCRT) for locally advanced esophageal squamous cell carcinoma (LA-ESCC) and identify  the possible risk factors.",Non-OADS,/arxiv_data1/oa_pdf/77/02/ott-9-3049.PMC4883805.pdf
"Keywords:  failure patterns, prognosis, risk factors Introduction Esophageal cancer, as a highly invasive and metastatic tumor, ranks among the top  five leading causes of morbidity and mortality in the People’s Republic of China.1  Due to its biological and histological specificity, lymph node (LN) metastases are  common, appearing early in the disease and often in “skip” patterns.2–4 A large majority  of esophageal cancers are diagnosed at locally advanced stage with extensive nodal correspondence: Jinming Yu Department of radiation Oncology,  shandong cancer hospital and institute,  no 440 Jiyan road, Jinan, shandong  250117, People’s republic of china Tel +86 531 8798 4729 Fax +86 531 8798 4079 email sdyujinming@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Out-field regional recurrence of esophageal carcinoma DOI: http://dx.doi.org/10.2147/OTT.S100946",Non-OADS,/arxiv_data1/oa_pdf/77/02/ott-9-3049.PMC4883805.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/77/02/ott-9-3049.PMC4883805.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/02/ott-9-3049.PMC4883805.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 151–167International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  151RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S8836 7Lifestyle changes and the risk of developing  endometrial and ovarian cancers: opportunities  for prevention and management Anna L Beavis1,* Anna Jo Bodurtha Smith2,* Amanda Nickles Fader1 1Department of Gynecology and  Obstetrics, The Kelly Gynecologic  Oncology Service, Johns Hopkins  Medicine, Baltimore, MD, 2Harvard  Medical School, Boston, MA, USA *These authors contributed equally  to this workAbstract:  Modifiable lifestyle factors, such as obesity, lack of physical activity, and smoking,  contribute greatly to cancer and chronic disease morbidity and mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
"The worldwide obesity epidemic may fuel an increase Correspondence: Amanda Nickles Fader The Kelly Gynecologic Oncology Service,  Johns Hopkins Medicine, 600 North  Wolfe Street, Phipps 287, Baltimore,  MD 21287, USA Tel +1 410 955 8240 email afader1@jhmi.ed u Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: Beavis et al Running head recto: Lifestyle factors and gynecologic cancer risk DOI: http://dx.doi.org/10.2147/IJWH.S88367",Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
Available from:  http://seer.cancer.gov/csr/1975_201 2.,Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01697566?,Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
Available from: https://clinicaltrials.gov/ct2/show/NC T02065687?term =endometrial +cancer +metformin&rank =5.,Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT00719303?,Non-OADS,/arxiv_data1/oa_pdf/d0/d0/ijwh-8-151.PMC4883806.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5d/3e/ceor-8-227.PMC4883807.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/5d/3e/ceor-8-227.PMC4883807.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).clinicoeconomics and Outcomes research 2016:8 227–233submit your manuscript | www.dovepress.co m Dove press  227 http: //dx.doi.org/10.2147/CEOR.S9731 9Potential resource and cost saving analysis of  subcutaneous versus intravenous administration  for rituximab in non-hodgkin’s lymphoma and  for trastuzumab in breast cancer in 17 italian  hospitals based on a systematic survey clemente Ponzetti1 Monica canciani2 Massimo Farina2 sara era3 stefan Walzer4,5 1group Policlinic Monza, alessandria,   national scientific associazione  nazionale dei Medici delle Direzioni  Ospedaliere (n ational association  of hospital Physicians), Bologna,   2studio emmeffe s.r.l, Milan, 3roche  s.p.a., Monza, italy; 4Mars Market  access and Pricing strategy gmbh,   Weil am rhein, 5health care  Management, state University Baden- Wuerttemberg, loerrach, germany correspondence: Massimo Farina   studio emmeffe s.r.l, Via Messina,   43 20154 Milano, italy   email mfarina@mfsrl.i tIntroduction:  Subcutaneous versions of different oncology therapies have been available for   patients for a few years, yet patient-relevant and hospital benefits have not been assessed in real life.",Non-OADS,/arxiv_data1/oa_pdf/5d/3e/ceor-8-227.PMC4883807.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/5d/3e/ceor-8-227.PMC4883807.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/3e/ceor-8-227.PMC4883807.pdf
Available from: http://dx.doi.org/10.1016/j.breast.,OADS,/arxiv_data1/oa_pdf/5d/3e/ceor-8-227.PMC4883807.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/96/41/jpr-9-287.PMC4883808.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/96/41/jpr-9-287.PMC4883808.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Cytidine 5’-diphosphocholine administration  prevents peripheral neuropathic pain after sciatic  nerve crush injury in rats Dessy R Emril1 Samekto Wibowo2 Lucas Meliala2 Rina Susilowati3 1Department of Neurology, Faculty  of Medicine, Syiah Kuala University,   Banda Aceh, 2Department of  Neurology, 3Department of Histology  and Cell Biology, Faculty of Medicine,   Universitas Gadjah Mada, Y ogyakarta,   Indonesia Correspondence: Dessy R Emril   Department of Neurology, Faculty  of Medicine, Syiah Kuala University/ Dr Zainoel Abidin Hospital, Tgk Daud  Beureueh 108, Banda Aceh,    Aceh 23126, Indonesia   T el +62 821 6171 6363   Email dessyezzy@gmail.co mBackground:  Cytidine 5’-diphosphocholine (citicoline) has been shown to have beneficial  effects in central nervous system injury as well as in motoric functional recovery after peripheral  nerve injury.",Non-OADS,/arxiv_data1/oa_pdf/96/41/jpr-9-287.PMC4883808.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/96/41/jpr-9-287.PMC4883808.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/41/jpr-9-287.PMC4883808.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1703–1714Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1703Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9569 1computer-aided vaccine designing approach  against fish pathogens Edwardsiella tarda  and  Flavobacterium columnare using bioinformatics  softwares radha Mahendran1 suganya Jeyabaskar1 gayathri sitharaman1 rajamani Dinakaran Michael2 agnal Vincent Paul1 1Department of Bioinformatics,   2centre for Fish immunology, school  of life sciences, Vels University,   Pallavaram, chennai, Tamil nadu, indiaAbstract:  Edwardsiella tarda and Flavobacterium columnare  are two important intracellular  pathogenic bacteria that cause the infectious diseases edwardsiellosis and columnaris in wild  and cultured fish.",Non-OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
"Aquaculture researchers are trying to identify more efficacious vac - cines and potent prophylactic and therapeutic drugs against bacterial fish diseases.2 Edwardsiella tarda and Flavobacterium columnare are two virulent intracellular  bacterial pathogens responsible for causing  edwardsiellosis and columnaris in most  fish species.correspondence: radha Mahendran Department of Bioinformatics, school  of life sciences, Vels University,  Velan nagar, P.V.Vaithiyalingam  road, Pallavaram, chennai 600 117,  Tamil nadu, india Tel +91 90 0323 7145 Fax +91 44 2266 2513 email mahenradha@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Mahendran et al Running head recto: In silico vaccine designing against Edwardsiella  tarda  and Flavobacterium  columnare DOI: http://dx.doi.org/10.2147/DDDT.S95691",Non-OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
"It has the efficiency to  predict antigens with ~75% accuracy, and the threshold  value is 1.000.25 Prediction of cTl epitopes CTL epitopes were predicted using the NetCTL.1.2 server  (http://www.cbs.dtu.dk/services/NetCT L).",OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
Rosetta FlexPepDock tool was used for high-resolution  peptide docking ( http://flexpepdock.furmanlab.cs.huji.,OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
Available from: http://www.uniprot.org/uniprot/Q4ACC 9.,Non-OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
Available from: http://www.uniprot.org/uniprot/G8X7P 2.,Non-OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
Available from: http://www.uniprot.org/uniprot/G8X7P 2.,Non-OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/26/dddt-10-1703.PMC4883809.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a4/49/opth-10-921.PMC4883812.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 921–928Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  921Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10568 6 statin medication in patients with epiretinal  membrane is associated with low intravitreal  ePO, TgF-beta-1, and VegF levels raimo T uuminen1 sirpa loukovaara2 1Department of Ophthalmology,   Kymenlaakso Central hospital, Kotka,   Finland; 2Unit of Vitreoretinal surgery,   Department of Ophthalmology,   helsinki University hospital,   University of helsinki, helsinki,   FinlandBackground:  In eyes with idiopathic epiretinal membrane (iERM), the intravitreal growth factor  and cytokine levels may associate with postvitrectomy outcomes.",Non-OADS,/arxiv_data1/oa_pdf/a4/49/opth-10-921.PMC4883812.pdf
"Limited understanding of the pathophysiology behind this  vision-threatening vitreoretinal interface disease is hindering the development of  nonsurgical treatment modalities.Correspondence: sirpa loukovaara Department of Ophthalmology,  Unit of Vitreoretinal surgery, helsinki  University hospital, haartmaninkatu 4 C,  Fi-00290 helsinki, Finland email sirpa.loukovaara@hus.fi  Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Tuuminen and Loukovaara Running head recto: Statin medication in iERM DOI: http://dx.doi.org/10.2147/OPTH.S105686",Non-OADS,/arxiv_data1/oa_pdf/a4/49/opth-10-921.PMC4883812.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a4/49/opth-10-921.PMC4883812.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/49/opth-10-921.PMC4883812.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/d1/ott-9-3031.PMC4883813.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3031–3037OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3031Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10414 2 expression of VegF and hiF-1 α in locally  advanced cervical cancer: potential biomarkers  for predicting preoperative radiochemotherapy  sensitivity and prognosis Pengfeng Zhu1 Yangjun Ou2 Yishan Dong1 Peizhen Xu1 lei Yuan3 1Department of gynecology,   2Department of Pathology, changzhou  Maternity and children health  care hospital affiliated to nanjing  Medical University, changzhou,   Jiangsu, 3Department of gynecology,   Obstetrics and gynecology hospital,   Fudan University, shanghai, People’s  republic of chinaAbstract:  Locally advanced cervical cancer (LACC) is an early-stage cervical cancer  characterized by a local tumor diameter of $4 cm.",Non-OADS,/arxiv_data1/oa_pdf/0d/d1/ott-9-3031.PMC4883813.pdf
"As recommended by the National Comprehensive Cancer  Network (NCCN) guidelines, the treatment modalities for this type of cancer are  direct radical hysterectomy, radical surgery following neoadjuvant chemotherapy, and correspondence: Peizhen Xu Department of gynecology, changzhou  Maternity and children health  Care Hospital Affiliated to Nanjing  Medical University, 16 Boai road,  changzhou 213003, Jiangsu, People’s  republic of china Tel +86 178 9516 8892 email xpz810529@163.co m lei Yuan Department of gynecology,  Obstetrics and gynecology  hospital, Fudan University, 419  Fangxie road, shanghai 200011,  People’s republic of china Tel +86 138 1670 7003 email ylronda@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhu et al Running head recto: VEGF and HIF-1 α expressions in patients with LACC DOI: http://dx.doi.org/10.2147/OTT.S104142",Non-OADS,/arxiv_data1/oa_pdf/0d/d1/ott-9-3031.PMC4883813.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0d/d1/ott-9-3031.PMC4883813.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/d1/ott-9-3031.PMC4883813.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/04/5b/mder-9-125.PMC4883814.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/04/5b/mder-9-125.PMC4883814.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Medical Devices: Evidence and Research 2016:9 125–130Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  125ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S9709 4Patient-based outcome analysis is important to  determine the success of total knee arthroplasty:  result of a focus group discussion Balaji Zacharia Manu Paul Mohammed Thanveeruddin  sherule Department of Orthopedics,   government Medical college,   Kozhikode, Kerala, india correspondence: Balaji Zacharia   Department of Orthopedics, government  Medical college, Kakkathottam (h)   chevayoor (PO)   Kozhikkode.",Non-OADS,/arxiv_data1/oa_pdf/04/5b/mder-9-125.PMC4883814.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/04/5b/mder-9-125.PMC4883814.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b4/05/ijnrd-9-119.PMC4883815.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b4/05/ijnrd-9-119.PMC4883815.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Health status, renal function, and quality of life  after multiorgan failure and acute kidney injury  requiring renal replacement therapy Robert Faulhaber-Walter1,2 Sebastian Scholz1,3 Herrmann Haller1 Jan T Kielstein1,* Carsten Hafer1,4,* 1Department of Renal and  Hypertensive Disease, Medical  School Hannover, Hannover,   Germany; 2Facharztzentrum Aarberg,   Waldshut-Tiengen, Germany;   3Sanitaetsversorgungszentrum  Wunstorf, Wunstorf, Germany;   4HELIOS Klinikum Erfurt, Erfurt,   Germany *These authors contributed equally to  this work Correspondence: Robert Faulhaber- Walter   Facharztzentrum Aarberg, Tannenstrasse 4,  79761 Waldshut-Tiengen, Germany   T el +49 7751 91680   Fax +49 7751 916829   Email rofaulhaber@web.d eBackground:  Critically ill patients with acute kidney injury (AKI) in need of renal replacement  therapy (RRT) may have a protracted and often incomplete rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/b4/05/ijnrd-9-119.PMC4883815.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/b4/05/ijnrd-9-119.PMC4883815.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/05/ijnrd-9-119.PMC4883815.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/53/97/ott-9-3025.PMC4883816.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3025–3030OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3025Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10289 5 Image-guided intensity-modulated radiotherapy  for refractory bilateral breast cancer in a patient  with extensive cutaneous metastasis in the chest  and abdominal walls Yueh-Feng Lu1 Yu-Chin Lin2 Kuo-Hsin Chen3,4 pei-Wei shueng1 Hsin-p ei Yeh1 Chen-Hsi Hsieh1,5,6 1Division of radiation Oncology,   Department of radiology, 2Division  of Oncology and Hematology,   Department of Medicine,   3Department of surgery, Far eastern  Memorial Hospital, New Taipei City,   4Department of electrical engineering,   Yuan-Ze University, Taoyuan,   5Department of Medicine, 6Institute  of Traditional Medicine, school  of Medicine, National Yang-Ming  University, Taipei, TaiwanAbstract:  Treatment for bilateral breast cancer with chest wall and abdominal skin invasion  normally involves conventional radiotherapy (RT); however, conventional RT provides inad - equate target volume coverage and excessive treatment of large volumes of normal tissue.",Non-OADS,/arxiv_data1/oa_pdf/53/97/ott-9-3025.PMC4883816.pdf
"In the majority of cases where skin metastasis has occurred, the primary cancer  is widespread and may be untreatable.6 In such cases of disseminated disease, the goals Correspondence: Chen-Hsi Hsieh Division of radiation Oncology,  Department of radiology, Far eastern  Memorial Hospital, 21 sec 2, Nanya s road,  Banciao District, New Taipei City 220,  Taiwan Tel +886 2 8966 7000 ext 1033 Fax +886 2 8966 4367 email chenciab@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Lu et al Running head recto: RT for breast cancer with skin metastasis DOI: http://dx.doi.org/10.2147/OTT.S102895",Non-OADS,/arxiv_data1/oa_pdf/53/97/ott-9-3025.PMC4883816.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/53/97/ott-9-3025.PMC4883816.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/97/ott-9-3025.PMC4883816.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-3039.PMC4883817.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3039–3047OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3039Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9892 3 Prognostic role of miR-9  expression in various  human malignant neoplasms: a meta-analysis Xiaodan Liu1,* Ziyan Luo1,* Hongxia Peng1 Hua Jiang2 Ling Xu2 1Division of Birth Cohort Study,   2Department of Hematology,   Guangzhou women and Children’s  Medical Center, Guangzhou Medical  University, Guangzhou, Guangdong,   People’s Republic of China *These authors contributed equally  to the workAbstract:  Emerging evidence has shown that aberrant microRNA expression has the potential  to be used for predicting survival and treatment response of malignant neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-3039.PMC4883817.pdf
"For instance, downregulation  of miR-100  was correlated with poor prognosis in cervical cancer and hepatocellular  carcinoma patients,5,6 and high expression of miR-21  predicted weak survival status  in pancreatic cancer and colorectal cancer.7,8 miR-9 , whose transcript was produced by three independent genes ( miR-9-1 ,  miR-9-2 , and miR-9-3 ), was also related to oncogenesis.9 The expression level of miR-9   was different in various carcinomas, which was also connected to tumor prognosis.Correspondence: Ling Xu Department of Hematology, Guangzhou  women and Children’s Medical Center,  9 Jinsui Road, Guangzhou 510623,  Guangdong Province, People’s Republic  of China Tel +86 1379 8111 250 Fax +86 0203 8367 162 email luoxul64@126.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Prognostic role of miR-9  expression in human malignant neoplasms DOI: http://dx.doi.org/10.2147/OTT.S98923",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-3039.PMC4883817.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-3039.PMC4883817.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/e8/ott-9-3039.PMC4883817.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/26/ijn-11-2235.PMC4883818.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2235–2250International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2235OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10040 4Development of octreotide-conjugated polymeric  prodrug of bufalin for targeted delivery to  somatostatin receptor 2 overexpressing breast  cancer in vitro and in vivo Tao liu1,* Tingting Jia2,* Xia Yuan2 cheng liu1 Jian sun1 Zhenhua Ni1 Jian Xu1 Xuhui Wang2 Yi Yuan2 1centralab, 2Department of Pharmacy,   Putuo hospital, shanghai University  of Traditional chinese Medicine,   shanghai, People’s republic of china *These authors contributed equally  to this workBackground:  Development of polymeric prodrugs of small molecular anticancer drugs has  become one of the most promising strategies to overcome the intrinsic shortcomings of small  molecular anticancer drugs and improve their anticancer performance.",Non-OADS,/arxiv_data1/oa_pdf/c0/26/ijn-11-2235.PMC4883818.pdf
"Some of the active components  of traditional Chinese medicine have been introduced into clinical application, eg,  PTX and camptothecin.7,8 Bufalin (BUF) extracted from the skin and parotid venom glands of the toad  shows effective therapeutic activity against a broad spectrum of tumors, including  breast cancer.9–15 However, its poor water solubility and severe adverse effects such correspondence: Yi Yuan; Xuhui Wang Department of Pharmacy, Putuo hospital,  shanghai University of Traditional  chinese Medicine, No 164 lanxi road,  shanghai 200062, People’s republic of  china Tel +86 21 2223 3222 ext 52103;   +86 21 2223 3222 ext 56553 Fax +86 21 5266 3229 email yuanyi0625@163.co m;   huixuwang@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Treatment of SSTR2 overexpressing breast cancer DOI: http://dx.doi.org/10.2147/IJN.S100404",Non-OADS,/arxiv_data1/oa_pdf/c0/26/ijn-11-2235.PMC4883818.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c0/26/ijn-11-2235.PMC4883818.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/26/ijn-11-2235.PMC4883818.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/5b/opth-10-935.PMC4883821.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 935–938Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  935Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10616 4retinal artery and vein thrombotic occlusion  during pregnancy: markers for familial  thrombophilia and adverse pregnancy outcomes Will s Kurtz1 Charles J glueck1 robert K hutchins2,3 robert a sisk2,3 Ping Wang1 1Cholesterol, Metabolism, and  Thrombosis Center, Jewish hospital  of Cincinnati, 2Cincinnati eye institute,   3Department of Ophthalmology,   University of Cincinnati College of  Medicine, Cincinnati, Ohio, UsaBackground:  Ocular vascular occlusion (OVO), first diagnosed during or immediately after  giving birth, often reflects superposition of the physiologic thrombophilia of pregnancy on previ - ously undiagnosed underlying familial or acquired thrombophilia associated with spontaneous  abortion, eclampsia, or maternal thrombosis.",Non-OADS,/arxiv_data1/oa_pdf/c0/5b/opth-10-935.PMC4883821.pdf
"Keywords:  thrombophilia, ocular thrombosis, retinal vascular occlusion, CRVO, BRAO,  pregnancy, miscarriage, fetal loss, ocular vascular occlusion, pre-eclampsia, eclampsia Introduction Retinal vascular occlusion (RVO) includes central retinal vein occlusion (CRVO) and  branch RVO, central retinal artery occlusion and branch retinal artery occlusion (BRAO),  amaurosis fugax, and non-arteritic ischemic optic neuropathy.1–5 CRVO–branch RVO6–8  and central retinal artery occlusion–BRAO2,4,9–13 are commonly associated with throm - bophilia in young patients,2–6,9,14–20 and visual consequences can be severe.21 Carotid  artery atherosclerosis is the most common etiology for central retinal artery occlusion Correspondence: Charles J glueck Cholesterol, Metabolism, and Thrombosis  Center, Jewish hospital of Cincinnati,  suite 430, 2135 Dana avenue, Cincinnati  Oh 45207, Usa Tel +1 513 924 8250 Fax +1 513 924 8273 email cjglueck@mercy.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kurtz et al Running head recto: Ocular vascular occlusion during pregnancy DOI: http://dx.doi.org/10.2147/OPTH.S106164",Non-OADS,/arxiv_data1/oa_pdf/c0/5b/opth-10-935.PMC4883821.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c0/5b/opth-10-935.PMC4883821.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/opth-10-935.PMC4883821.pdf
"9,11-13 © Keishi Okamoto, Haruko Ueda, Tomoo Shimada, Kentaro Tamura, Yasuko Koumoto, Masao Tasaka, Miyo Terao Morita, and Ikuko Hara-Nishimura *Correspondence to: Ikuko Hara-Nishimura; Email: ihnishi@gr.bot.kyoto-u.ac.jpReceived: 12/24/2014; Accepted: 01/07/2015 http://dx.doi.org/10.1080/15592324.2015.1010947 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/2e/kpsb-11-03-1010947.PMC4883830.pdf
"For estimation of the velocity, moving plastids in four orﬁve randomly selected sequential frames of 8 (wild-type) and 17 (abcb19-101 ) time-lapse images (143 £143mm) were tracked manually using the ImageJ software (http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/28/2e/kpsb-11-03-1010947.PMC4883830.pdf
"3, e1149669 (4 pages)http://dx.doi.org/10.1080/15592324.2016.1149669",Non-OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Plant Cell Physiol 2014; 55:1544-55; PMID:24929423; http://dx.doi.org/10.1093/pcp/pcu084 2.,Non-OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Nat Rev Mol Cell Biol 2013; 14:787-802; PMID:24263360; http://dx.doi.org/10.1038/nrm3702 3.,OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Plant Cell Physiol 2012; 53:1355-65; PMID:22764279; http://dx.doi.org/10.1093/pcp/pcs0995.,Non-OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
J Integr Plant Biol 2012; 54:851-67; PMID:23046073; http://dx.doi.org/10.1111/j.1744-7909.2012.01175.x.,OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Autophagy 2006; 2:96-106; PMID:16874101; http://dx.doi.org/ 10.4161/auto.2.2.2366 7.,Non-OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Front Plant Sci 2014; 5:629; PMID:25477890; http://dx.doi.org/10.3389/fpls.2014.00629 8.,OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
J Cell Sci 2014; 127:1161-8; PMID:24463818; http://dx.doi.org/10.1242/jcs.139709 9.,OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Eur J Cell Biol 2003; 82:323-32; PMID:12868600; http://dx.doi.org/10.1078/0171-9335- 00318 10.,OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Plant Cell Physiol 2003; 44:914-21; PMID:14519773; http://dx.doi.org/10.1093/pcp/pcg118 11.,Non-OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Biochim Biophys Acta 2014; 1837:512-21;PMID:24269172; http://dx.doi.org/10.1016/j.bbabio.2013.11.009 12.,OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
Front Plant Sci 2015; 6:94;PMID:25745429; http://dx.doi.org/10.3389/fpls.2015.00094 13.,OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
PlantCell Physiol 2002; 43:1534-41; PMID:12514251; http://dx.doi.org/10.1093/pcp/pcf173e1149669-4 K. TOYOOKA ET AL.,OADS,/arxiv_data1/oa_pdf/e1/ec/kpsb-11-03-1149669.PMC4883831.pdf
"Toinvestigate the biological ro le of DELLAs binding to GAF1, we generated transgenic plants expressing a mutant version ofGAF1 that cannot bind DELLA ( DPAM) under the control © Jutarou Fukazawa, Takeshi Ito, Yuji Kamiya, Shinjiro Yamaguchi, and Yohsuke Takahashi *Correspondence to: Jutarou Fukazawa; Email: jutarouf@hiroshima-u.ac.jpSubmitted: 04/10/2015; Revised: 05/11/2015; Accepted: 05/13/2015 http://dx.doi.org/10.1080/15592324.2015.1052923 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/e8/kpsb-10-10-1052923.PMC4883832.pdf
PMID:17194763; http://dx.doi.org/10.1105/ tpc.106.047415 17.,Non-OADS,/arxiv_data1/oa_pdf/1a/e8/kpsb-10-10-1052923.PMC4883832.pdf
Plant Physiol 2013; 162:2125-39; PMID:23818171; http://dx.doi.org/10.1104/pp.,Non-OADS,/arxiv_data1/oa_pdf/1a/e8/kpsb-10-10-1052923.PMC4883832.pdf
"The questions, the methods, the experimental objects, all have been changing© Stanislav Kopriva *Correspondence to: Stanislav Kopriva; Email: skopriva@uni-koeln.de Submitted: 05/20/2015; Accepted: 05/22/2015http://dx.doi.org/10.1080/15592324.2015.1055436 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
"Some thoughts and experiments concern- ing vegetation By John Woodward, M. D. of the col- lege of physicians, et R. S. et professor of physick in gresham college, Phil Trans 1699; 21:193-227; http://dx.doi.org/10.1098/rstl.1699.0040 3.",Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Annu Rev Plant Biol 2011; 62:157-84; PMID:21370978; http://dx.doi.org/10.1146/annurev-arplant-042110-103921 7.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Front Plant Sci 2014; 5:589; PMID:25400653; http://dx.doi.org/10.3389/fpls.2014.00589 8.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 1932; 7:565-95; PMID:16652796;http://dx.doi.org/10.1104/pp.7.4.565 9.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Cell 1993; 72:705-13; PMID:8453665; http://dx.doi.org/ 10.1016/0092-8674(93)90399-B 10.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Proc Natl Acad Sci USA 1995; 92:9373-7; PMID:7568135; http://dx.doi.org/ 10.1073/pnas.92.20.9373 11.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Phys- iol 1926; 1:77-87; PMID:16652467; http://dx.doi.org/ 10.1104/pp.1.1.77 12.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Proc Soil Sci Soc Amer 1937; 2:229-38; http://dx.doi.org/ 10.2136/sssaj1938.036159950002000C0033x 13.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Eur J Agron 2001; 14:81-111; http://dx.doi.org/10.1016/S1161- 0301(00)00082-4 14.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2003; 33:633-50; PMID:12609038; http://dx.doi.org/ 10.1046/j.1365-313X.2003.01657.x16.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2003;33:651-63; PMID:12609039; http://dx.doi.org/ 10.1046/j.1365-313X.2003.01658.x 17.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 2003; 132:597-605; PMID:12805590; http://dx.doi.org/10.1104/pp.102.019802 18.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 1944; 19:227-44; PMID:16653911; http://dx.doi.org/ 10.1104/pp.19.2.227 20.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Annu Rev Plant Physiol 1962; 13:201-24; http://dx.doi.org/10.1146/annurev.pp.13.060162.001221 21.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Proc Natl Acad Sci USA 1955; 41: 880-90;PMID:16589765; http://dx.doi.org/10.1073/ pnas.41.11.880 22.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
J Am Chem Soc 1956; 78:2652-3; http://dx.doi.org/10.1021/ja01592a097 23.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 1959; 34:73-80; PMID:16655178; http://dx.doi.org/10.1104/ pp.34.1.73 24.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 1960; 35:72-80; PMID:16655316; http://dx.doi.org/10.1104/ pp.35.1.72 25.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Annu Rev Plant Physiol 1967; 18: 59-84; http://dx.doi.org/ 10.1146/annurev.pp.18.060167.000423 27.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
J Biol Chem 2000; 275:930-6; PMID:10625629; http://dx.doi.org/10.1074/jbc.275.2.930 32.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Annu Rev Plant Physiol Plant Mol Biol 2000; 51:141-65; PMID:15012189; http://dx.doi.org/10.1146/annurev.arplant.51.1.141 33.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
J Biol Chem 2001; 276:46989-94;PMID:11598126; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Nature 2012; 488:531-4; PMID: 22864417; http://dx.doi.org/10.1038/nature11285 35.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 1960; 35:72-80; PMID:16655316; http://dx.doi.org/10.1104/pp.35.1.72 36.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 1969; 44:1241-6; PMID:16657197; http://dx.doi.org/10.1104/pp.44.9.1241 37.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
"Neuenschwander U, Suter M, Brunold C. Regulation of sulfate assimilation by light and O-Acetyl-l-Serine in Lemna minor L. Plant Physiol 1991; 97:253-8; PMID: 16668378; http://dx.doi.org/10.1104/pp.97.1.253 39.",OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 1999; 20:37-44; PMID:10571863; http://dx.doi.org/10.1046/j.1365-313X.1999.00573.x 41.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 2000; 122:737-46; PMID:10712537; http://dx.doi.org/10.1104/ pp.122.3.737 42.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2002; 32:879-89; PMID:12492831; http://dx.doi.org/10.1046/j.1365-313X.2002.01477.x 43.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2002; 31:729-40;PMID:12220264; http://dx.doi.org/10.1046/j.1365- 313X.2002.01391.x 44.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Nat Genet 2007; 39:896-900; PMID:17589509; http://dx.doi.org/10.1038/ng2050 45.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2009; 57:313-21; PMID:18801012;http://dx.doi.org/10.1111/j.1365-313X.2008.03690.x 46.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Cell 2010; 22:1216-31; PMID: 20424176; http://dx.doi.org/10.1105/tpc.110.074088 47.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
J Biol Chem 2005; 280:25590-5; PMID:15866872; http://dx.doi.org/10.1074/jbc.M502332200 48.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 2005; 138:304-18; PMID: 15834012; http://dx.doi.org/10.1104/pp.104.053793 49.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
J Exp Bot 2005; 56:1887- 96; PMID:15911562; http://dx.doi.org/10.1093/jxb/ eri179 50.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Science 2000; 290:2110-3; PMID:11118138; http://dx.doi.org/10.1126/ science.290.5499.2110 51.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2012; 70:666-77; PMID:22243437; http://dx.doi.org/10.1111/j.1365- 313X.2012.04905.x 52.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2014; 78:659-73; PMID:24617819; http://dx.doi.org/ 10.1111/tpj.12502 53.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Cell 2006; 18:3235-51; PMID:17114350; http://dx.doi.org/10.1105/tpc.106.046458 54.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Physiol Plant 2007; 129:351-63; http://dx.doi.org/10.1111/j.1399- 3054.2006.00814.x 55.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 2004; 136:3209-22; PMID:15466229; http://dx.doi.org/10.1104/pp.104.047068 56.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2011; 67:1042-54; PMID:21623972; http://dx.doi.org/10.1111/j.1365-313X.2011.04656.x 57.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Genome Res 1995;5:321-33; PMID:8750192; http://dx.doi.org/10.1101/ gr.5.4.321 58.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Theor Appl Genet 1995; 91:802-8; PMID:24169920; http://dx.doi.org/10.1007/ BF0022096359.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Genetics 2006;173:1629-36; PMID:16702431; http://dx.doi.org/ 10.1534/genetics.106.056986 61.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
PLoS Genet 2008; 4:e1000004;PMID:18454190; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant Physiol 2014; 166:1593-608; PMID:25245030; http://dx.doi.org/10.1104/ pp.114.247825 64.,Non-OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Plant J 2014; 77:31-45;; http://dx.doi.org/10.1111/ tpj.12359 66.,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
Front Plant Sci 2014; 5:646; PMID:25477892; http://dx.doi.org/10.3389/ fpls.2014.00646 www.tandfonline.com e1055436-5 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/61/1b/kpsb-10-09-1055436.PMC4883835.pdf
"8-10It can © Kanako Yano, Takahiro Yanagisawa, Kyosuke Mukae, Yasuo Niwa, Yuko Inoue, and Yuji Moriyasu *Correspondence to: Yuji Moriyasu; Email: moriyasu@mail.saitama-u.ac.jpSubmitted: 08/07/2015; Accepted: 08/08/2015 http://dx.doi.org/10.1080/15592324.2015.1082699 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Trends CellBiol 1994; 4:139-43; PMID:14731737; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
FEBS Lett 1993; 333:169-74; PMID:8224160; http://dx.doi.org/10.1016/0014-5793(93)80398-E 4.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
FEBS Lett 1994; 349:275-80; PMID:8050581; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
J Cell Biol1995; 131:591-602; PMID:7593182; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Dev Cell 2003; 5:539- 45; PMID:14536056; http://dx.doi.org/10.1016/ S1534-5807(03)00296-X 7.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
J Cell Biol 1999; 147:435-46; PMID:10525546;http://dx.doi.org/10.1083/jcb.147.2.435 8.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Nat Cell Biol 2007;9:1102-09; PMID:17909521; http://dx.doi.org/ 10.1038/ncb1007-1102 9.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Annu Rev Cell Dev Biol 2011; 27:107-32; PMID:21801009; http://dx.doi.org/10.1146/annurev-cellbio-092910-154005 10.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Curr Biol 2012; 22: R29-R34; PMID:22240478; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Autophagy 2006; 2:2-11; PMID:16874030; http://dx.doi.org/10.4161/auto.2092 13.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Autophagy 2007; 3:106-16; PMID:17204848; http://dx.doi.org/10.4161/auto.3595 14.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Trends Plant Sci 2012; 17:526-37; PMID:22694835; http://dx.doi.org/10.1016/j.tplants.2012.05.006 15.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Cell Physiol 2012; 53:1355-65; PMID:22764279; http://dx.doi.org/10.1093/pcp/pcs099 16.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
J Biol Chem 2002; 277:33105-14; PMID:12070171; http://dx.doi.org/ 10.1074/jbc.M204630200 18.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant Cell 2004; 16:2967-83; PMID:15494556; http://dx.doi.org/ 10.1105/tpc.104.025395 19.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant J 2005; 42:598-608; PMID:15860017; http://dx.doi.org/10.1111/j.1365-313X.2005.02396.x 20.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant Physiol 2005; 138:2097-110; PMID:16040659; http://dx.doi.org/10.1104/ pp.105.060673 21.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Autophagy 2006; 2:96-106; PMID:16874101; http://dx.doi.org/10.4161/auto.2.2.2366 22.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant Signal Behav 2013; 8: e22510; PMID:23123450; http://dx.doi.org/10.4161/psb.22510 23.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Front Plant Sci 2014; 5: Article 172; PMID:24817874;http://dx.doi.org/10.3389/fpls.2014.00172 24.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Biochem Biophys Res Com- mun 1993; 193:999-1005; PMID:8391816; http://dx.doi.org/10.1006/bbrc.1993.1724 26.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Cell Struct Funct 1993; 18:139-49; PMID:8242793; http://dx.doi.org/ 10.1247/csf.18.139 27.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Biosci Biotech Bio- chem 1994; 58:425-27; http://dx.doi.org/10.1271/ bbb.58.425 28.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant J 2005; 41:117-24; PMID:15610354; http://dx.doi.org/ 10.1111/j.1365-313X.2004.02282.x 29.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
"Dettmer J, Hong-Hermesdorf A, Stierhof Y-D, Schu- macher K. Vacuolar HC-ATPase activity is required for endocytic and secretory trafﬁcking in Arabidopsis.Plant Cell 2006; 2006; 18:715-30; PMID:16461582; http://dx.doi.org/10.1105/tpc.105.037978 30.",OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant Cell 2010; 22:1344-57; PMID:20435907;http://dx.doi.org/10.1105/tpc.109.072637 31.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Botanica Acta 1992; 105:421-26; http://dx.doi.org/10.1111/j.1438-8677.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Botanica Acta 1995; 108:67-73; http://dx.doi.org/10.1111/j.1438-8677.1995.tb00833.x 33.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Cell Struct Funct 1998; 23:33-42; PMID:9639028; http://dx.doi.org/10.1247/ csf.23.33 35.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Current Opinion in Plant Biol 2007; 10:587-93; PMID:17702643; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant Physiol 2007; 143:291-99; PMID:17098847; http://dx.doi.org/10.1104/pp.106.092106 37.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Methods 2015; 75:181-88; PMID:25239736; http://dx.doi.org/10.1016/j.ymeth.2014.09.003 38.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Biol Cell 2006; 98:53-67; PMID:16354162; http://dx.doi.org/10.1042/BC20040516 39.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant Cell Physiol 2011; 52:2074-87; PMID:22039105; http://dx.doi.org/10.1093/pcp/ pcr137 40.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Methods in Enzymology2008; 451:557-80; PMID:19185740; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant Physiol 1995; 109:1309-15; PMID:8539292; http://dx.doi.org/10.1104/pp.109.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant Cell Phys-iol 1998; 39:905-13; PMID:9816675; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Protoplasma 2004; 224:255- 60; PMID:15614486; http://dx.doi.org/10.1007/ s00709-004-0070-6 49.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
J Cell Biol 1996; 133:1251-63; PMID:8682862; http://dx.doi.org/10.1083/jcb.133.6.1251 50.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Anal Biochem 1984; 143:30-34; PMID:6442109; http://dx.doi.org/ 10.1016/0003-2697(84)90553-0 51.,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Anal Biochem 1976; 70:241-50; PMID:1259145; http://dx.doi.org/10.1016/ S0003-2697(76)80064-4 53.,Non-OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
Plant J 1999; 18:455-63;PMID:10406127; http://dx.doi.org/10.1046/j.1365- 313X.1999.00464.x e1082699-12 Volume 10 Issue 11 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/ff/72/kpsb-10-11-1082699.PMC4883836.pdf
"Given that cell-to-cell movement throughplasmodesmata is important for loadingKeywords: Arabidopsis , cell-to-cell move- ment, DIR1, phloem, plasmodesmata, Pseudomonas syringae , systemic acquired resistance © Philip Carella, Daniel C Wilson, and Robin K Cameron *Correspondence to: Robin K Cameron; Email: rcamero@mcmaster.ca Submitted: 07/14/2015Accepted: 07/20/2015http://dx.doi.org/10.1080/15592324.2015.1075683 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
BMC Plant Biol 2011; 11:1-16; PMID:21205309; http://dx.doi.org/10.1186/1471- 2229-11-125 4.,Non-OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Front Plant Sci 2013; 4:1-20; PMID:23346092; http://dx.doi.org/10.3389/fpls.2013.00230 6.,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Plant Cell 2011;23:3353-73; PMID:21934146; http://dx.doi.org/ 10.1105/tpc.111.087742 9.,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
PLoSBiol 2008; 6:e7; PMID:18215111; http://dx.doi.org/ 10.1371/journal.pbio.0060007 10.,Non-OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Plant Biol 2015; 17:395-401; PMID:25296648; http://dx.doi.org/10.1111/plb.12234 11.,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Plant Cell 1999; 11:309-22; PMID:10072393; http://dx.doi.org/10.1105/tpc.11.3.309 12.,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Plant Physiol 2001; 126:39-46; PMID:11351069; http://dx.doi.org/10.1104/ pp.126.1.39 13.,Non-OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Plant J 2005; 41:319-31;PMID:15634207; http://dx.doi.org/10.1111/j.1365- 313X.2004.02298.x 14.,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Ann Rev Plant Biol2009; 60:207-21; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Plant Cell 1991; 3:49- 59; PMID:1824334; http://dx.doi.org/10.1105/ tpc.3.1.49 16.,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Front Plant Sci 2013; 4:54; PMID:23516120; http://dx.doi.org/10.3389/ fpls.2013.00154 17.,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
Trends Plant Sci 2012; 17:538-45; PMID:22749315; http://dx.doi.org/10.1016/j.tplants.2012.05.011 www.tandfonline.com e1075683-3 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/1c/60/kpsb-10-10-1075683.PMC4883840.pdf
"© Chika Tateda, Zhongqin Zhang, and Jean T Greenberg *Correspondence to: Jean T Greenberg; Email: jgreenbe@uchicago.eduSubmitted: 11/20/2014; Revised: 12/22/2014; Accepted: 01/05/2015 http://dx.doi.org/10.1080/15592324.2015.1010912 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 2005; 44:798-809; PMID:16297071; http://dx.doi.org/10.1111/j.1365- 313X.2005.02567.x 2.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Mol Plant 2014; 7:1365-83; PMID:24923602; http://dx.doi.org/10.1093/mp/ ssu072 3 .,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant Cell 2003; 15: 2408-20; PMID:14507999; http://dx.doi.org/10.1105/tpc.015412 4.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant Cell 2014; pii: tpc.114.131938; 26:4171-87; PMID:25315322; http://dx.doi.org/10.1105/tpc.114.131938.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 2001; 28:209-16; PMID:11722764; http://dx.doi/10.1046/j.1365-313X.2001.01158.x 6.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant Cell 1999; 11:1695- 708; PMID:10488236; http://dx.doi.org/10.1105/ tpc.11.9.1695 7.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Mol Cell 2000; 5:1003- 11; PMID:10911994; http://dx.doi.org/10.1016/ S1097-2765(00)80265-8 8.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
PlantCell 2006; 18:465-76; PMID:16377758; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
J Biol Chem 2010; 285:28902-11;PMID:20610395; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Cell 2006; 125:749-60; PMID:16713565; http://dx.doi.org/10.1016/j.cell.2006.03.037 11.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
EMBO J 2009; 28:3439- 49; PMID:19763087; http://dx.doi.org/10.1038/emboj.2009.263 12.,Non-OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Nature 2010; 465:632-6; PMID:20520716; http://dx.doi.org/10.1038/nature09083 13.,Non-OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Cell 1994; 77:551-63; PMID:8187175; http://dx.doi.org/10.1016/0092-8674(94)90217-8 14.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 1998; 16:209-21; PMID:9839466; http://dx.doi.org/ 10.1046/j.1365-313x.1998.00286.x 15.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
PLoS Pathog 2010; 6:e1001011; PMID:20661428; http://dx.doi.org/10.1371/journal.ppat.1001011 16.,Non-OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 2014; 77:222-34; http://dx.doi.org/ 10.1111/tpj.12382 17.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 1992; 2: 655-60;http://dx.doi.org/10.1111/j.1365-313X.1992.tb00134.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant Cell 2012; 24:1256-70; PMID:22427336; http://dx.doi.org/ 10.1105/tpc.112.095778 19.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Mol Plant Pathol 2013; 14:58-70; PMID:22947164; http://dx.doi.org/10.1111/j.1364-3703.2012.00827.x 20.,Non-OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant Physiol 2001; 126:517-23; PMID:11402183; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 2004; 38:119-30; PMID:15053765; http://dx.doi.org/ 10.1111/j.1365-313X.2004.02028.x 23.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 1992; 2:643-54; http://dx.doi.org/ 10.1111/j.1365-313X.1992.tb00133.x 24.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant Cell1996; 8: 629-43; http://dx.doi.org/10.1105/ tpc.8.4.629 26.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 1996; 10:61-70; http://dx.doi.org/10.1046/j.1365- 313X.1996.10010061.x 27.,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
Plant J 1996; 10:71-82; PMID:8758979; http://dx.doi.org/10.1046/j.1365- 313X.1996.10010071.x e1010912-4 Volume 10 Issue 10 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/e8/58/kpsb-10-10-1010912.PMC4883847.pdf
"4, e1161878 (4 pages)http://dx.doi.org/10.1080/15592324.2016.1161878",Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Adv Agronomy 2014; 124:37-89; http://dx.doi.org/10.1016/B978-0-12-800138-7.00002-4 4.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Plant Signal Behav 2010; 5 –6:635- 643; PMID:20495384; http://dx.doi.org/10.4161/psb.5.6.11211 7.,OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Plant Physiol 2015; 169:2587-2596; PMID:26450705; http://dx.doi.org/10.1104/pp.15.00596 8.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
J Plant Physiol 2010; 167:633-642; PMID:20185204; http://dx.doi.org/10.1016/j.jplph.2009.11.018 9.,OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Plant Soil 2012; 359:297-319; http://dx.doi.org/10.1007/s11104-012-1191-x 10.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
NO and IAA Key Regulators in the Shoot Growth Promoting Action of Humic Acid in Cucumis sativus L. J Plant Growth Reg 2014; 33:30-439; http://dx.doi.org/10.1007/s00344-013-9394-9 11.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Env Exp Bot 2012; 24-32; http://dx.doi.org/10.1016/j.envexpbot.2011.10.001 12.,OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Rhizosphere humic acid interacts with root cell walls to reduce hydraulic conductivity and plant development.Plant Soil 2010; 336:313-322; http://dx.doi.org/10.1007/s11104- 010-0483-2 13.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Planta 2000;221:874-882; PMID:11144273; http://dx.doi.org/10.1007/s004250000412 14.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Plant Physiol 2012; 159:632-641; PMID:22492846; http://dx.doi.org/10.1104/pp.112.196428 15.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Chem Biol Tech Agr 2014; 1:3-13; http://dx.doi.org/10.1186/2196-5641-1-316.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Ecol Eng 2012;47:203-208; http://dx.doi.org/10.1016/j.ecoleng.2012.06.011 17.,OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Trends Plant Sci 2011; 16:300-309; PMID:21482172; http://dx.doi.org/10.1016/j.tplants.2011.03.007 19.,OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Func Plant Biol 2016; 43:87-104; http://dx.doi.org/10.1071/ FP15252 20.,OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
Chem Biol Tech Agr 2015; 2:1-12; http://dx.doi.org/10.1186/s40538-014-0028-7 21.,Non-OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
The supramolecular structure of humic substances: a novel understanding of humus chemistry and implications in soil science.Adv Agr 2002; 75:57-134; http://dx.doi.org/10.1016/S0065-2113(02)75003-7e1161878-4 M. OLAETXEA ET AL.,OADS,/arxiv_data1/oa_pdf/43/3e/kpsb-11-04-1161878.PMC4883868.pdf
"The late induction of GUDK under SA treatment is probably a secondary response mediated by reactive oxygen species accumulation.22 © Venkategowda Ramegowda, Supratim Basu, Chirag Gupta, and Andy Pereira *Correspondence to: Andy Pereira; Email: apereira@uark.eduSubmitted: 01/12/2015; Revised: 03/18/2015; Accepted: 03/19/2015 http://dx.doi.org/10.1080/15592324.2015.1034421 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
"To determine which biological processes are regulated by GUDK, we evaluated the association of all kinases in the ricegenome (http://phylomics.ucdavis.edu/kinase/) with biological process terms in the gene ontology (GO) database.",OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Field Crops Res 2006; 96:252-9; http://dx.doi.org/10.1016/j.fcr.2005.07.007 2.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Rice 2012; 5:1-9; PMID:24764501; http://dx.doi.org/10.1186/1939-8433-5-6 3.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Front Plant Sci 2014; 5:170; PMID:24904597; http://dx.doi.org/10.3389/fpls.2014.00170 4.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Physiol 2007; 143:1739-51; PMID:17293435;http://dx.doi.org/10.1104/pp.106.094532 5.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant J 2003; 33:751-63; PMID:12609047; http://dx.doi.org/ 10.1046/j.1365-313X.2003.01661.x 6.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Mol Biol 2008; 67:169-81; PMID:18273684; http://dx.doi.org/ 10.1007/s11103-008-9309-5 7.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Genes Dev 2009; 23:1805-17; PMID: 19651988; http://dx.doi.org/10.1101/gad.1812409 8.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant J 2011; 65:907-21; PMID:21332845; http://dx.doi.org/10.1111/j.1365-313X.2010.04477.x 9.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Planta 2009; 229:605-15; PMID:19048288; http://dx.doi.org/10.1007/s00425- 008-0857-310.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant J 2007; 51:617-30; PMID:17587305; http://dx.doi.org/10.1111/j.1365-313X.2007.03168.x 11.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Mol Genet Genomics 2010;284:173-83; PMID:20632034; http://dx.doi.org/ 10.1007/s00438-010-0557-0 12.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Mol Biol 2008; 67:589- 602; PMID:18470484; http://dx.doi.org/10.1007/ s11103-008-9340-6 13.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
J Exp Bot 2011; 62:4863-74; PMID:21725029; http://dx.doi.org/ 10.1093/jxb/err144 www.tandfonline.com e1034421-3 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
FEBS Lett 2008;582:1037-43; PMID:18325341; http://dx.doi.org/ 10.1016/j.febslet.2008.02.052 15.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Proc Natl Acad Sci U S A 2006; 103:12987-92; PMID:16924117; http://dx.doi.org/ 10.1073/pnas.0604882103 16.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Physiol 2010; 153:185-97; PMID:20335401;http://dx.doi.org/10.1104/pp.110.154773 17.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Physiol 2008; 148:1938-52;PMID:18931143; http://dx.doi.org/10.1104/ pp.108.128199 18.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Biotech J 2011; 9:747-58; PMID:21284800; http://dx.doi.org/10.1111/j.1467- 7652.2010.00584.x 19.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Sci 2014; 214:106-12; PMID:24268168; http://dx.doi.org/10.1016/j.plantsci.2013.10.006 20.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
J Exp Bot 2010; 61:4145-56; PMID:20660496; http://dx.doi.org/ 10.1093/jxb/erq212 21.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Physiol 2014; 166:1634-45; PMID:25209982; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Sci 2001; 160:1095-106; PMID:11337066; http://dx.doi.org/10.1016/S0168- 9452(01)00327-2 23.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
J Exp Bot 2009; 60:2325-39; PMID:19443613; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
PLoS Biol 2007; 5:e8; PMID:17214507;http://dx.doi.org/10.1371/journal.pbio.0050008 25.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Nat Commun 2014; 5:5302; PMID:25358745; http://dx.doi.org/10.1038/ ncomms6302 26.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
BMC Bioinformatics 2005; 6:144; PMID:15941488; http://dx.doi.org/10.1186/1471- 2105-6-144 27.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Physiol 2009; 150:1368-79; PMID:19429605;http://dx.doi.org/10.1104/pp.109.137554 28.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Biotech J 2013; 11:101-14; PMID:23094910; http://dx.doi.org/ 10.1111/pbi.12011 29.,OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
Plant Biotech J 2012; 10:792- 805; PMID:22551450; http://dx.doi.org/10.1111/ j.1467-7652.2012.00697.x 30.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
2013 (http://CRAN.R-project.org/packageDgplots.,Non-OADS,/arxiv_data1/oa_pdf/30/e6/kpsb-10-11-1034421.PMC4883908.pdf
"From the very early contact times, the oxidative burst (O 2¡¢generation) and the related enzymes (SOD and POX) measured in the apoplast of the intact roots in contact with the PF presentedvalues much greater than those inKeywords: defense reactions, mycorrhiza, nitric oxide, olive seedlings roots, patho- genic fungi, reactive oxygen species, redoxactivities, rhizophagus irregularis, verticil-lium dahliae © Francisco Espinosa, Inmaculada Garrido, and María Carmen /C19Alvarez-Tinaut *Correspondence to: Francisco Espinosa; Email: espinosa@unex.es Submitted: 03/11/2015Revised: 05/06/2015Accepted: 05/06/2015 http://dx.doi.org/10.1080/15592324.2015.1049789 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/0c/kpsb-10-09-1049789.PMC4883917.pdf
Plos One 2014; 9(6) e100132; PMID:24967716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0c/kpsb-10-09-1049789.PMC4883917.pdf
Protoplasma 2009; 237:27-39; PMID:19763783; http://dx.doi.org/10.1007/s00709-009-0069-04.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/kpsb-10-09-1049789.PMC4883917.pdf
"Kulik A, Noirot E, Grandperret V, Bourque S, Fromen- tin J, Salloignon P, Truntzer C, Dobrowolska G, Simo- Plas F, Wendehenne D. Interplays between nitric oxid and reactive oxygen species in cryptogein signalling.Plant Cell Environment 2015; 38:331-48; PMID:24506708; http://dx.doi.org/10.1111/pce.12295 5.",OADS,/arxiv_data1/oa_pdf/43/0c/kpsb-10-09-1049789.PMC4883917.pdf
Trends Plant Sci 2014; 19 (10):623630; PMID:25088679; http://dx.doi.org/10.1016/j.tplants.,OADS,/arxiv_data1/oa_pdf/43/0c/kpsb-10-09-1049789.PMC4883917.pdf
"Nature 2014; 514, 367-71; PMID:25162526; http://dx.doi.org/10.1038/ nature13593 www.tandfonline.com e1049789-3 Plant Signaling & Behavior",OADS,/arxiv_data1/oa_pdf/43/0c/kpsb-10-09-1049789.PMC4883917.pdf
"6DuringKeywords: autophagy, chloroplasts, crop plants, nitrogen remobilization, protein degradation, rice © Masanori Izumi, Jun Hidema, and Hiroyuki Ishida *Correspondence to: Hiroyuki Ishida; Email:hiroyuki@biochem.tohoku.ac.jp Submitted: 09/14/2015 Accepted: 09/24/2015 http://dx.doi.org/10.1080/15592324.2015.1101199 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Ann Appl Biol 2001; 138:69-81; http://dx.doi.org/10.1111/j.1744-7348.2001.tb00086.x 3.,OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Physiol 1991; 96:355-62; PMID:16668193; http://dx.doi.org/10.1104/pp.96.2.355 4.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Cell Physiol 2003; 44:914-21; PMID:14519773; http://dx.doi.org/ 10.1093/pcp/pcg118 6.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Nat Rev Mol Cell Biol 2009; 10:458-67; PMID:19491929; http://dx.doi.org/10.1038/ nrm2708 7.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Cell Physiol 2012; 53:1355-65; PMID:22764279; http://dx.doi.org/10.1093/pcp/pcs099 9.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Annu Rev Plant Biol 2012;63:215-37; PMID:22242963; http://dx.doi.org/ 10.1146/annurev-arplant-042811-105441 10.,OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Physiol 2008; 148:142-55; PMID:18614709; http://dx.doi.org/ 10.1104/pp.108.122770 12.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Physiol 2010; 154:1196-209; PMID:20807997; http://dx.doi.org/10.1104/pp.110.158519 13.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Cell Environ 2013; 36:1147-59; http://dx.doi.org/10.1111/pce.12049 14.,OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Physiol 2013; 161:1682-93; PMID:23457226; http://dx.doi.org/10.1104/ pp.113.215632 15.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
DNA Res 2011; 18:363-77;PMID:21795261; http://dx.doi.org/10.1093/dnares/ dsr024 17.,OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Autophagy 2014; 10:878-88; PMID: 24674921; http://dx.doi.org/10.4161/auto.28279 18.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Physiol 2015; 167:1307-20; PMID:25717038; http://dx.doi.org/ 10.1104/pp.114.254078 19.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Autophagy supports biomass production and nitrogen use efﬁciency at the vegetative stage in rice.Plant Physiol 2015; 168:60-73; PMID:25786829; http://dx.doi.org/10.1104/pp.15.00242 20.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Cell 2015; 27:1389-408; PMID:25944100; http://dx.doi.org/ 10.1105/tpc.15.00158 21.,OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Plant Cell Rep 2014; 33:1697-710;PMID:24996626; http://dx.doi.org/10.1007/s00299- 014-1648-x 2 2 .,OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
BMC Plant Biol 2015; 15:95; PMID:25888209; http://dx.doi.org/10.1186/ s12870-015-0472-y 2 3 .,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Nature 2015; 522:359- 62; PMID:26040717; http://dx.doi.org/10.1038/ nature14506 24.,Non-OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
Febs Lett 2010; 584:1350-8; PMID:20079356; http://dx.doi.org/ 10.1016/j.febslet.2010.01.007 www.tandfonline.com e1101199-3 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/ff/d9/kpsb-10-11-1101199.PMC4883919.pdf
"To date, Lifeact is considered as the marker of choice to visualize pollen tubeF-actin 3and it has already been employedKeywords: acquosome, actin ring, ARO1 , Lat52 , Lifeact, pollen tube, stress, tagRFP- T © Frank Vogler and Stefanie Sprunck *Correspondence to: Stefanie Sprunck; Email: Stefanie.Sprunck@biologie.uni-regensburg.de Submitted: 07/14/2015Accepted: 07/20/2015 http://dx.doi.org/10.1080/15592324.2015.1075684 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop-erly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant Cell 1993; 5:1303- 14; PMID:12271030; http://dx.doi.org/10.1105/tpc.5.10.1303 2.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
J Exp Bot 2010; 61:1969-86; PMID:20159884; http://dx.doi.org/10.1093/jxb/erq012 3.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Front Plant Sci 2015; 5:786;PMID:25620974; http://dx.doi.org/10.3389/fpls.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Front Plant Sci 2015; 6:246; PMID:25954283; http://dx.doi.org/10.3389/ fpls.2015.00246 5.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Nat Methods 2008; 5:605-7; PMID:18536722;http://dx.doi.org/10.1038/nmeth.1220 6.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Nat Methods 2008; 5:545-51; PMID:18454154;http://dx.doi.org/10.1038/nmeth.1209 7.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Sex Plant Reprod 2006; 19:51- 62; http://dx.doi.org/10.1007/s00497-006-0021-9 9.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
http://dx.doi.org/10.1007/978-1-60761-765-5_11 10.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant J 2009; 59:169-78; PMID:19309456; http://dx.doi.org/10.1111/j.1365- 313X.2009.03851.x 11.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant Signaling Behav 2011; 6:1710-3; http://dx.doi.org/10.4161/psb.6.11.17477 12.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant Cell 2008; 20:2798-814; PMID:18931021; http://dx.doi.org/10.1105/tpc.108.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant Cell Physiol 2009; 50:1041-8; PMID:19369273; http://dx.doi.org/10.1093/pcp/pcp055 14.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
PloS one 2009; 4:e5744;PMID:19478943; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
J Cell Sci 2010;123:3019-28; PMID:20699356; http://dx.doi.org/ 10.1242/jcs.071126 17.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Trafﬁc 2011; 12:1537-51; PMID:21797958; http://dx.doi.org/10.1111/j.1600- 0854.2011.01256.x 18.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Protoplasma 2008; 234:33- 50; PMID:18807117; http://dx.doi.org/10.1007/s00709-008-0013-8 19.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Protoplasma 1988; 147:5-15; http://dx.doi.org/10.1007/BF01403873 20.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant Cell 2006; 18:2194-206; PMID:16905656; http://dx.doi.org/10.1105/tpc.106.040956 21.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant Cell 2010;22:3034-52; PMID:20817848; http://dx.doi.org/ 10.1105/tpc.110.075960 22.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
2010; 61: 1959-68; PMID:20351019; http://dx.doi.org/10.1093/jxb/ erq053 23.,Non-OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant J 2004; 39:761-75;PMID:15315637; http://dx.doi.org/10.1111/ j.1365-313X.2004.02147.x 24.,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
Plant Reprod 2014; 27:153-167; PMID:25077683; http://dx.doi.org/10.1007/ s00497-014-0247-x e1075684-4 Volume 10 Issue 10 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/01/fc/kpsb-10-10-1075684.PMC4883927.pdf
"11,12,13,14The over- expression of the Arabidopsis thalianaTCTP gene, AtTCTP1 , induces drought tolerance via stomatal closure, 15while a Nicotiana benthamiana TCTP negativelyKeywords: adventitious roots, Agrobacte- rium rhizogenes, plant regeneration, RNAand protein long-distance transport, TCTP © Roberto Toscano-Morales, Beatriz Xoconostle-C azares, Ang /C19elica Concepci /C19on Martínez-Navarro, and Roberto Ruiz-Medrano *Correspondence to: Roberto Ruiz-Medrano; Email: rmedrano@cinvestav.mx Received: 06/15/2015 Revised: 07/01/2015 Accepted: 07/04/2015 http://dx.doi.org/10.1080/15592324.2015.1071003 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
"A m s o nR ,P e c eS ,M a r i n eJ C ,D iF i o r eP P ,T e l e r - man A. TPT1/ TCTP-regulated pathways in pheno- t y p i cr e p r o g r a m m i n g .T r e n d sC e l lB i o l2 0 1 3 ; 23:37-46; PMID:23122550; http://dx.doi.org/10.1016/j.tcb.2012.10.002 2.",Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Nature 2007; 445:785-8; PMID:17301792; http://dx.doi.org/ 10.1038/nature05528 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Mol Biol Cell 2007; 18:2525-32; PMID:17475776; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
RNA 2002; 8:478-96; PMID:11991642; http://dx.doi.org/ 10.1017/S1355838202022586 6.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Science 1995; 69:688-690;http://dx.doi.org/10.1126/science.7542803 7.,Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
J Immunol 2001; 166:6545-54; PMID:11359806;http://dx.doi.org/10.4049/jimmunol.166.11.6545 8.,Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
J Immunol 2009; 183:2373-81; PMID:19605695; http://dx.doi.org/10.4049/ jimmunol.0900668 9.,Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Curr Biol 2007; 17:801-7; PMID:17442571;http://dx.doi.org/10.1016/j.cub.2007.03.062 10.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
PLoS One 2014; 9:e85514; http://dx.doi.org/10.1371/ journal.pone.0085514 11.,Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
J Environ Sci 2012; 24:2149-58; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Plant Cell Tiss Organ Cult 2010: 103:217-226; http://dx.doi.org/ 10.1007/s11240-010-9769-6 14.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
J Plant Physiol 2013; 170:497-504; PMID:23273927; http://dx.doi.org/10.1016/j.jplph.2012.11.014 15.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Mol Cells 2012; 33:617-26; PMID:22610367; http://dx.doi.org/10.1007/s10059-012-0080-8 16.,Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Plant Cell Physiol 2013;54:1403-14; PMID:23788648; http://dx.doi.org/ 10.1093/pcp/pct090 17.,Non-OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
J Biol Chem 2004; 279:46104-12; PMID:15319436; http://dx.doi.org/10.1074/jbc.M404850200 20.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Biomaterials 2011; 32:222-30; PMID:20863558;http://dx.doi.org/10.1016/j.biomaterials.2010.08.077 21.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Nat Plants 2015; 1:1-7; http://dx.doi.org/ 10.1038/nplants.2015.25 23.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Mol Cell Proteomics 2009; 8:343-56; PMID:18936055; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Plant Signal Behav 2013; 8:e26477;PMID:24065051; http://dx.doi.org/10.4161/ psb.26477 25.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Plant Cell 2008; 20:3430-47; PMID:19060111; http://dx.doi.org/ 10.1105/tpc.108.061010 28.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Front Plant Sci 2014; 5:705; PMID:25566280; http://dx.doi.org/10.3389/ fpls.2014.00705 29.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Front Plant Sci 2014; 5:495; PMID:25324849; http://dx.doi.org/10.3389/ fpls.2014.00495 30.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
Dev Cell 2010; 18:463-71;PMID:20230752; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/26/kpsb-11-03-1071003.PMC4883931.pdf
"4, e1169357 (4 pages)http://dx.doi.org/10.1080/15592324.2016.1169357",Non-OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Annu Rev Genet 2010; 44:1-24; PMID:20649414; http://dx.doi.org/10.1146/annurev-genet-102209-163500 2.,Non-OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Trends Plant Sci 2012; 17:250-9; PMID:22305233; http://dx.doi.org/10.1016/j.tplants.2012.01.003 3.,OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
JPlant Interact 2011; 6:113-9; http://dx.doi.org/10.1080/ 17429145.2010.544779 4.,Non-OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Plant Signal Behav 2014; 9:e27700; PMID:24492469;http://dx.doi.org/10.4161/psb.27700 6.,OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Plant Physiol 2015; 169:2907-21; PMID:26453434; http://dx.doi.org/10.1104/pp.15.00646 7.,Non-OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
J Econ Entomol 2000; 93:1192-8; PMID:10985030; http://dx.do i.org/10.1603/0022-0493-93.4.1192 8.,OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Crop Protect 1999; 18:39-45; http://dx.doi.org/10.1016/S0261-2194(98)00087-8 9 .,OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Plant J 2009; 60:638-48; PMID:19656341; http://dx.doi.org/10.1111/j.1365-313X.2009.03988.x 10.,OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Plant Physiol 2011; 157:1987- 99; PMID:21984727; http://dx.doi.org/10.1104/pp.111.183749 11.,Non-OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Plant J 2011;68:583-96; PMID:21831212; http://dx.doi.org/10.1111/j.1365-313X.2011.04709.x 12.,OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Mol Plant 2014; 7:1670-82;PMID:25064847; http://dx.doi.org/10.1093/mp/ssu085 13.,OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Annu Rev Phytopathol 2005; 43:491-521; PMID:16078893; http://dx.doi.org/10.1146/annurev.phyto.43.040204.135944 14.,Non-OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Biochim Biophys Acta 2007; 1769:497- 505; PMID:17532485; http://dx.doi.org/10.1016/j.bbaexp.2007.04.006 15.,OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
Plant Phys-iol 2010; 154:444-8; PMID:20921160; http://dx.doi.org/10.1104/pp.110.161273 17.,Non-OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
"Shen X, Liu H, Yuan B, Li X, Xu C, Wang S. OsEDR1 negatively regu- lates rice bacterial resistance via activation of ethylene biosynthesis.Plant Cell Environ 2011; 34:179-91; PMID:20807375; http://dx.doi.org/10.1111/j.1365-3040.2010.02219.xe1169357-4 L. HU ET AL.",OADS,/arxiv_data1/oa_pdf/4d/52/kpsb-11-04-1169357.PMC4883949.pdf
"4, e1135281 (4 pages)http://dx.doi.org/10.1080/15592324.2015.1135281",Non-OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Plant Cell 2012; 24:163-77; PMID:22294619; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Plant Cell 2009; 21:1141-54; PMID:19376932; http://dx.doi.org/10.1105/tpc.108.065334 5.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Cell 2015; 162:1353-64; PMID:26343580; http://dx.doi.org/10.1016/j.cell.2015.08.028 7.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Nat Cell Biol 2009; 11:797-806; PMID:19525940; http://dx.doi.org/10.1038/ncb1886 9.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
PLoS Genet 2013; 9:e1003704; PMID:23990797; http://dx.doi.org/10.1371/journal.pgen.1003704 11.,Non-OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Nat Plants 2015; 1:15094; http://dx.doi.org/10.1038/ nplants.2015.94 12.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
EMBO J 1998; 17:5563-76; PMID:9755157; http://dx.doi.org/10.1093/emboj/ 17.19.5563 14.,Non-OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
P roc Natl Acad Sci U S A 2007; 104:15566-71; PMID:17878302; http://dx.doi.org/10.1073/ pnas.0706592104 15.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Plant Cell 2005; 17:1749-63; PMID:15849274; http://dx.doi.org/10.1105/tpc.105.031732 16.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Plant Cell 2012; 24:589-607; PMID: 22327741; http://dx.doi.org/10.1105/tpc.111.094672 17.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Annu Rev Plant Biol 2010; 61:263-89; PMID:20192742; http://dx.doi.org/10.1146/annurev- arplant-042809-112315 18.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Science 2004; 306:2206-11; PMID:15618507; http://dx.doi.org/10.1126/science.1102765 19.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
Plant Physiol 2014; 165:1521-32; PMID:24948829; http://dx.doi.org/ 10.1104/pp.114.241216e1135281-4 A. ENDLER ET AL.,OADS,/arxiv_data1/oa_pdf/72/23/kpsb-11-04-1135281.PMC4883956.pdf
"They include the recycling of amino acidsunder nutrient starvation and stress conditions and removing © Kyosuke Mukae, Yuko Inoue, and Yuji Moriyasu *Correspondence to: Yuji Moriyasu; Email: moriyasu@mail.saitama-u.ac.jpSubmitted: 08/17/2015; Accepted: 08/20/2015 http://dx.doi.org/10.1080/15592324.2015.1086859 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
"In contrast, the drug-resistancegene cassettes Pm35S-NPTII-35SPA orPm35S-APH4 –35SPA were excised with Hind III and BamH I from pTN82 or pTN86, respectively (http://moss.nibb.ac.jp/).",Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
"Accession numbers Nucleotide sequence data for real-time and reverse transcription PCR from this article can be found in the Physcomitrella Cosmoss database (https://www.cosmoss.or g/physcome_project/wiki/Down- loads) under the following accession numbers: PpATG5 (Pp1s227_54), PpATG7 (Pp1s73_159), PpATG8a (Pp1s209_114), PpRPL22 (Pp1s352_17), PpSEN1 (Pp1s81_135), PpSAG12 (Pp1s19_362), PpSAG13 (Pp1s457_13), PpSAG18 (Pp1s74_138).",Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Trends CellBiol 1994; 4:139-43; PMID:14731737; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Autophagy 2007; 3:295; PMID:17404494; http://dx.doi.org/10.4161/auto.4144 5.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Science 2000; 290:1717-21; PMID:11099404; http://dx.doi.org/10.1126/ science.290.5497.1717 6.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Gene 1996; 178:139-43; PMID:8921905;http://dx.doi.org/10.1016/0378-1119(96)00354-X 8.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
J Biol Chem 1998; 273:33889-92; PMID:9852036;http://dx.doi.org/10.1074/jbc.273.51.33889 9.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
EMBORep 2008; 9:859-64; PMID:18704115; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Plant J 2010; 62:483-93; PMID:20136727; http://dx.doi.org/ 10.1111/j.1365-313X.2010.04166.x 11.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
EMBO J 2012; 31:4304-17; PMID:23064152; http://dx.doi.org/ 10.1038/emboj.2012.278 12.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Cell Structure Function2002; 27:409-20; PMID:12576634; http://dx.doi.org/ 10.1247/csf.27.409 13.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
J Biol Chem 2002; 277:33105-14; PMID:12070171; http://dx.doi.org/ 10.1074/jbc.M204630200 14.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Plant Physiol 2007; 143:291-9; PMID:17098847; http://dx.doi.org/ 10.1104/pp.106.092106 16.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Plant Cell Online 2013; 25:1383-99; http://dx.doi.org/10.1105/tpc.112.108993 18.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Plant Physiol 2015; 167:1307-20; PMID:25717038;http://dx.doi.org/10.1104/pp.114.254078 20.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
J Cell Sci 2014; 127:1161-8;PMID:24463818; http://dx.doi.org/10.1242/jcs.139709 22.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Plant Cell Online 2009; 21:2914-27; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Plant Physiol 1972; 49:64-71; PMID:16657898;http://dx.doi.org/10.1104/pp.49.1.64 26.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Meth- ods Enzymol 2008; 451:557-80; PMID:19185740;http://dx.doi.org/10.1016/S0076-6879(08)03232-1 29.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Biochemistry (Mosc) 2009; 74:480- 90; http://dx.doi.org/10.1134/S0006297909050022 31.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
J Biol Chem 2005;280:31582-6; PMID:16027116; http://dx.doi.org/ 10.1074/jbc.M506736200 32.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
FEBS Letters 1993; 333:169-74; PMID:8224160; http://dx.doi.org/10.1016/0014-5793(93)80398-E 33.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
DNA Res 2000; 7:9-17; PMID:10718194; http://dx.doi.org/10.1093/dnares/7.1.9 36.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Annu Rev Plant Biol 2002; 53:477-501; PMID:12221986; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Mol Gen Genet 1991; 226:418-24; PMID:2038304; http://dx.doi.org/10.1007/BF00260654 38.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Plant Physiol 1949; 24:1; PMID:16654194; http://dx.doi.org/10.1104/pp.24.1.1 39.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Analytical Biochem 1976; 70:241-50; PMID:1259145; http://dx.doi.org/ 10.1016/S0003-2697(76)80064-4 41.,Non-OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Biochem J 1954; 57:508;PMID:13181867; http://dx.doi.org/10.1042/bj0570508 www.tandfonline.com e1086859-11 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/15/f4/kpsb-10-11-1086859.PMC4883962.pdf
Available at: http://pngu.mgh.,Non-OADS,/arxiv_data1/oa_pdf/b0/49/i1552-5783-57-6-2763.PMC4884056.pdf
Available at: http://broadinstitute.github.io/picard/.,Non-OADS,/arxiv_data1/oa_pdf/b0/49/i1552-5783-57-6-2763.PMC4884056.pdf
Available at: http://www.inside-r.org/packages/cran/ meta/docs/metaprop.,Non-OADS,/arxiv_data1/oa_pdf/b0/49/i1552-5783-57-6-2763.PMC4884056.pdf
Available at: https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-513/.,OADS,/arxiv_data1/oa_pdf/b0/49/i1552-5783-57-6-2763.PMC4884056.pdf
Available at: https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-2836/.,OADS,/arxiv_data1/oa_pdf/b0/49/i1552-5783-57-6-2763.PMC4884056.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e4/0c/1707.PMC4884061.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/17/d1/1709.PMC4884062.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3f/93/1712.PMC4884063.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0b/85/1728.PMC4884064.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d8/2d/1740.PMC4884065.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e5/ec/1753.PMC4884066.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8c/c4/1764.PMC4884067.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7d/7e/1776.PMC4884068.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6e/39/1786.PMC4884069.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ee/e3/1797.PMC4884070.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/23/13/1809.PMC4884071.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0f/db/1821.PMC4884072.pdf
"Protein concentrations were determined with extinction co - efficients estimated from amino acid sequences with ProtParam  (http://web.expasy.org/protparam): SpAin1/SpAin1(R216E) ( A280 =  86,477 M−1 cm−1), HsACTN4 ( A280 = 125,500 M−1 cm−1), SpFim1  (A280 = 55,140 M−1 cm−1), and fascin ( A280 = 68,152 M−1 cm−1).",OADS,/arxiv_data1/oa_pdf/0f/db/1821.PMC4884072.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/29/23/1834.PMC4884073.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/36/f6/1845.PMC4884074.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/59/a8/1853.PMC4884075.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/83/89/1863.PMC4884076.pdf
Available at: http://www.cdc.gov/stroke/facts.htm.,Non-OADS,/arxiv_data1/oa_pdf/4f/07/ANA-79-895.PMC4884133.pdf
Available at: https://www.clini caltrials.gov/ct2/results?term 5stroke1tms& recr 5&rslt5 &type5&cond 5&intr5&titles5&outc5&spons5&lead5&i d5&state1 5&cntry1 5&state2 5&cntry2 5&state3 5&cntry3 5&locn 5&gndr5&rcv_ s5&rcv_e5&lup_s5&lup_e5.,Non-OADS,/arxiv_data1/oa_pdf/4f/07/ANA-79-895.PMC4884133.pdf
Available at: https://www.clinicaltrials .gov/ct2/results?term 5stroke1tdc-recr 5&rslt5 &type5&cond5&intr5&titles5&outc5&spons 5&lead5&id5&state 15&cntry1 5&state2 5&cntry2 5&state3 5&cntry3 5&locn5&gndr5& rcv_s5&rcv_e5&lup_s5&lup_e5.,Non-OADS,/arxiv_data1/oa_pdf/4f/07/ANA-79-895.PMC4884133.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7f/ba/ircmj-18-03-22420.PMC4884212.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2016, 27: 31557 - http://dx.doi.org/10.3402/mehd.v27.31557 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8e/4b/MEHD-27-31557.PMC4884264.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 31557 - http://dx.doi.org/10.3402/mehd.v27.31557",Non-OADS,/arxiv_data1/oa_pdf/8e/4b/MEHD-27-31557.PMC4884264.pdf
"The use of probiotics should therefore be considered with care, at least in such cases, hence in line with the advice from TheNorwegian Scientific Committee for Food Safety (VKM) against the use of probiotics for critically ill patients (www.vkm.no/dav/009488e0b8.pdf).Probiotic lactic acid bacteria Citation: Microbial Ecology in Health & Disease 2016, 27: 31557 - http://dx.doi.org/10.3402/mehd.v27.31557 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8e/4b/MEHD-27-31557.PMC4884264.pdf
Microb Ecol Health Dis 2014; 25: 25817. doi:http://dx.doi.org/10.3402/mehd.v25.25817 4.,Non-OADS,/arxiv_data1/oa_pdf/8e/4b/MEHD-27-31557.PMC4884264.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 31557 - http://dx.doi.org/10.3402/mehd.v27.31557",Non-OADS,/arxiv_data1/oa_pdf/8e/4b/MEHD-27-31557.PMC4884264.pdf
"Microb Ecol Health Dis 2015; 26: 27997, doi:http://dx.doi.org/10.3402/mehd.v26.27997 33.",Non-OADS,/arxiv_data1/oa_pdf/8e/4b/MEHD-27-31557.PMC4884264.pdf
"Int J Antimicrob Agents 2013; 42: 47581.Probiotic lactic acid bacteria Citation: Microbial Ecology in Health & Disease 2016, 27: 31557 - http://dx.doi.org/10.3402/mehd.v27.31557 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8e/4b/MEHD-27-31557.PMC4884264.pdf
Dystonic contractions of abdominalFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1* To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/25/38/tre-06-374-7522-1.PMC4884265.pdf
"Gait ataxia and generalized dystonia were unchanged.Becker AE, Vargas W, Pearson TS Dystonia in AVED Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/25/38/tre-06-374-7522-1.PMC4884265.pdf
"Coronal T2-weighted magnetic resonance imaging showing normal cerebellum.Dystonia in AVED Becker AE, Vargas W, Pearson TS Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/25/38/tre-06-374-7522-1.PMC4884265.pdf
"Since AVED may be treatable if diagnosed early, it should be considered in the differential diagnosis of progressive dystonia, parti cularly when the dystonia is cervical, or is accompanied by head tremor.Table 1.Clinical Characteristics and Treatment Response in Patients with AVED and Dystonia Study Age at Onset (years)Initial Symptoms Age at Dystonia Onset (years)Dystonia DistributionVitamin E Treatment (target dose/day; total duration)Clinical Course Krendel et al.177 Gait difficulty, clumsiness, dysarthria19 GD Neck UE LE3,600 IU; 5 mo Stable Stumpf et al.184 Unsteady gait, 30 Face 800 mg; 6 mo Stable Amiel et al.157 Ataxia 16 Face UE1,000 mg; 5 yr Improved: social contact, speech Jackson et al.197 Head and hand tremor22 GD Face Neck Trunk LE1,200 IU; 3 yr Stable Yokota et al.2030 ND ND ND ND Stable Cavalier et al.213N D N D N DN D N D Schuelke et al.229 Clumsiness 13 ND 40 mg/kg; 18 mo Improved: psychiatric, cognitive, ataxia, dysarthria, sensation, Deep tendon reflex’s Angelini et al.58 Cervical myoclonus- dystoniaAt onset Neck Trunk2,400 mg; 1.75 yr Improved: ataxia, dystonia, myoclonus Roubertie et al.168.6 Gait instability, clumsiness, slurred/ scanning speech11.75 GD Neck Trunk UE LE2,000 mg; 5 yr Improved: ataxia Onset: progressive dystonia Mariotti et al.38 ND ND ND 2,400 mg; 5 yr Improved: ataxia, dystonia Our case: female 11 Dystonic head tremor At onset Neck UE2,400 IU; 10 mo Onset: ataxia Our case: male 11 Dystonic head tremor At onset GD Neck Trunk UE LE2,400 IU; 10 mo Improved: dysarthria, dysdiadochokinesia Abbreviations: AVED, Ataxia with Vitamin E Deficiency; GD, Generalized Dystonia (defined as combination of segmental crural plus other area of body ); LE, Lower Extremity; mo, Months; ND, Not Described; UE, Upper Extremity; yr, Years.Becker AE, Vargas W, Pearson TS Dystonia in AVED Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/25/38/tre-06-374-7522-1.PMC4884265.pdf
"doi: 10.1016/S0022-3476(99)70424-5Dystonia in AVED Becker AE, Vargas W, Pearson TS Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/25/38/tre-06-374-7522-1.PMC4884265.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7a/3e/ircmj-18-03-23677.PMC4884271.pdf
"Search Strategy for Retrieving Data Elements of Information Management System for Traffic Accidents Sites, Criteria, Strategy Descriptions, Characteristics Websitesworld health organization, texas department of transportation; www .miros.gov .my; www .jmwengineering.com/aims00/ new .html; http://roadsafety .transport.nsw .gov .au, http://internationaltransportforum.org/irtadpublic; website: www.sgi.",Non-OADS,/arxiv_data1/oa_pdf/7a/3e/ircmj-18-03-23677.PMC4884271.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/62/8c/ircmj-18-03-24527.PMC4884272.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/32/86/ircmj-18-03-23814.PMC4884299.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/16/ckv231.PMC4884328.pdf
Available from http://ec.europa.eu/health/data_collection/tools/mechanisms/index_en.htm 86 Expert Group on Health Information.,OADS,/arxiv_data1/oa_pdf/6c/16/ckv231.PMC4884328.pdf
Available fromhttp://ec.europa.eu/health/strategy/docs/non_paper_his_eric_en.pdf .................. ................... ................... .................. ................ ...............,Non-OADS,/arxiv_data1/oa_pdf/6c/16/ckv231.PMC4884328.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/9a/ckw025.PMC4884330.pdf
"We conducted this systematic reviewwithin the framework for the Swedish Agency for Health and Technology Assessment and Assessment of Social Services, a public national agency with the charge of providing impartial and scientif-ically reliable information to decision makers and health careproviders (http://www.sbu.se/en/Assessment-and-Evidence/).",Non-OADS,/arxiv_data1/oa_pdf/17/9a/ckw025.PMC4884330.pdf
The whole search strategy is available at http://sbu.se/240E.We only accepted articles in scientific journals with independent peer-reviews.,Non-OADS,/arxiv_data1/oa_pdf/17/9a/ckw025.PMC4884330.pdf
"For more detailed information regarding outcome, see detailed tables of all included studies at http://sbu.se/240E.",Non-OADS,/arxiv_data1/oa_pdf/17/9a/ckw025.PMC4884330.pdf
"Relevance criteria are presented in http://sbu.se/240E.Second, the scientific experts performed a quality assessment.",Non-OADS,/arxiv_data1/oa_pdf/17/9a/ckw025.PMC4884330.pdf
A list of relevant articles meeting the inclusion criteria judged to be of low quality is available at http://sbu.se/240E.,Non-OADS,/arxiv_data1/oa_pdf/17/9a/ckw025.PMC4884330.pdf
The final list of studies judged to be of high or medium high quality is listed in http://sbu.se/240E.,Non-OADS,/arxiv_data1/oa_pdf/17/9a/ckw025.PMC4884330.pdf
A detailedtable showing the full results of the data extraction is available athttp://sbu.se/240E.,OADS,/arxiv_data1/oa_pdf/17/9a/ckw025.PMC4884330.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/67/ckw031.PMC4884332.pdf
2009. http://www.cdc.gov/h1n1flu/guidance/exclusion.htm.,Non-OADS,/arxiv_data1/oa_pdf/56/67/ckw031.PMC4884332.pdf
2010. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/56/67/ckw031.PMC4884332.pdf
doi: http://www.nature.com/nature/journal/v452/n7188/suppinfo/nature06732_S1.html.,Non-OADS,/arxiv_data1/oa_pdf/56/67/ckw031.PMC4884332.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/67/ckw031.PMC4884332.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e3/11/num-08-02-34061.PMC4884403.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8e/f3/ircmj-18-03-23890.PMC4884438.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/05/57/ircmj-18-03-22465.PMC4884439.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ef/05/ircmj-18-03-21019.PMC4884440.pdf
"Patients and Methods This was a single-center randomized, double-blind, place - bo-controlled two-week trial approved by the institutional  ethics committee of Ahvaz Jundishapur university of medi - cal sciences and registered in the Iranian registry of clinical  trials (http://irct.ir) under the IRCT No.",Non-OADS,/arxiv_data1/oa_pdf/ef/05/ircmj-18-03-21019.PMC4884440.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8e/9e/ircmj-18-03-22054.PMC4884442.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/55/94/ircmj-18-03-25716.PMC4884443.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/6a/emss-68169.PMC4884448.pdf
"Although complications were not examined as a primary end point in the present study, previous large prospective studies have reported transient hoarseness or change in voice as the most common side effect in one-third to one-half of patients, infection in 3% to 4% of cases, and other possible adverse events including cough, paresthesia, pain, dyspnea, or headache.7,10,19Similarly, although the cost of VNS therapy was not a focus of this study, previous cost-utility analyses have been reported and have typically demonstrated cost savings with VNS compared with continued medical therapy for intractable epilepsy.20,21 Systematic Literature Review To help support registry-based results, a systematic review of the literature was performed, as summarized in the Figure ,Supplemental Digital Content (http://links.lww.com/NEU/A821).",Non-OADS,/arxiv_data1/oa_pdf/ec/4e/neu-79-345.PMC4884552.pdf
2012. http://www.prnewswire.com/news-releases/cyberonics-announces-100000th- patient-implant-of-vns-therapy-184314661.html.,Non-OADS,/arxiv_data1/oa_pdf/ec/4e/neu-79-345.PMC4884552.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/54/57/ircmj-18-03-22615.PMC4884607.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bc/1c/ircmj-18-03-24231.PMC4884608.pdf
Avail - able from: http://statistics.ostan-es.ir/.,Non-OADS,/arxiv_data1/oa_pdf/bc/1c/ircmj-18-03-24231.PMC4884608.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/81/num-08-02-35356.PMC4884609.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/52/df/ircmj-18-03-21072.PMC4884614.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8b/79/ircmj-18-03-21627.PMC4884615.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.Dear Editor, Depression, common throughout the world, is a state of  low mood and aversion to activity that can affect a person’s  thoughts, behavior, feelings, and sense of well-being (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/0d/98/ircmj-18-03-21993.PMC4884624.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b9/0f/ircmj-18-03-22455.PMC4884625.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d6/c5/ircmj-18-03-22076.PMC4884626.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cd/8c/ircmj-18-03-24966.PMC4884627.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3e/12/ircmj-18-03-22260.PMC4884628.pdf
"This process has been defined as a hippocampal computation during which  This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ Correspondence should be addressed to: Paula Vieweg, German Center for Neurodegenerative Diseases (DZNE) Aging & Cognition  Research Group, Building 64, Room 520, Leipziger Str.",Non-OADS,/arxiv_data1/oa_pdf/e1/5f/emss-68200.PMC4884644.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"2 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"We found average rapamycin levels were 35.12 93.354 ppbAdaptations to chronic rapamycin in mice Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"4 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"(h) Ratios of eIF4E to 4E-BP1.Adaptations to chronic rapamycin in mice Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"6 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"(g) and (h) Graphs of qRT-PCR results compared to (B2M) forRpl22l1 and Rpl22 , respectively.Adaptations to chronic rapamycin in mice Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"8 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"2013; 49: 336 /C144.Adaptations to chronic rapamycin in mice Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"10 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"2010; 65(12): 1275 /C184.Adaptations to chronic rapamycin in mice Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 31688 - http://dx.doi.org/10.3402/pba.v6.31688 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c5/53/PBA-6-31688.PMC4884683.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.279 REVIEW ARTICLE Skin Pigmentation and Pigmentary Disorders: Focus  on Epidermal/Dermal Cross-T alk Emanuela Bastonini*, Daniela Kovacs*, Mauro Picardo Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatologic Institute, IRCCS, Rome, It aly Variation in human skin and hair color is the most notable as- pect of human variability and several studies in evolution, ge-netics and developmen tal biology contribut ed to explain the  mechanisms underlying human skin pigmentation, which is  responsible for differences in skin color across the world’s populations.",Non-OADS,/arxiv_data1/oa_pdf/90/20/ad-28-279.PMC4884703.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.290 ORIGINAL ARTICLE Treatment of Melasma with the Photoacoustic T win  Pulse Mode of Low-Fluence 1,064 nm Q-Switched Nd:YAG Laser Jee Young Kim, Misoo Choi, Chan Hee Nam, Ji Seok Kim, Myung Hwa Kim, Byung Cheol Park,  Seung Phil Hong Department of Dermatology, Dankook University College of Medicine, Cheonan, Korea Background:  Low-fluence 1,064 nm Q-switched Nd:YAG la- ser has been widely used for the treatment of melasma.",Non-OADS,/arxiv_data1/oa_pdf/fe/64/ad-28-290.PMC4884704.pdf
"The instant peak  energy of the singly Q-switched  beam is 1.3 J, whereas the  energy of doubly Q-switched beams (each beam en-ergy is about 0.8 J) in the PTP mode is 1.6 J, and as a re- sult, the instant peak energy is increased up to 123%  (http://www.wtlaser.com/kr/products/pastelle.asp).",Non-OADS,/arxiv_data1/oa_pdf/fe/64/ad-28-290.PMC4884704.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.297 ORIGINAL ARTICLE A Randomized, Evaluator-Blinded, Split-Face  Comparison Study of the Efficacy and Safety of a Novel Mannitol Containing Monophasic Hyaluronic Acid Dermal Filler for the Treatment of Moderate to Severe Nasolabial Folds  Byung Wook Kim, Ik Jun Moon, Woo Jin Yun, Bo Young Chung1, Sang Duck Kim2, Ga-Young Lee3,*,  Sung Eun Chang*  Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, 1Department of Dermatology, Hallym  University Kangnam Sacred Heart Hospital , Hallym University College of Medicine, 2Bright and Clear Dermatology Clinic, 3Department  of Dermatology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Background:  Mannitol containing mo nophasic filler with  higher crosslinking has not be en well studied for moderate  and severe nasolabial fold (NLF) correction.",Non-OADS,/arxiv_data1/oa_pdf/5f/3f/ad-28-297.PMC4884705.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.304 ORIGINAL ARTICLE Protective Effect of T opical Vitamin D 3 against  Photocarcinogenesis in a Murine Model Ji Seok Kim, Minyoung Jung , Jiyeon Yoo, Eung Ho Choi1, Byung Cheol Park, Myung Hwa Kim,  Seung Phil Hong Department of Dermatology, Dankook University College of Medicine, Cheonan, 1Department of Dermatology, Yonsei University Wonju  College of Medicine, Wonju, Korea Background:  Although the incidence of non-melanoma skin  cancer is increasing, there are no effective practical pre-ventive measures other than avoiding sun exposure.",Non-OADS,/arxiv_data1/oa_pdf/cb/01/ad-28-304.PMC4884706.pdf
"Melanoma Res 2003;13:635-639. http://dx.doi.org/10.5021/ad.2016.28.3.395 Interstitial Granulomatous Dermatitis Associated with  Rheumatoid Arthritis Yoon Seob Kim, Ji Hyun Lee, Jun Young Lee, Young Min Park Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Interstitial granulomatous dermatitis (IGD) is a rare and pe-culiar disorder with cutaneous and joint manifestations 1.",Non-OADS,/arxiv_data1/oa_pdf/36/c5/ad-28-314.PMC4884707.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.321 ORIGINAL ARTICLE Correlation between Severity of Atopic Dermatitis and  Sleep Quality in Children and Adults Tae Seok Kong, Tae Young Han, June Hyunkyung Lee, Sook Ja Son Department of Dermatology, Eulji Medical Center, Eulji University College of Medicine, Seoul, Korea Background:  The atopic dermatitis (AD) can limit a patient’s  physical and psychosocial development as well as lower their overall quality of life (QOL), including sleep quality.",Non-OADS,/arxiv_data1/oa_pdf/83/12/ad-28-321.PMC4884708.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.327 ORIGINAL ARTICLE Epigallocatechin Gallate-Mediated Alteration of the  MicroRNA Expression Profile in 5 α-Dihydrotestosterone-  Treated Human Dermal Papilla Cells Shanghun Shin*, Karam Kim*, Myung Joo Lee, Jeongju Lee, Sungjin Choi, Kyung-Suk Kim,  Jung-Min Ko, Hyunjoo Han, Su Young Kim, Hae Jeong Youn1, Kyu Joong Ahn1, In-Sook An2,  Sungkwan An, Hwa Jun Cha Korea Institute for Skin and Clinical Sciences and Molecu lar-Targeted Drug Research Center, Konkuk University, 1Department of  Dermatology, Konkuk University School of Medicine, Seoul, 2KISCS Incorporated, Cheongju, Korea Background:  Dihydrotestosterone (DHT) induces andro- genic alopecia by shortening the hair follicle growth phase, resulting in hair loss.",Non-OADS,/arxiv_data1/oa_pdf/17/42/ad-28-327.PMC4884709.pdf
"Bioinformatics analysis and target prediction The PITA (http://genie.weizmann.ac.il), microRNAorg (http://  www.microrna.org), and TargetScan (http://www.targetscan.",OADS,/arxiv_data1/oa_pdf/17/42/ad-28-327.PMC4884709.pdf
"Number of targets of selected miRNAs based on three prediction databases Targets of up-regulated miRNAs Targets of down-regulated miRNAs Targetscan PITA microRNAorg Targetscan PITA microRNAorg 673 415 833 535 173 470 Intersection of three target prediction databases: 306 Intersection of three target prediction databases: 134 TargetScan: http://www.targetscan.org, PITA: http://genie.weizma nn.ac.il, microRNAorg: http://www.",OADS,/arxiv_data1/oa_pdf/17/42/ad-28-327.PMC4884709.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.335 ORIGINAL ARTICLE Clinical Features and Awareness of Hand Eczema  in Korea Jae Beom Park, Seung Ho Lee1, Kea Jeung Kim2, Ga-Young Lee2, Jun-Mo Yang2, Do Won Kim3,  Seok Jong Lee3, Cheol Heon Lee4, Eun Joo Park4, Kyu Han Kim5, Hee Chul Eun5, Sung Eun Chang6,  Kee Chan Moon6, Seong Hyun Kim7, Seong Jin Kim8, Byung-Soo Kim9, Jun Young Lee10, Hyung-Ok Kim10,  Hoon Kang10, Min Geol Lee11, Soo-Chan Kim11, Young Suck Ro12, Joo Yeon Ko12, Mi Youn Park13,  Myung Hwa Kim14, Jeong Hyun Shin15, Hae Young Choi16, Chang Kwun Hong17, Sung Yul Lee18,  Hana Bak19, Sang Wook Son, Ai Young Lee1 Department of Dermatology, Korea University College of Medicine, Seoul, 1Dongguk University Ilsan Hospital, Goyang,  2Sungkyunkwan University School of Medicine, Seoul, 3Kyungpook National University School of Medicine, Daegu, 4Hallym University  College of Medicine, Chuncheon, 5Seoul National University College of Medicine, 6University of Ulsan College of Medicine, Seoul, 7Ilsan  Paik Hospital, Inje University College of Medicine, Goyang, 8Chonnam National University Medical School, Gwangju, 9Pusan National  University Hospital, Busan, 10College of Medicine, The Catholic University of Korea, 11Yonsei University Co llege of Medicine, 12Hanyang  University College of Medicine, 13National Medical Center, Seoul, 14Dankook University Medical College, Cheonan, 15Inha University  School of Medicine, Incheon, 16Ewha Womans University School of Medicine, 17Chung-Ang University School of Medicine, Seoul,  18Soonchunhyang University College of Medicine, Cheonan, 19Hana Clininc, Seoul, Korea Background:  Hand eczema is one of the most common skin  disorders and negatively affects quality of life.",Non-OADS,/arxiv_data1/oa_pdf/62/e3/ad-28-335.PMC4884710.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.344 ORIGINAL ARTICLE CSP0510 Lotion as a Novel Moisturizer Containing  Citric Acid and T risodium Phosphate Relieves Objective and Subjective Symptoms of Atopic Dermatitis  Ho-June Lee, Nam-Woong Yang1, Jee-Young Choi, Jee-Bum Lee, Seung-Chul Lee Department of Dermatology, Chonnam National University Medical School, 1Department of Microbiology, School of Medicine, Chosun  University, Gwangju, Korea Background:  Moisturizers with anti-inflammatory or an- ti-itch activity should be develope d for the safe and effective  management of atopic dermatitis (AD).",Non-OADS,/arxiv_data1/oa_pdf/26/32/ad-28-344.PMC4884711.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.352 ORIGINAL ARTICLE Ampelopsis japonica  Makino Extract Inhibits the  Inflammatory Reaction Induced by Pathogen-Associated Molecular Patterns in Epidermal Keratinocytes Mi-Ra Choi1, Dae-Kyoung Choi1, Ki-Duck Kim1, Sue Jeong Kim1, Dong-Il Kim2, Myung Im1,  Young Lee1, Young-Joon Seo1, Chang Deok Kim1, Jeung-Hoon Lee1,3 1Department of Dermatology, Chungnam National University School of Medicine, Daejeon, 2Department of Obstetrics and Gynecology,  Dongguk University College of Korean Medicine, Seoul, 3Skin Med Company, Daejeon, Korea Background:  Keratinocytes are the major cells in epidermis,  providing barrier components such as cornified cells through the sophisticated differentiation process.",Non-OADS,/arxiv_data1/oa_pdf/67/89/ad-28-352.PMC4884712.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.364 ORIGINAL ARTICLE Efficacy and Safety of Alitretinoin for Chronic Hand  Eczema in Korean Patients Hyoung Il Kwon, Jeong Eun Kim, Joo Yeon Ko, Young Suck Ro Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea Background:  Chronic hand eczema (CHE) tends to be re- fractory to conventional therapy.",Non-OADS,/arxiv_data1/oa_pdf/d5/6a/ad-28-364.PMC4884714.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.371 CASE REPORT CD30-Positive Anaplastic Lymphoma Kinase-Negative  Systemic Anaplastic Large-Cell Lymphoma in a 9-Year-Old Boy Jeong Eun Kim, Eui Hyun Oh, Young Suck Ro, Joo Yeon Ko Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea Anaplastic large-cell lymphoma (ALCL) is a CD30-positive  T-cell/null-cell lymphoma that is clinically classified into ei-ther primary cutaneous ALCL or systemic ALCL (S-ALCL)  sub-types.",Non-OADS,/arxiv_data1/oa_pdf/f2/73/ad-28-371.PMC4884715.pdf
"3, 2016 http://dx.doi.org/10.5021/ad.2016.28.3.375 CASE REPORT T umoral Calcinosis as an Initial Complaint  of Juvenile-Onset Amyopathic Dermatomyositis Eun Jin Doh, Jungyoon Moon, Sue Shin1, Soo Hyun Seo1, Hyun Sun Park, Hyun-Sun Yoon, Soyun Cho Departments of Dermatology and 1Laboratory Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical  Center, Seoul, Korea Calcinosis is rarely observed in juvenile-onset amyopathic  dermatomyositis in contrast to juvenile-onset dermatomyositis.",Non-OADS,/arxiv_data1/oa_pdf/0c/a9/ad-28-375.PMC4884716.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.3.383 A Case of Papular Mycosis Fungoides: A New Clinical  Variant of Early Mycosis Fungoides Soo Jin Kim, András Schaffer1, Ho Yeol Lee, Ji Young Seo, Hai-Jin Park Department of Dermatology, Inje University Ilsan Paik Hospital, Goyang, Korea, 1Dermatopathology Center, Washington University  School in St. Louis, St. Louis, MO, USA  Dear Editor: Mycosis fungoides (M F) is the most common form of cuta- neous T-cell lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/49/7b/ad-28-383.PMC4884718.pdf
"(C) Clinical improvement of skin lesion 11 months after treatment, (D) close up view of the lesion.http://dx.doi.org/10.5021/ad.2016.28.3.385 A Case of Phaeohyphomycosis Caused  by Exophiala lecanii -corni Kyou Chae Lee, Min Ji Kim, Soo Yuhl Chae, Hae Sook Lee, Yong Hyun Jang, Seok-Jong Lee,  Do Won Kim, Weon Ju Lee Department of Dermatology, Kyungpook National University School of Medicine, Daegu, Korea Dear Editor: Phaeohyphomycosis refers to subcutaneous and systemic  fungal infections characterized by dematiaceous septate mycelial elements 1.",Non-OADS,/arxiv_data1/oa_pdf/9f/87/ad-28-385.PMC4884719.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.3.388 Classic Juvenile Pityriasis Rubra Pilaris Treated  with Oral Alitretinoin Hyun Soo Lee, Eun-So Lee Department of Dermatology, Ajou University School of Medicine, Suwon, Korea Dear Editor: Pityriasis rubra pilaris (PRP) is a papulosquamous disorder  of unknown etiology.",Non-OADS,/arxiv_data1/oa_pdf/f4/ce/ad-28-388.PMC4884720.pdf
"(B)  After several weeks, the nodule on  the left calf developed into a pro-gressive ulcer covered with gra- nulation-like tissues, gradually pe- netrating into the muscle layer.http://dx.doi.org/10.5021/ad.2016.28.3.391 Histiocytic Infiltrate in Angioimmunoblastic T-Cell  Lymphoma with Cutaneous Nodules and Progressive Ulceration: A Rare Manifestation Min Seok Kim, Won Joo Kwon, Ji Min Ha, Eun Byul Cho, Eun Joo Park, Kwang Ho Kim,  Kwang Joong Kim  Department of Dermatology, Hallym University Sacred Heart Hospital, Anyang, Korea Dear Editor: Angioimmunoblastic T-cell lymphoma (AITL) is an ag- gressive non-Hodgkin’s nodal peripheral T-cell lymphoma that accounts for 18% of periph eral T-cell lymphoma, and  cutaneous AITL has not been well characterized in terms  of clinical and histopathologic features 1.",Non-OADS,/arxiv_data1/oa_pdf/43/db/ad-28-391.PMC4884721.pdf
"N Eng J Med 2010;362:875-885. http://dx.doi.org/10.5021/ad.2016.28.3.393 Cutaneous Metastatic Rectal Adenocarcinoma  in Zosteriform Distribution In Hyuk Kwon, Heesang Kye, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye, Jae Eun Choi Department of Dermatology, Korea University College of Medicine, Seoul, Korea Dear Editor: A 54-year-old woman presented with mildly stinging,  painful, grouped nodules on the left vulvar area.",Non-OADS,/arxiv_data1/oa_pdf/43/db/ad-28-391.PMC4884721.pdf
"N Eng J Med 2010;362:875-885. http://dx.doi.org/10.5021/ad.2016.28.3.393 Cutaneous Metastatic Rectal Adenocarcinoma  in Zosteriform Distribution In Hyuk Kwon, Heesang Kye, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye, Jae Eun Choi Department of Dermatology, Korea University College of Medicine, Seoul, Korea Dear Editor: A 54-year-old woman presented with mildly stinging,  painful, grouped nodules on the left vulvar area.",Non-OADS,/arxiv_data1/oa_pdf/be/04/ad-28-393.PMC4884722.pdf
"Melanoma Res 2003;13:635-639. http://dx.doi.org/10.5021/ad.2016.28.3.395 Interstitial Granulomatous Dermatitis Associated with  Rheumatoid Arthritis Yoon Seob Kim, Ji Hyun Lee, Jun Young Lee, Young Min Park Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Interstitial granulomatous dermatitis (IGD) is a rare and pe-culiar disorder with cutaneous and joint manifestations 1.",Non-OADS,/arxiv_data1/oa_pdf/be/04/ad-28-393.PMC4884722.pdf
"Melanoma Res 2003;13:635-639. http://dx.doi.org/10.5021/ad.2016.28.3.395 Interstitial Granulomatous Dermatitis Associated with  Rheumatoid Arthritis Yoon Seob Kim, Ji Hyun Lee, Jun Young Lee, Young Min Park Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Interstitial granulomatous dermatitis (IGD) is a rare and pe-culiar disorder with cutaneous and joint manifestations 1.",Non-OADS,/arxiv_data1/oa_pdf/d1/85/ad-28-395.PMC4884723.pdf
"The arrowhead indicates the biopsy site.http://dx.doi.org/10.5021/ad.2016.28.3.398 A Case of Multiple Canaliform Median Raphe Cysts  Showing a Mixed T ype Lining of Epithelium: A Case Report and Review of the Literature Sungsik Shin, Seung Kyung Hann1, Do Young Kim Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, 1Drs.",Non-OADS,/arxiv_data1/oa_pdf/52/8a/ad-28-398.PMC4884724.pdf
"Blue to purple discoloration with petechiae on the right  foot.http://dx.doi.org/10.5021/ad.2016.28.3.400 Blue T oe Syndrome as an Early Sign of Disseminated  Intravascular Coagulation Kwang-Hyun Choi, Jisook Yoo, Joon Won Huh, Young-In Jeong, Min Soo Kim, Mihn Sook Jue,  Hyang-Joon Park  Department of Dermatology, VHS Medical Center, Seoul, Korea Dear Editor: Blue toe syndrome (BTS) is often described as painful dig- its with blue or purple disc oloration without direct trau- ma1.",Non-OADS,/arxiv_data1/oa_pdf/0c/c7/ad-28-400.PMC4884725.pdf
"(C) Biopsy showed palisading gra nulomas surrounding degenerated  connective tissue and fibrin (H&E, ×200).http://dx.doi.org/10.5021/ad.2016.28.3.402 Development of Rheumatoid Nodules after Anti-T umor  Necrosis Factor- α Treatment with Adalimumab for  Rheumatoid Arthritis Sungsik Shin, Kee Yang Chung, Dae Suk Kim Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seo ul,  Korea Dear Editor: A 40-year-old male presented with 4 months history of  multiple various sized erythe matous to violaceous sub- cutaneous nodules on both extensor surfaces of elbows,  which was partially movabl e and showed no symptoms  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/26/97/ad-28-402.PMC4884726.pdf
"(B) abdomen (27×21 cm sized).http://dx.doi.org/10.5021/ad.2016.28.3.404 Acquired Unilateral Nevoid T elangiectasia Accompanied  by Liver Metastasis of Colon Cancer Hyun Ju Kim, Kyung O Kim, Ye Seul Kim, Sung Yul Lee1, Young Lip Park, Sanghoon Lee Department of Dermatology, Soon Chun Hyang University Bucheon Hospital, Bucheon, 1Department of Dermatology, Soon Chun Hyang  University Cheonan Hospital, Cheonan, Korea Dear Editor: Unilateral nevoid telangiectasia (UNT) syndrome is a rare  vascular dermatosis, characteriz ed by areas of superficial  telangiectases distributed in a dermatomal, unilateral pat- tern usually on the upper trunk and extremities.",Non-OADS,/arxiv_data1/oa_pdf/ff/fa/ad-28-404.PMC4884727.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.3.406 The Efficacy and Prognostic Factors for Long Pulse  Neodymium: Yttrium-Aluminum-Garnet Laser Treatment on Onychomycosis: A Pilot Study Sha Lu1,*, Jing Zhang1,*, Yuheng Liang1,2, Xiqing Li1, Wenying Cai1, Liyan Xi1 1Department of Dermatology and Venereology, Sun Ya t-sen Memorial Hospital, Sun Yat-sen University, 2Institute of Pathogenic  Microbiology, Guangdong Provincial Center for Di sease Control and Prevention, Guangzhou, China Dear Editor: Onychomycosis is a chronic fu ngal infection of the nails  caused by dermatophytes, yeasts or non-dermatophyte  molds and represents about 50% of all onychopathies and  30% of all cutaneous fungal infections1,2.",Non-OADS,/arxiv_data1/oa_pdf/08/20/ad-28-406.PMC4884728.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.3.409 Exacerbation of Psoriasis after Imatinib Mesylate  Treatment  Joon Ho Shim, Seung Hwan Oh, Ji-Young Jun, Jun-Hwan Kim, Hae-Young Park, Ji-Hye Park,  Dong-Youn Lee Department of Dermatology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Dear Editor: A 52-year-old male diagnosed with metastatic melanoma  began treatment with 400 mg oral imatinib daily.",Non-OADS,/arxiv_data1/oa_pdf/a0/ba/ad-28-409.PMC4884729.pdf
"http://dx.doi.org/10.5021/ad.2016.28.3.411 A Case of Multiple Desmoplastic Trichoepithelioma Seong Hun Moon, Hyun Seok Choi, Hyoung Il Kwon, Joo Yeon Ko, Jeong Eun Kim  Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea Dear Editor: A 23-year-old woman presented with multiple, pro- gressively growing, asymptomatic, depressed macules on  face for 2 years.",Non-OADS,/arxiv_data1/oa_pdf/a0/ba/ad-28-409.PMC4884729.pdf
"http://dx.doi.org/10.5021/ad.2016.28.3.411 A Case of Multiple Desmoplastic Trichoepithelioma Seong Hun Moon, Hyun Seok Choi, Hyoung Il Kwon, Joo Yeon Ko, Jeong Eun Kim  Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea Dear Editor: A 23-year-old woman presented with multiple, pro- gressively growing, asymptomatic, depressed macules on  face for 2 years.",Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ad-28-411.PMC4884730.pdf
"Histopathology 2008;52:865-876.   http://dx.doi.org/10.5021/ad.2016.28.3.413 A Case of T erra Firma-Forme Dermatosis:  Differentiation from Other Dirty-Appearing Diseases Jungyoon Moon, Min-Woo Kim, Hyun-Sun Yoon, Soyun Cho, Hyun-sun Park Department of Dermatology, SMG-SNU Boramae Medical Center, Seoul, Korea Dear Editor: Terra firma-forme dermatosis (TFFD), which derives its term from the Latin phrase ‘terra-firma’ meaning dry land, is a rare skin disorder char acterized by hyperpigmentation  resembling dirt-like  brown patches 1,2.",Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ad-28-411.PMC4884730.pdf
"Histopathology 2008;52:865-876.   http://dx.doi.org/10.5021/ad.2016.28.3.413 A Case of T erra Firma-Forme Dermatosis:  Differentiation from Other Dirty-Appearing Diseases Jungyoon Moon, Min-Woo Kim, Hyun-Sun Yoon, Soyun Cho, Hyun-sun Park Department of Dermatology, SMG-SNU Boramae Medical Center, Seoul, Korea Dear Editor: Terra firma-forme dermatosis (TFFD), which derives its term from the Latin phrase ‘terra-firma’ meaning dry land, is a rare skin disorder char acterized by hyperpigmentation  resembling dirt-like  brown patches 1,2.",Non-OADS,/arxiv_data1/oa_pdf/a8/60/ad-28-413.PMC4884731.pdf
The EVER2 gene consists of 16 exons and   15 introns and encodes only one transcript of the length  of about 4419 bp ( http://www.ensembl.org/Homo_sapi - ens/Transcript/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/43/PDIA-33-27312.PMC4884774.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/26/89/mtna201555a.PMC4884788.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/15/9f/mtna201557a.PMC4884789.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/94/b6/mtna201559a.PMC4884790.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/2a/main.PMC4885010.pdf
"After discussions  with  neurosurgery,  the  team  decided  to  repeat  the  labs http://dx.doi.org/10.1016/j.ijscr.2016.05.004 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/b6/2a/main.PMC4885010.pdf
[1](link to http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
"[2](link to http://dx.doi.org/10.1016/ j.redox.2015.09.005 ) discusses different pathways of bacterially- induced mtROS formation and its role for activation of the NLRP3inﬂammasome via direct redox modi ﬁcations of the NLRP3 com- ponents as well as redox-sensitive indirect pathways such as Nrf2/ HO-1, NF κB/iNOS and TXNIP/mtDAMP interaction with the NLRP3 inﬂammasome leading to the formation of the pro-in ﬂammatory cytokine IL-1 β. Mitochondrial damage-associated molecular pat- terns (mtDAMPs) include the participation of mtDNA and/or car-diolipin that are released or surfaced by dysfunctional mitochon-dria.",OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[3](link to http://dx.doi.org/ 10.1016/j.redox.2015.07.008 ) highlights the adaptive cellular anti- oxidant responses to oxidative stress.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[4](http://dx.doi.org/10.1016/j.re dox.2015.08.010 ) provides insight into the impact of calcium levels on ROS sources such as mitochondria and NADPH oxidases.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[5](http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
"[6](http://dx.doi.org/10.1016/j.re dox.2015.08.018 ) provides detailed insights in the physiological function of adipocytes and the ratio and interconversion betweenwhite and brown adipose tissue, as well as the physiologicalconsequences of this interconversion.",OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
Dysfunctional adipocytes alsoContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.12.007 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[7](http://dx.doi.org/10.1016/j.redox.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
"[8](http://dx.doi.org/10.1016/j.re dox.2015.06.014 ) provides an introduction on cancerogenesis with emphasis on the contribution of oxidative stress to this process, highlighting impaired DNA damage repair as one important con- stituent of cancer development.",Non-OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[9](http://dx.doi.org/10.1016/j.redox.2012.10.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
"[10] (http://dx.doi.org/10.1016/j.re dox.2015.06.012 ) provides an overview on NADPH oxidase iso- forms in different cell types and their pathophysiological actions in vascular in ﬂammation and oxidative stress, vascular dysfunction and remodeling and ﬁnally progression to atherosclerosis.",OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[11] (http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[12] (http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[13] (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[14] (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[15] (http://dx.doi.org/10.1016/j.re dox.2015.07.009 ) concentrates on the role of ROS for genetic dis- ease such as Nox2 subunit-de ﬁciencies in chronic granulomatous disease (CGD) and discuss the paradox of the absence of ROS and simultaneous hyperin ﬂammation in CGD.,Non-OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
"[16] (http://dx.doi.org/10.1016/j.re dox.2015.07.003 ) provides an overview on the impact of oxidative stress and redox modi ﬁcations on the proteasomal activity, high- lighting classical examples such as hydroxylation-triggered HIF-1 α degradation, oxidative Nrf2 stabilization and nuclear translocation, but also the canonical pathway of NF κB activation by ubiquitina- tion and proteasomal degradation of its inhibitor (I κBα).",Non-OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[17] (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
[18] (http://dx.doi.org/10.1016/j.re dox.2015.07.018 ) highlights the role of oxidative stress in β-tha- lassemia and sickle cell disease.,OADS,/arxiv_data1/oa_pdf/0d/88/main.PMC4885012.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/58/main.PMC4885014.pdf
"Respiratory  wise  he  had  a  sat- uration  of  92%  measured  by  standard  pulsoxemitry,  earlier  in  the http://dx.doi.org/10.1016/j.ijscr.2016.05.012 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/61/58/main.PMC4885014.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/2a/main.PMC4885017.pdf
Anastomosis  was  performed http://dx.doi.org/10.1016/j.ijscr.2016.04.032 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/da/2a/main.PMC4885017.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/51/main.PMC4885112.pdf
"Wounded  free  wall  of the right  atrium  and  ventricle  were  sutured  with  four  interrupted 4/0  polypropylene  stitches  buttressed  by  pericardial  strips,  and http://dx.doi.org/10.1016/j.ijscr.2016.05.014 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/71/51/main.PMC4885112.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/da/main.PMC4885113.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.03.010 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/da/main.PMC4885113.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/46/main.PMC4885115.pdf
MDCT http://dx.doi.org/10.1016/j.ijscr.2016.04.036 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/dd/46/main.PMC4885115.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/cc/main.PMC4885116.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.015 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/da/cc/main.PMC4885116.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/f9/main.PMC4885117.pdf
"In physical examination,  pain,  tenderness,  and  limitation  of movement  ability  in  the  region  where  the  proximal  phalanges http://dx.doi.org/10.1016/j.ijscr.2016.05.013 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6b/f9/main.PMC4885117.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/04/0d/aapm-06-02-34271.PMC4885122.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/40/main.PMC4885136.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.024 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/33/40/main.PMC4885136.pdf
"Interne  36  (2015)  848–853, http://dx.doi.org/10.1016/j.revmed.2015.02.007 .",OADS,/arxiv_data1/oa_pdf/33/40/main.PMC4885136.pdf
"5  (6)  (2014)  e19465, http://dx.doi.org/10.5812/numonthly.19465 .",Non-OADS,/arxiv_data1/oa_pdf/33/40/main.PMC4885136.pdf
"7  (2009  Feb  5)  13,  http://dx.doi.org/10.1186/ 1477-7819-7-13 .",Non-OADS,/arxiv_data1/oa_pdf/33/40/main.PMC4885136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/35/f2/main.PMC4885137.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.03.006 202,OADS,/arxiv_data1/oa_pdf/35/f2/main.PMC4885137.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e5/21/main.PMC4885138.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.03.010 206,OADS,/arxiv_data1/oa_pdf/e5/21/main.PMC4885138.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/64/main.PMC4885142.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.021 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7c/64/main.PMC4885142.pdf
[5]  http://www.care-statement.org/  (accessed  05.06.2016.).,Non-OADS,/arxiv_data1/oa_pdf/7c/64/main.PMC4885142.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.Although efficient hospital and intensive care unit (ICU)  throughput depends upon the expeditious admission  and discharge of ICU patients (1), health care systems are  facing ethical challenges of caring for complex patients  that are known as multimorbidity (2-8).",Non-OADS,/arxiv_data1/oa_pdf/12/71/aapm-06-02-32902.PMC4885143.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/ba/main.PMC4885144.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.019 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/ba/main.PMC4885144.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/62/1e/main.PMC4885147.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.03.011 199,OADS,/arxiv_data1/oa_pdf/62/1e/main.PMC4885147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/88/main.PMC4885148.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.03.014 196,OADS,/arxiv_data1/oa_pdf/14/88/main.PMC4885148.pdf
"This is an Open Access article distributed under the terms of the Creative Commons   Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/77/dxv072.PMC4885216.pdf
"CDB0977K:  http://www.clst.riken.jp/arg/mutant%20mice%20list.html )  were generated by three of us (S.I., K.B.",OADS,/arxiv_data1/oa_pdf/bb/77/dxv072.PMC4885216.pdf
To view please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/bd/bmjgast-2016-000091.PMC4885269.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/bd/bmjgast-2016-000091.PMC4885269.pdf
http://www.hra.nhs.uk 34.,Non-OADS,/arxiv_data1/oa_pdf/56/bd/bmjgast-2016-000091.PMC4885269.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/65/68/bmjgast-2016-000079.PMC4885270.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010544).,Non-OADS,/arxiv_data1/oa_pdf/a5/f9/bmjopen-2015-010544.PMC4885273.pdf
"Available online at http://www.R-project.org/: Vienna,Austria: the R Foundation for Statistical Computing, 2011).",Non-OADS,/arxiv_data1/oa_pdf/a5/f9/bmjopen-2015-010544.PMC4885273.pdf
"005, September 2002.Geneva: World Health Organization, 2002. http://apps.who.int/medicinedocs/en/d/Jh3011e/ 2. WHO.",OADS,/arxiv_data1/oa_pdf/a5/f9/bmjopen-2015-010544.PMC4885273.pdf
Geneva: World Health Organization.http://www.who.int/medicines/publications/primary_care_8April09.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/a5/f9/bmjopen-2015-010544.PMC4885273.pdf
"Segmentation of regions of interest (ROIs) including the globus pallidus, putamen, caudate nucleus andhippocampus was conducted with FMRIB Software Library (FSL)-Integrated Registration and Segmentation Toolbox (FSL-FIRST 5.0) software (http://www.fmrib.ox.ac.uk/fsl/ ﬁrst/index.html).",OADS,/arxiv_data1/oa_pdf/d3/3a/bmjdrc-2015-000175.PMC4885274.pdf
Obesity and overweight Fact sheet January 2015. http://www.who.int/mediacentre/factsheets/fs311/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/84/1f/bmjopen-2015-010335.PMC4885275.pdf
"Noncommunicable Diseases (NCD) Country Profiles, 2014. http://www.who.int/nmh/countries/npl_en.pdf 10.",Non-OADS,/arxiv_data1/oa_pdf/84/1f/bmjopen-2015-010335.PMC4885275.pdf
: http://www.who.int/ growthref/en/.,OADS,/arxiv_data1/oa_pdf/84/1f/bmjopen-2015-010335.PMC4885275.pdf
To view please visit the journal (http://dx.doi:10.,Non-OADS,/arxiv_data1/oa_pdf/aa/40/bmjdrc-2015-000172.PMC4885277.pdf
"http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.30 BMI, body mass index; HbA1c, glycated hemoglobin.",OADS,/arxiv_data1/oa_pdf/aa/40/bmjdrc-2015-000172.PMC4885277.pdf
†Age-standardized and sex-standardized; standard: German population 31 December 2006 (http://www.destatis.de).,OADS,/arxiv_data1/oa_pdf/aa/40/bmjdrc-2015-000172.PMC4885277.pdf
†Age-standardized and sex-standardized; standard: German population 31 December 2006 (http://www.destatis.de).,OADS,/arxiv_data1/oa_pdf/aa/40/bmjdrc-2015-000172.PMC4885277.pdf
http://www.destatis.de (accessed 5 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/aa/40/bmjdrc-2015-000172.PMC4885277.pdf
http://www.commonwealthfund.org/~/media/ BMJ Open Diabetes Research and Care 2016; 4:e000172.,Non-OADS,/arxiv_data1/oa_pdf/aa/40/bmjdrc-2015-000172.PMC4885277.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009718).,Non-OADS,/arxiv_data1/oa_pdf/16/15/bmjopen-2015-009718.PMC4885278.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/ac/bmjopen-2015-010671.PMC4885284.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010615).,Non-OADS,/arxiv_data1/oa_pdf/1f/eb/bmjopen-2015-010615.PMC4885285.pdf
http://planetree.org/.,Non-OADS,/arxiv_data1/oa_pdf/1f/eb/bmjopen-2015-010615.PMC4885285.pdf
http://www.neuro-oncology.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/1f/eb/bmjopen-2015-010615.PMC4885285.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/4f/36/IJOrtho-50-234.PMC4885290.pdf
The number  of citations per article was obtained from the Scopus web  site (http://www.scopus.com).,OADS,/arxiv_data1/oa_pdf/9b/9b/IJOrtho-50-322.PMC4885303.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010033).,Non-OADS,/arxiv_data1/oa_pdf/ed/70/bmjopen-2015-010033.PMC4885311.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010253).,Non-OADS,/arxiv_data1/oa_pdf/5d/c7/bmjopen-2015-010253.PMC4885312.pdf
"Canberra: AIHW, 2014 (updated 8 February 2015; cited 1 March 2015).http://www.aihw.gov.au/acim-books 2.",Non-OADS,/arxiv_data1/oa_pdf/5d/c7/bmjopen-2015-010253.PMC4885312.pdf
http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737423006 3.,OADS,/arxiv_data1/oa_pdf/5d/c7/bmjopen-2015-010253.PMC4885312.pdf
Further information including a list of publications is available at http://crahw.anu.edu.au/research/projects/personality-total-health-path- through-life.,Non-OADS,/arxiv_data1/oa_pdf/e9/d6/bmjopen-2015-009834.PMC4885313.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/d6/bmjopen-2015-009834.PMC4885313.pdf
Secondary Extended Labour ForceUnderutilisation Rate 2014. http://www.abs.gov.au/AUSSTATS/abs@.nsf/39433889d406eeb9ca2570610019e9a5/ef44f37da92fddeeca2571a3001a4180!OpenDocument (accessed 12Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/e9/d6/bmjopen-2015-009834.PMC4885313.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010216).,Non-OADS,/arxiv_data1/oa_pdf/93/ff/bmjopen-2015-010216.PMC4885314.pdf
http://www.gmc-uk.org/guidance/10247.asp.,Non-OADS,/arxiv_data1/oa_pdf/93/ff/bmjopen-2015-010216.PMC4885314.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010407).,Non-OADS,/arxiv_data1/oa_pdf/c8/21/bmjopen-2015-010407.PMC4885315.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010151).,Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
23This protocol has been devel- oped a priori and registered on the Research RegistryUIN: reviewregistry29 (http://www.researchregistry.com).,OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
25It has been recognised as an approach to poten- tially minimise language bias in systematic reviews.26 Searching other resourcesGrey literature searches will include a search of Open Grey (http://www.opengrey.eu).,Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/incidence/uk-breast-cancer-incidence-statistics 2.,Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
http://www.hscic.gov.uk/catalogue/PUB02731/clin-audi-supp-prog-mast-brea-reco-2011-rep1.pdf (accessed 28 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
http://www.cancer.gov/ cancertopics/pdq/treatment/breast/healthprofessional 4.,Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 23.",OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
"Oxford Centre for Evidence-Based Medicine, 2011:5653. http://www.cebm.net/index.aspx?o=5653 25.",Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
2013. http://translate.google.com/about/intl/en_ALL/ 26.,Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
http://handbook.cochrane.org/chapter_8/table_8_5_a_the_cochrane_collaborations_tool_for_assessing.htm 28.,OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
2014 (cited 10 August 2015).http://www.riskofbias.info 29.,Non-OADS,/arxiv_data1/oa_pdf/19/70/bmjopen-2015-010151.PMC4885316.pdf
2013. http://www.hcvaction.org.uk/sites/default/files/resources/The%20Uncomfortable%20Truth.pdf(accessed 24 Nov 2015).,OADS,/arxiv_data1/oa_pdf/3a/b4/bmjopen-2015-010661.PMC4885317.pdf
2008. http://www.bhiva.org/documents/Guidelines/Testing/ GlinesHIVTest08.pdf (accessed 24 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/3a/b4/bmjopen-2015-010661.PMC4885317.pdf
http://www.cdc.gov/mmwr/ preview/mmwrhtml/rr5514a1.htm (accessed 24 Nov 2015).,OADS,/arxiv_data1/oa_pdf/3a/b4/bmjopen-2015-010661.PMC4885317.pdf
http://www.nice.org.uk/guidance/ph43/resources/hepatitis-b-and-c-ways-to-promote-and-offer-testing-draft-guidance2 (accessed 24 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/3a/b4/bmjopen-2015-010661.PMC4885317.pdf
https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/469501/NAISM_Data_Tables_2014_v3.pdf (accessed 24 Nov 2015).,OADS,/arxiv_data1/oa_pdf/3a/b4/bmjopen-2015-010661.PMC4885317.pdf
http://webarchive.nationalarchives.gov.uk/ 20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4012128.pdf(accessed 24 Nov 2015).,OADS,/arxiv_data1/oa_pdf/3a/b4/bmjopen-2015-010661.PMC4885317.pdf
http://webarchive.nationalarchives.gov.uk/ 20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4011840.pdf (accessed 24 November 2015).,OADS,/arxiv_data1/oa_pdf/3a/b4/bmjopen-2015-010661.PMC4885317.pdf
http://ecdc.europa.eu/en/publications/Publications/101012_TER_HepBandC_survey.pdf (accessed 24 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/3a/b4/bmjopen-2015-010661.PMC4885317.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009934).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
"Arlington, VA: American Psychiatric Publishing, 2013. http://dx.doi.org.ezproxy.newcastle.edu.au/10.1176/appi.books.9780890425596.dsm16 (accessed 4 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
http://www.aihw.gov.au/publication-detail/?,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
http://www.pc.gov.au/inquiries/completed/gambling-2009/report/gambling-report-volume1.pdf (accessed 5 Aug 2015).,OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
"Fitzroy: CAPR Centre for Alcohol Policy Research, 2010. http://www.capr.edu.au/research/harm-to-others/(accessed 5 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
2013. http://www.aic.gov.au/publications/current%20series/tandi/441-460/tandi454.html (accessed 6 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
2009. http://store.samhsa.gov/ product/Guiding-Principles-and-Elements-of-Recovery-Oriented-Systems-of-Care/SMA09-4439 (accessed 17 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
2013. https://www.health.gov.au/internet/main/publishing.nsf/content/mental-pubs-n-recovgde (accessed 17 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
2015. http://www.nta.nhs.uk/r-Evidence20and20Guidance.aspx(accessed 18 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
2012. https://www.nice.org.uk/guidance/qs23 (accessed 18Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
2011. https://www.nice.org.uk/guidance/cg115(accessed 18 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
2009. http://www.health.gov.au/internet/main/publishing.nsf/content/0FD6C7C289CD31C9CA257BF0001F96BD/$File/AustAlctreatguidelines%202009.pdf (accessed 18 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
https://ndarc.med.unsw.edu.au/resource/comorbidity-guidelines-full-document(accessed 18 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
http://smartrecoveryaustralia.com.au/ (accessed 14 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
"Melbourne: The Australian Psychological Society, 2010.https://www.psychology.org.au/practitioner/resources/interventions/(accessed 5 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
http://handbook.cochrane.org/ (accessed 5 May 2015).,OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
2009. http://www.pedro.org.au 34.,Non-OADS,/arxiv_data1/oa_pdf/1b/06/bmjopen-2015-009934.PMC4885378.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011039).,Non-OADS,/arxiv_data1/oa_pdf/e1/05/bmjopen-2016-011039.PMC4885424.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.2517b.,OADS,/arxiv_data1/oa_pdf/e1/c4/bmjopen-2015-010889.PMC4885425.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010706).,Non-OADS,/arxiv_data1/oa_pdf/e8/61/bmjopen-2015-010706.PMC4885426.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/61/bmjopen-2015-010706.PMC4885426.pdf
October 2004. http://www.nhi.gov.tw/Resource/webdata/ Attach_8661_1_s92.pdf (accessed 8 Jun 2011).31.,OADS,/arxiv_data1/oa_pdf/e8/61/bmjopen-2015-010706.PMC4885426.pdf
2015. https://theconversation.com/if-we-dont-talk-about-value-cancer-drugs-will-become-terminal-for-health-systems-44072 45.,Non-OADS,/arxiv_data1/oa_pdf/e8/61/bmjopen-2015-010706.PMC4885426.pdf
Statistics Bureau Ministry of Internal Affairs and Communications website (http://www.stat.go.jp/english/index.htm): 2013.,OADS,/arxiv_data1/oa_pdf/a7/fe/bmjopen-2015-010990.PMC4885427.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 19.",Non-OADS,/arxiv_data1/oa_pdf/a7/fe/bmjopen-2015-010990.PMC4885427.pdf
doi:10.1136/ openhrt-2016-000448 Accepted 1 May 2016 ▸http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ec/19/openhrt-2016-000448.PMC4885428.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011492).,Non-OADS,/arxiv_data1/oa_pdf/78/9f/bmjopen-2016-011492.PMC4885430.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/9f/bmjopen-2016-011492.PMC4885430.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/8672790 http://dx.doi.org/10.1093/occmed/46.1.25 28.,Non-OADS,/arxiv_data1/oa_pdf/78/9f/bmjopen-2016-011492.PMC4885430.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011780).,Non-OADS,/arxiv_data1/oa_pdf/69/a9/bmjopen-2016-011780.PMC4885431.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011869).,Non-OADS,/arxiv_data1/oa_pdf/f6/4c/bmjopen-2016-011869.PMC4885433.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/openhrt-2015-000309).,Non-OADS,/arxiv_data1/oa_pdf/b2/eb/openhrt-2015-000309.PMC4885434.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/eb/openhrt-2015-000309.PMC4885434.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011344).,Non-OADS,/arxiv_data1/oa_pdf/4f/6b/bmjopen-2016-011344.PMC4885437.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/6b/bmjopen-2016-011344.PMC4885437.pdf
http://www.inpes.sante.fr/70000/dp/15/dp150224-def.pdf (accessed 24 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/4f/6b/bmjopen-2016-011344.PMC4885437.pdf
EUROSTUDENT V 2012 – 2015 http://www.eurostudent.eu/download_files/documents/ EVSynopsisofIndicators.pdf (accessed 4 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/4f/6b/bmjopen-2016-011344.PMC4885437.pdf
"METHODS AND ANALYSIS This review protocol has been published in the PROSPERO International Prospective Register of system-atic reviews (http://www.crd.york.ac.uk/PROSPERO), registration number CRD42016032852.",OADS,/arxiv_data1/oa_pdf/4e/b3/bmjopen-2016-011266.PMC4885440.pdf
http://www.embase.com/search/results?,OADS,/arxiv_data1/oa_pdf/4e/b3/bmjopen-2016-011266.PMC4885440.pdf
http://circ.ahajournals.org/content/72/6/1155.citation 9.,Non-OADS,/arxiv_data1/oa_pdf/4e/b3/bmjopen-2016-011266.PMC4885440.pdf
2015 (cited 7 December 2015) p. 1. http://www.who.int/nationalpolicies/processes/priorities/en/ 11.,Non-OADS,/arxiv_data1/oa_pdf/4e/b3/bmjopen-2016-011266.PMC4885440.pdf
http://www.niaid.nih.gov/ topics/strepThroat/Documents/groupasequelae.pdf (accessed1M a r2 0 1 6 ) .,Non-OADS,/arxiv_data1/oa_pdf/4e/b3/bmjopen-2016-011266.PMC4885440.pdf
2000 (cited 7 December 2015) p. 1. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 26.,Non-OADS,/arxiv_data1/oa_pdf/4e/b3/bmjopen-2016-011266.PMC4885440.pdf
"http://media.wix.com/ugd/dded87_29c5b002d99342f788c6 8 Moloi AH, et al.BMJ Open 2016; 6:e011266.",Non-OADS,/arxiv_data1/oa_pdf/4e/b3/bmjopen-2016-011266.PMC4885440.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010865).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
7 July 2015. http://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/07/clinical-pharmacists-gp-pilot.pdf (accessed 15 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
http://www.cfpnet.ca/bank/document_en/84-2015-provincial-chart.pdf (accessed 3 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
http://www.ckapha.org/?module=file&act=procFileDownload&file_srl=110268&sid=c10c280b8c5e106c2a245f3e49924b6a (accessed 15 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
2010.http://www.euro.who.int/__data/assets/pdf_file/0003/124419/e94296.pdf (accessed 15 May 2016).,OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
https://www.equipp.org/default.aspx (accessed 2 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
http://www.pharmacyquality.com/ (accessed 2 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
http://cdn2.hubspot.net/hub/37772/file-969056016-jpg/images/equipp_participating_wholesalers_and_psaos.jpg?t=1443732210895 (accessed 15 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
June 2015. https://www.pharmacists.ca/pharmacy-in-canada/scope-of-practice-canada/ (accessed 15 May2016).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
"Targeted Intervention, 2010. http://www.wppf.org/images/stories/newsatt/3_ 677.pdf (accessed 15 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
http://www.cmq.org/page/en/direction-amelior-exercice.aspx (accessed 15 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
http://www.ats.ucla.edu/stat/sas/faq/relative_risk.htm (accessed 7 Mar 2016).,OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
http://core.ac.uk/download/pdf/98608.pdf (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
http://www.cbc.ca/news/canada/montreal/quebec-pharmacists-granted-more-power-by-government-1.3121547(accessed 15 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/98/68/bmjopen-2015-010865.PMC4885441.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2015-000225).,Non-OADS,/arxiv_data1/oa_pdf/aa/d5/rmdopen-2015-000225.PMC4885442.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/d5/rmdopen-2015-000225.PMC4885442.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011405).,Non-OADS,/arxiv_data1/oa_pdf/85/eb/bmjopen-2016-011405.PMC4885444.pdf
"Trial registers and directory of open-access repositorywebsites including http://www.clinicaltrial.gov, http:// www.opendor.org and the Web of science conference proceedings will also be searched.",OADS,/arxiv_data1/oa_pdf/85/eb/bmjopen-2016-011405.PMC4885444.pdf
http://www.sign.ac.uk/pdf/sign89.pdf (accessed 24 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/85/eb/bmjopen-2016-011405.PMC4885444.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org, 2014.",OADS,/arxiv_data1/oa_pdf/85/eb/bmjopen-2016-011405.PMC4885444.pdf
"Cochrane Collaboration Qualitative Methods Group, 2011. http://cqrmg.cochrane.org/supplemental-handbook-guidance 34.",OADS,/arxiv_data1/oa_pdf/85/eb/bmjopen-2016-011405.PMC4885444.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/64/9f/bmjopen-2016-011077.PMC4885445.pdf
"Brussels, Belgium: International Diabetes Federation, 2013. http://www.idf.org/diabetesatlas.",Non-OADS,/arxiv_data1/oa_pdf/64/9f/bmjopen-2016-011077.PMC4885445.pdf
http://nces.ed.gov/pubs2006/2006483.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/64/9f/bmjopen-2016-011077.PMC4885445.pdf
"Geneva: World Health Organization, 1999. http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf (accessed 26 Feb 2010).",Non-OADS,/arxiv_data1/oa_pdf/64/9f/bmjopen-2016-011077.PMC4885445.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011410).,Non-OADS,/arxiv_data1/oa_pdf/5f/4f/bmjopen-2016-011410.PMC4885446.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011057).,Non-OADS,/arxiv_data1/oa_pdf/1e/9c/bmjopen-2016-011057.PMC4885447.pdf
ISBN 7334-1423-7330. http://www7332.psy.unsw.edu.au/groups/dass/ 33.,Non-OADS,/arxiv_data1/oa_pdf/1e/9c/bmjopen-2016-011057.PMC4885447.pdf
2014. http://www.priory.com/psych/MalayGDS.htm 40.,Non-OADS,/arxiv_data1/oa_pdf/1e/9c/bmjopen-2016-011057.PMC4885447.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000224).,Non-OADS,/arxiv_data1/oa_pdf/28/93/rmdopen-2015-000224.PMC4885448.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010824).,Non-OADS,/arxiv_data1/oa_pdf/72/e6/bmjopen-2015-010824.PMC4885449.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c1/fd/aapm-06-02-35600.PMC4885454.pdf
http://jktgfoundation.org/data/QOCInformationWhitePaper_2014July%20FNL.pdf (accessed 20May 2016).,OADS,/arxiv_data1/oa_pdf/50/5d/bmjopen-2016-011241.PMC4885460.pdf
2008. http://kff.org/health-reform/poll-finding/ 2008-update-on-consumers-views-of-patient-2/ (accessed 23 Mar2015).,Non-OADS,/arxiv_data1/oa_pdf/50/5d/bmjopen-2016-011241.PMC4885460.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/aapm-06-02-35333.PMC4885461.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011186).,Non-OADS,/arxiv_data1/oa_pdf/99/2e/bmjopen-2016-011186.PMC4885462.pdf
http://dx.doi.org/10.1136/ bmjopen-2012-001570 6.,Non-OADS,/arxiv_data1/oa_pdf/64/d6/bmjopen-2015-010871.PMC4885464.pdf
2013. http://www.cqc.org.uk/public/reports-surveys-and-reviews/surveys/inpatient-survey-2013(accessed 11 Feb 2015).,OADS,/arxiv_data1/oa_pdf/64/d6/bmjopen-2015-010871.PMC4885464.pdf
http://www.gro-scotland.gov.uk/ statistics/theme/population/projections/sub-national/2010-based/tables.html (accessed 16 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/64/d6/bmjopen-2015-010871.PMC4885464.pdf
http://dx.doi.org/10.1046/j.1532-5415.2001.49260.,Non-OADS,/arxiv_data1/oa_pdf/64/d6/bmjopen-2015-010871.PMC4885464.pdf
http://www.angelfire.,Non-OADS,/arxiv_data1/oa_pdf/64/d6/bmjopen-2015-010871.PMC4885464.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011196).,Non-OADS,/arxiv_data1/oa_pdf/52/dc/bmjopen-2016-011196.PMC4885465.pdf
http://data.worldbank.org/ indicator/IS.VEH.NVEH.P3.,Non-OADS,/arxiv_data1/oa_pdf/52/dc/bmjopen-2016-011196.PMC4885465.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011333).,Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2005. http://unesdoc.unesco.org/images/0014/001428/142825e.pdf#page=80 (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
http://www.esundhed.dk/sundhedsregistre/MFR/Sider/MFR03.aspx (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2011. http://gynobsguideline.dk/files/Graviditas%20prolongata2011_endelig.pdf(accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2012. http://www.dr.dk/Nyheder/Indland/2012/03/11/171542.htm (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2013070690. http://www.sum.dk/Aktuelt/Nyheder/Sygehusvaesen/2013/September/~/media/ Filer%20-%20Publikationer_i_pdf2013/Plan-for-overvaagning- og-tilsyn-med-laegemidler/Plan%20for%20overv%C3%A5gning%20og%20tilsyn%20med%20brug%20af%20l%C3%A6gemidler%20til%20igangs%C3%A6ttelse%20af%20f%C3%B8dsler.ashx (accessedJan 2016).,OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
http://www.ft.dk/samling/20131/almdel/suu/spm/4/svar/1084487/1294279.pdf (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2013110065. http://laegemiddelstyrelsen.dk/da/udgivelser/2014/~/media/C4327AC28F504B18BF4283FD1511B63B.ashx (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
http://www.ft.dk/samling/20121/almdel/suu/bilag/212/1240842.pdf (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2012. http://www.accessdata.fda.gov/drugsatfda_ docs/label/2012/019268s047lbl.pdf (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2012. http://www.indlaegssedler.dk/indlaegssedler/indlaegsseddel/1062 (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2009. http://www.accessdata.fda.gov/drugsatfda_ docs/label/2009/019268s041lbl.pdf (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
January 2013. http://clin.au.,Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
"2012. http://www.produktresume.dk/docushare/dsweb/Get/Document-9194/Minprostin,+vagitorier+3+mg.doc (accessed Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
http://apps.who.int/iris/bitstream/10665/44531/1/ 9789241501156_eng.pdf (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
2012. http://ipdas.ohri.ca/index.html (accessed Jan2016).,OADS,/arxiv_data1/oa_pdf/d1/62/bmjopen-2016-011333.PMC4885466.pdf
"Get it Right First Time, Br Orthop Assoc News 2011;50:8. http://arma.uk.net/wp-content/ uploads/2013/12/Improving-quality-orthopaedic-care.pdf\nhttp://www.gettingitrightfirsttime.com/downloads/briggsreporta4_fin.pdf(accessed 12 Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/10103353.,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
2012. http://www.heson-line.nhs.uk (accessed 6 Jan 2016).8.,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/19305451 (accessed 9 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
Health and Social Care InformationCentre website: http://www.hscic.gov.uk/ (accessed 21 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
http://www.ncbi.nlm.nih.gov/pubmed/12141621 (accessed 23 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
http://www.njrcentre.org.uk/njrcentre/ Healthcareproviders/Collectingdata/Datacollectionforms/tabid/103/Default.aspx (accessed 16 Dec 2014).,OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
NJR A1 Form 2. http://www.njrcentre.org.uk/njrcentre/Portals/0/ Documents/England/MDSv4.0.A1.pdf (accessed 6 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
http://www.njrcentre.org.uk/njrcentre/Portals/0/ Documents/England/Data collection.forms/MDSv6.0_A2_V004.pdf(accessed 6 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
3rd printing 2003edition 2004. http://www.amazon.co.uk/Model-Selection-Multimodel-Inference-Information-Theoretic/dp/0387953647 (accessed 25 Feb2014).,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
http://systems.hscic.gov.uk/data/clinicalcoding/codingstandards/opcs4 (accessed 27 Oct 2014).,OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
http://www.hscic.gov.uk/hes (accessed 6 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/0a/b1/bmjopen-2016-011332.PMC4885469.pdf
"Rosemont, IL, USA, 2013. http://www.aaos.org/research/guidelines/ TreatmentofOsteoarthritisoftheKneeGuideline.pdf 14.",Non-OADS,/arxiv_data1/oa_pdf/33/6f/bmjopen-2016-011618.PMC4885472.pdf
http://www.agreetrust.org/ 17.,Non-OADS,/arxiv_data1/oa_pdf/33/6f/bmjopen-2016-011618.PMC4885472.pdf
2014. http://www.arthritisaustralia.com.au/index.php/reports/time-to-move-arthritis-reports.html 19.,Non-OADS,/arxiv_data1/oa_pdf/33/6f/bmjopen-2016-011618.PMC4885472.pdf
http://qim.cochrane.org/supplemental-handbook-guidance41.,Non-OADS,/arxiv_data1/oa_pdf/33/6f/bmjopen-2016-011618.PMC4885472.pdf
"Oxford: Public Health Resource Unit; UK: Milton Keynes Primary Care Trust, 2002. http://media.wix.com/ugd/dded87_29c5b002d99342f788c6ac670e49f274.pdf 43.",Non-OADS,/arxiv_data1/oa_pdf/33/6f/bmjopen-2016-011618.PMC4885472.pdf
http://cqrmg.cochrane.org/supplemental-handbook-guidance 44.,OADS,/arxiv_data1/oa_pdf/33/6f/bmjopen-2016-011618.PMC4885472.pdf
"1521-0111/89/6/630 –644$25.00 http://dx.doi.org/10.1124/mol.116.103267 MOLECULAR PHARMACOLOGY Mol Pharmacol 89:630 –644, June 2016 Copyright ª2016 The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/a0/c4/mol.116.103267.PMC4885501.pdf
"1521-0111/89/6/618 –629$25.00 http://dx.doi.org/10.1124/mol.115.103176 MOLECULAR PHARMACOLOGY Mol Pharmacol 89:618 –629, June 2016 Copyright ª2016 The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/be/26/mol.115.103176.PMC4885504.pdf
Immunoreactive bands of phospho-ERK1/2 were quantified by densitometric analysis using theImageJ program (http://rsb.info.nih.gov/ij/) and normalized to theintensity of total-ERK1/2.,OADS,/arxiv_data1/oa_pdf/be/26/mol.115.103176.PMC4885504.pdf
"Analysis was performed using the public domain National Institutes of Health Image programImageJ/FIJI software, which is freely available at http://fiji.sc/Fiji as described before(Yudowski and von Zastrow, 2011; Flores-Otero et al., 2014; Roman-Vendrell et al., 2014).",OADS,/arxiv_data1/oa_pdf/be/26/mol.115.103176.PMC4885504.pdf
Array images wereanalyzed quantified by densitometric analysis using the ImageJ program (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/be/26/mol.115.103176.PMC4885504.pdf
"1521-0103/357/3/606 –618$25.00 http://dx.doi.org/10.1124/jpet.116.232009 THEJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 357:606 –618, June 2016 Copyright ª2016 The Author(s) This is an open access article distributed under the CC BY Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/34/e2/jpet.116.232009.PMC4885512.pdf
"1521-0103/357/3/580 –590$25.00 http://dx.doi.org/10.1124/jpet.116.232983 THEJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 357:580 –590, June 2016 Copyright ª2016 The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/15/55/jpet.116.232983.PMC4885513.pdf
"Any internet user can register an online account via one of the country-speci ﬁc internet websites of TCOY (http://www.takecareofyou.nl, http://www.Table 2 Continued No Arm 1: alcohol and depression self-help Arm 2: alcohol self-help only M7 Meeting your needs (2650 words) ▸Sleep: tips for better sleep hygiene ▸Rumination: 6 ways to deal with it –Become aware of it –Stop your thoughts –Let them pass (including an audio file of 5 min) –Relax –Appreciate the positive; diary of gratitude –Tackle problems (referring to M3) ▸Social contacts: importance of and how to (re)inforce themProgressive muscle relaxation (770 words) ▸Basic overview ▸FAQ ▸Exercise in written words ▸Guided instructions via audio file (15 min) ▸Training in daily life M8 Preserve success (750 words) ▸Your toughest moments?",Non-OADS,/arxiv_data1/oa_pdf/5d/ce/bmjopen-2016-011457.PMC4885516.pdf
"takecareofyou.de, http://www.takecareofyou.ch), by pro- viding a unique username and email address.",Non-OADS,/arxiv_data1/oa_pdf/5d/ce/bmjopen-2016-011457.PMC4885516.pdf
Draft comprehensive mental health action plan 2013 – 2020. http://bit.ly/Vhhh8s 2.,Non-OADS,/arxiv_data1/oa_pdf/5d/ce/bmjopen-2016-011457.PMC4885516.pdf
Available at: http://www.iso.org/sites/JCGM/GUM/JCGM 100/C045315e-html/C045315e.html?csnumber =50461 .,Non-OADS,/arxiv_data1/oa_pdf/55/48/mbp-20-325.PMC4885524.pdf
"Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.115.015710Received February 3, 2015; accepted July 13, 2015.From Strategy and Research Department, National Health Insurance (CNAMTS), Paris, France (G.M., P.-O.B., C.B., P.R., F.A.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/cir-132-1252.PMC4885525.pdf
*Drs Maura and Blotière are joint first authors.The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/cir-132-1252.PMC4885525.pdf
http://ansm.sante.fr/Dossiers/Les-anticoagulants/Les-anticoagulants-en-France-Etudes-et-surveillance/%28offset%29/0#paragraph_58691.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/cir-132-1252.PMC4885525.pdf
Available at: http://www.sgo.or.,Non-OADS,/arxiv_data1/oa_pdf/36/d4/pas-40-770.PMC4885527.pdf
Available at: http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/36/d4/pas-40-770.PMC4885527.pdf
1993-2014.Available at: http://www.genetsets.org.,Non-OADS,/arxiv_data1/oa_pdf/36/d4/pas-40-770.PMC4885527.pdf
Updated May 2013. http://www.fic.nih.gov/News/Events/implementation-science/Pages/faqs.aspx.,OADS,/arxiv_data1/oa_pdf/6c/eb/acm-91-30.PMC4885528.pdf
http://www.fic.nih.gov/funding/Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6c/eb/acm-91-30.PMC4885528.pdf
2013. http://www.todayshospitalist.com/index.php?b=articles_read&cnt=1801#sthash.8XK6IbUD.dpuf.,Non-OADS,/arxiv_data1/oa_pdf/6c/eb/acm-91-30.PMC4885528.pdf
"December 19, 2013. http://community.the-hospitalist.org/2013/12/19/global-health-hospitalists-strange-but-noble-bedfellows/.",Non-OADS,/arxiv_data1/oa_pdf/6c/eb/acm-91-30.PMC4885528.pdf
October 2014. https://www.aamc.org/download/152968/data.,OADS,/arxiv_data1/oa_pdf/6c/eb/acm-91-30.PMC4885528.pdf
October 2012. http://newamerica.net/publications/policy/safety_net_or_windfall.,Non-OADS,/arxiv_data1/oa_pdf/6c/eb/acm-91-30.PMC4885528.pdf
"May 26, 2011. http://www.thecrimson.com/article/2011/5/26/health-global-training-medical/.",Non-OADS,/arxiv_data1/oa_pdf/6c/eb/acm-91-30.PMC4885528.pdf
http://www.jo.se/en/.,Non-OADS,/arxiv_data1/oa_pdf/82/e0/acm-91-333.PMC4885532.pdf
http://www.theioi.org/the-i-o-i/about-the-ioi.,Non-OADS,/arxiv_data1/oa_pdf/82/e0/acm-91-333.PMC4885532.pdf
http://www.ohio.edu/ombuds/about/history.cfm.,Non-OADS,/arxiv_data1/oa_pdf/82/e0/acm-91-333.PMC4885532.pdf
http://www.ombudsassociation.org.,Non-OADS,/arxiv_data1/oa_pdf/82/e0/acm-91-333.PMC4885532.pdf
http://www.usombudsman.org/model-shield-law/.,Non-OADS,/arxiv_data1/oa_pdf/82/e0/acm-91-333.PMC4885532.pdf
"In December 2012, after several  months of internal discussion and  preparation, the University of Utah  Health Care system began to post each provider’s patient satisfaction  data—scores and comments—on the  university’s public Web site (e.g., http://healthcare.utah.edu/fad/mddetail.php?physicianID=u0102229).",Non-OADS,/arxiv_data1/oa_pdf/0f/c2/acm-91-338.PMC4885533.pdf
June 2011. http://www.acep.org/ patientsatisfaction/.,Non-OADS,/arxiv_data1/oa_pdf/0f/c2/acm-91-338.PMC4885533.pdf
"March 12, 2012. http://searchengineland.com/study-72-of-consumers-trust- online-reviews-as-much-as-personal- recommendations-114152.",Non-OADS,/arxiv_data1/oa_pdf/0f/c2/acm-91-338.PMC4885533.pdf
2012.  http://www.pwc.com/us/en/health- industries/publications/health-care-social-media.jhtml.,Non-OADS,/arxiv_data1/oa_pdf/0f/c2/acm-91-338.PMC4885533.pdf
"Several organizations includi ng the US Preventative Task Force, the American Society of Clinical Oncology, and the National Comprehensive C ancer Network recommend breast cancer chemopreventio n for individuals at increased risk (Bevers et al., 2010; Moyer and Force USPST, 2013; Visvanathan et al., 2013; http://www.nccn.org/p rofessiona ls/physi cian_gls/pdf/b reast_risk.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/f6/a2/cej-25-03.PMC4885537.pdf
", 2013; http://www.nccn.",Non-OADS,/arxiv_data1/oa_pdf/f6/a2/cej-25-03.PMC4885537.pdf
"With nearly 50 000 deaths each year ultimat ely attributed to hip fractures (Deprey, 2009; Stevens and Rudd, 2013; http://www.cdc.gov/ homeandrecreationalsafe ty/falls/adulthipfx.html ), osteoporosis re- presents a major competing threat to health in postmeno- pausal women and cannot be ignored when considering chemoprevention options, including AIs.",Non-OADS,/arxiv_data1/oa_pdf/f6/a2/cej-25-03.PMC4885537.pdf
Available at: http://www.cancer.gov/bcrisktool/ .,Non-OADS,/arxiv_data1/oa_pdf/f6/a2/cej-25-03.PMC4885537.pdf
"Circ Cardiovasc Qual Outcomes is available at http://circoutcomes.ahajournals.org DOI: 10.1161/CIRCOUTCOMES.115.001958Received April 27, 2015; accepted June 17, 2015.From the Mid America Heart Institute, Kansas City, MO (J.A.S., P.G.J.",Non-OADS,/arxiv_data1/oa_pdf/83/04/hcq-8-469.PMC4885562.pdf
"The Data Supplement is available at http://circoutcomes.ahajournals.org/lookup/suppl/doi:10.1161/CIRCOUTCOMES.115.001958/-/DC1.Correspondence to John Spertus, MD, MPH, 4401 Wornall Rd, 5th Floor SLNI, Kansas City, MO 64111.",Non-OADS,/arxiv_data1/oa_pdf/83/04/hcq-8-469.PMC4885562.pdf
"Discussion As the US healthcare system struggles to provide more cost- effective, patient-centered care, there is a growing need  to efficiently monitor the health status of its patients.33 For  example, the Centers for Medicare and Medicaid Services has begun soliciting proposals for PROs measures to become  part of its quality assessment programs (http://www.cms.",Non-OADS,/arxiv_data1/oa_pdf/83/04/hcq-8-469.PMC4885562.pdf
"Mackintsosh A, Gibbons E, Fitzpatrick R. A structured review of patient-reported outcome measures for people with heart failure: an update 2009. http://phi.uhce.ox.ac.uk/pdf/PROMs_Oxford_HeartFailure_17092010.pdf.",Non-OADS,/arxiv_data1/oa_pdf/83/04/hcq-8-469.PMC4885562.pdf
New Insights into HE ( http://www.hepaticencephalo pathy.info and http://www.HEFastFacts.info ) is an edu- cational programme developed by a Steering Committee ofhepatologists and gastroenterologists from across Europe.,Non-OADS,/arxiv_data1/oa_pdf/05/0d/meg-28-146.PMC4885589.pdf
"Nuclear Medicine Communications 2016, 37:689 –698 Video abstract: http://links.lww.com/NMC/A55 Keywords: diffuse, fluorine-18 fluorodeoxyglucose, large B-cell, lymphoma, positron-emission tomography, prognosis aDepartment of Hematology, Chang Hai Hospital, Second Military Medical University, Departments ofbHematology,cNuclear Medicine anddPathology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China Correspondence to Jianmin Wang, MD, Department of Hematology, Chang Hai Hospital, Second Military Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/ef/59/mnm-37-689.PMC4885594.pdf
http://www.ihi.org/Engage/ Initiatives/TripleAim/Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ec/5d/acm-91-354.PMC4885596.pdf
http://center.hj.se/do wnload/18.7b2d1d971365d15588680006296/Per-Erik+Ellstr%C3%B6m.pdf.,OADS,/arxiv_data1/oa_pdf/ec/5d/acm-91-354.PMC4885596.pdf
Available from:  http://www.sportsci.org/jour/03/wghtrials.,Non-OADS,/arxiv_data1/oa_pdf/e0/cb/JBS-33-1196511.PMC4885621.pdf
2007;10(2):89-95. doi:  http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/48/JBS-33-1198209.PMC4885622.pdf
2014;3(4):284-92. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/48/JBS-33-1198209.PMC4885622.pdf
2015;18(2):179-86. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/48/JBS-33-1198209.PMC4885622.pdf
Available  from: http://sportsci.org/resource/stats/ index.html/Log.,Non-OADS,/arxiv_data1/oa_pdf/1c/4c/JBS-33-1198635.PMC4885627.pdf
2005 Available at: http://sportsci.org/ resource/stats/index.,Non-OADS,/arxiv_data1/oa_pdf/fa/a4/JBS-33-1198636.PMC4885628.pdf
"Inside FIBA: Rules, regulations, other  docs: Basketball rules, http://www.fiba.",Non-OADS,/arxiv_data1/oa_pdf/16/05/JBS-33-1200512.PMC4885632.pdf
Available at: http://www.ncaa.org/ championships/playing-rules/mens- basketball-rules-game.,Non-OADS,/arxiv_data1/oa_pdf/16/05/JBS-33-1200512.PMC4885632.pdf
Keywords Movement artifact; Gamma oscillation; Basal forebrain; Event-related potential; 1/ f power  spectrum; Functional connectivity This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/82/nihms786869.PMC4885644.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that thework is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/19/ciw139.PMC4885647.pdf
Available at: http://www.childrenandaids.org/situation .,Non-OADS,/arxiv_data1/oa_pdf/50/19/ciw139.PMC4885647.pdf
Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/ epidemiology/2012/201207_FactSheet_Global_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/50/19/ciw139.PMC4885647.pdf
"Available at: http://www.unaids.org/en/resources/documents/2014/name,93710, en.asp .",Non-OADS,/arxiv_data1/oa_pdf/50/19/ciw139.PMC4885647.pdf
Available at: http://data.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/50/19/ciw139.PMC4885647.pdf
Available at: http://www.who.int/hiv/pub/ ca_stocktaking/en/ .,Non-OADS,/arxiv_data1/oa_pdf/50/19/ciw139.PMC4885647.pdf
Available at: http://www.unicef.org/publications/ index_57005.html .,Non-OADS,/arxiv_data1/oa_pdf/50/19/ciw139.PMC4885647.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/50/19/ciw139.PMC4885647.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/d9/ciw163.PMC4885650.pdf
Available at: https://aidsinfo.nih.gov/ content ﬁles/lvguidelines/adultandadolescentgl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/d9/ciw163.PMC4885650.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_ docs/label/2015/205834s001lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/d9/ciw163.PMC4885650.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/ 204671s000lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/d9/ciw163.PMC4885650.pdf
Available at: http://regist2.virology-education.com/ abstractbook/2015_4.pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/d9/ciw163.PMC4885650.pdf
Available at: http://www.reyataz.com/ .,Non-OADS,/arxiv_data1/oa_pdf/03/d9/ciw163.PMC4885650.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/5e/ciw185.PMC4885654.pdf
Duplicate reads were collapsedusing FASTX-Toolkit (version 0.0.13; http://hannonlab.cshl.,OADS,/arxiv_data1/oa_pdf/cc/5e/ciw185.PMC4885654.pdf
Outputs were visualized in MEGAN (version 5) for taxonomic assignment and reads aligned using Bowtie2 against the Comprehensive Antibiotic ResistanceDatabase (CARD; http://arpcard.mcmaster.ca ).,OADS,/arxiv_data1/oa_pdf/cc/5e/ciw185.PMC4885654.pdf
Metagenomic data was aligned using Bowtie2 to the Comprehen-sive Antibiotic Resistance Database ( http://arpcard.mcmaster.ca )t od e t e c tA B R genes.,OADS,/arxiv_data1/oa_pdf/cc/5e/ciw185.PMC4885654.pdf
Identified ABR genes were classified according t o Comprehensive Antibiotic Resistance Database (http://arpcard.mcmaster.ca ).,OADS,/arxiv_data1/oa_pdf/cc/5e/ciw185.PMC4885654.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ad/68/2186-3326-78-0123.PMC4885812.pdf
"The main sources are the official website of Ministry of Health (MoH), Myanmar (http://www.moh.gov.mm) and the 2014 Myanmar Population and Housing Census (http://countryoffice.unfpa.org/myanmar/ census/).",Non-OADS,/arxiv_data1/oa_pdf/ad/68/2186-3326-78-0123.PMC4885812.pdf
World Development Indicators at http://datatopics.worldbank.org/hnp/popestimates.,Non-OADS,/arxiv_data1/oa_pdf/ad/68/2186-3326-78-0123.PMC4885812.pdf
World Population Policies 2013 at http://www.un.org/en/development/desa/population/publications/policy/world-population-policies-2013.,Non-OADS,/arxiv_data1/oa_pdf/ad/68/2186-3326-78-0123.PMC4885812.pdf
Available at: http://www.who.int/gho/publications/world_health_statistics/2014/en/.,Non-OADS,/arxiv_data1/oa_pdf/ad/68/2186-3326-78-0123.PMC4885812.pdf
Available at: http://www.data.,OADS,/arxiv_data1/oa_pdf/ad/68/2186-3326-78-0123.PMC4885812.pdf
Available at: https://www.quandl.com/data/WHO/62_MMR-Measles-MCV-immunization-coverage-among-1-year-olds-Myanmar.,Non-OADS,/arxiv_data1/oa_pdf/ad/68/2186-3326-78-0123.PMC4885812.pdf
Available at: http://www.oecd.org/dac/stats/.,Non-OADS,/arxiv_data1/oa_pdf/ad/68/2186-3326-78-0123.PMC4885812.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2e/70/2186-3326-78-0135.PMC4885813.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c8/1c/2186-3326-78-0143.PMC4885814.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6f/88/2186-3326-78-0151.PMC4885815.pdf
2009; Available from: http://www.who.int/gpsc/5may/tools/en/.,OADS,/arxiv_data1/oa_pdf/6f/88/2186-3326-78-0151.PMC4885815.pdf
Available from: http://www.who.int/gpsc/country_work/gpsc_ccisc_fact_sheet_en.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/6f/88/2186-3326-78-0151.PMC4885815.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/be/c2/2186-3326-78-0163.PMC4885816.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4e/e4/2186-3326-78-0175.PMC4885817.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/2186-3326-78-0183.PMC4885818.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/1c/0f/2186-3326-78-0195.PMC4885819.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/bf/b7/2186-3326-78-0205.PMC4885820.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/55/21/2186-3326-78-0215.PMC4885821.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/aa/8f/2186-3326-78-0229.PMC4885822.pdf
"However, in our  previous study, only 17.2% of patients with PCG had CYP1B1   mutations in a Han Chinese population [ 14], corresponding Molecular Vision  2016; 22:528-535 <http://www.molvis.org/molvis/v 22/528> Received 5 March 2016 | Accepted 26 May 2016 | Published 28 May 2016© 2016 Molecular Vision 528Screening of the LTBP2  gene in 214 Chinese sporadic CYP1B1 - negative patients with primary congenital glaucoma Xueli Chen,1 Yuhong Chen,1 Bao Jian Fan,4 Mingying Xia,5 Li Wang,1 Xinghuai Sun1,2,3 1Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai,  China; 2State Key Laboratory of Medical Neurobiology, Institutes of Brain Science and Collaborative Innovation Center for Brain  Science, Fudan University, Shanghai, China; 3Key Laboratory of Myopia, Ministry of Health (Fudan University), and Shanghai  Key Laboratory of Visual Impairment and Restoration (Fudan University), Shanghai, China; 4Department of Ophthalmology,  Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA; 5Key Laboratory of Contemporary Anthropology  and Center for Evolutionary Biology, School of Life Sciences, Fudan University, Shanghai, China Purpose:  To identify deleterious mutations in the latent transforming growth factor-β–binding protein 2 ( LTBP2 ) gene  in sporadic patients with primary congenital glaucoma (PCG) from a Han Chinese population, which had been excluded  for mutations in the CYP1B1  gene.",Non-OADS,/arxiv_data1/oa_pdf/0c/e5/mv-v22-528.PMC4885908.pdf
Molecular Vision  2016; 22:528-535 <http://www.molvis.org/molvis/v 22/528> © 2016 Molecular Vision  529to the lower incidence of PCG in the Han Chinese population  [4].,Non-OADS,/arxiv_data1/oa_pdf/0c/e5/mv-v22-528.PMC4885908.pdf
"Molecular Vision  2016; 22:528-535 <http://www.molvis.org/molvis/v 22/528> © 2016 Molecular Vision  530and reverse primers (0.5 µmol/l), magnesium chloride (1.5  mmol/l), deoxyribonucleotide triphosphate (dNTP; 0.2 µmol/ ml) and Taq polymerase (1 U; Takara Bio Inc, Shiga, Japan), as  per the following procedure: initial denaturation at 95 °C for  5 min, 35 cycles of denaturation at 94 °C for 45 s, annealing  at a primer-specific temperature for 45 s, extension at 72 °C  for 1 min and a final extension at 72 °C for 10 min.",Non-OADS,/arxiv_data1/oa_pdf/0c/e5/mv-v22-528.PMC4885908.pdf
Molecular Vision  2016; 22:528-535 <http://www.molvis.org/molvis/v 22/528> © 2016 Molecular Vision  531of the extracellular matrix (ECM) that interact with fibrillin  microfibrils and have several different roles in microfibril  biology.,Non-OADS,/arxiv_data1/oa_pdf/0c/e5/mv-v22-528.PMC4885908.pdf
Molecular Vision  2016; 22:528-535 <http://www.molvis.org/molvis/v 22/528> © 2016 Molecular Vision  532 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/e5/mv-v22-528.PMC4885908.pdf
Molecular Vision  2016; 22:528-535 <http://www.molvis.org/molvis/v 22/528> © 2016 Molecular Vision  533ACKNOWLEDGMENTS The samples used for the analyses described in this manu - script were obtained from the EENT Biobank.,Non-OADS,/arxiv_data1/oa_pdf/0c/e5/mv-v22-528.PMC4885908.pdf
Molecular Vision  2016; 22:528-535 <http://www.molvis.org/molvis/v 22/528> © 2016 Molecular Vision  534l4q24.3.,Non-OADS,/arxiv_data1/oa_pdf/0c/e5/mv-v22-528.PMC4885908.pdf
Molecular Vision  2016; 22:528-535 <http://www.molvis.org/molvis/v 22/528> © 2016 Molecular Vision  53529.,Non-OADS,/arxiv_data1/oa_pdf/0c/e5/mv-v22-528.PMC4885908.pdf
"Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> Received 4 July 2015 | Accepted 26 May 2016 | Published 28 May 2016© 2016 Molecular Vision 536Stage-specific differentiation of iPSCs toward retinal ganglion cell  lineage Fei Deng,1 Mengfei Chen,1 Ying Liu,1 Huiling Hu,2 Yunfan Xiong,1 Chaochao Xu,1 Yuchun Liu,1 Kangjun Li,1  Jing Zhuang,1 Jian Ge1 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China; 2Shengzhen  Ophthalmic Center of Jinan University, Shenzhen Eye Hospital, Shenzhen, China Purpose:  As an alternative and desirable approach for regenerative medicine, human induced pluripotent stem cell  (hiPSC) technology raises the possibility of developing patient-tailored cell therapies to treat intractable degenerative  diseases in the future.",Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
"Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  537During retinogenesis, human embryonic stem cells (hESCs)  undergo a stepwise and conserved developmental process  through primitive eye field (EF) and retinal progenitor cell  (RPC) stages toward committed neuronal subtypes [ 9].",Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  538medium (removal of bFGF from the hESC medium).,Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
"Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  539antibodies Nanog (Cell Signaling, Danvers, MA), Oct3/4,  Pax6, Nestin, Tuj, Chx10 (all from Millipore, Temecula,  CA), Sox2, ZO1, Rx, calretinin, iSlet1, synaptophysin (all  from Abcam, Burlingame, CA), Otx2 (Invitrogen), Chx10  (Santa Cruz, Dallas, TX), and Rx (Santa Cruz) were used  at 1:200 dilution.",Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  540Statistical analysis:  At least three replicates were performed  for each experiment.,Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  541migratory single cell-RPCs formed a monolayer to fill the  gaps between the clusters (Figure 4B) and highly expressed  RPC-related marker Pax6 as determined with confocal  immunofluorescence analysis (Figure 4C–D).,Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  542 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
"Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  543Ki67+ proliferative RPCs predominated, reminiscent of the  neuroblastic layer within the developing human retina.",Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
"Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  544Matrigel-coated culture with the addition of DKK1, Noggin,  and Lefty A, a combination of developmental stimuli factors  that had been used in previous protocols to mimic the micro - environmental signals of retinogenesis [ 3].",Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  545which is far from enough to achieve highly homogeneous  neural differentiation for clinical use.,Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
"Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  546Based on previous investigations, we devised a targeted and  multidimensional RGC induction strategy for TiPSCs.",Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
Molecular Vision  2016; 22:536-547 <http://www.molvis.org/molvis/v 22/536> © 2016 Molecular Vision  547regulating the specification of retinal ganglion cells.,Non-OADS,/arxiv_data1/oa_pdf/76/84/mv-v22-536.PMC4885909.pdf
" Case Rep Nephrol Dial  2016;6:32 –39  DOI: 10.1159/000444250   Published online: February 24, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   2296‒9705/16/0061‒0032$39.50/0   www.karger.com/cnd   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/7c/ca/cnd-0006-0032.PMC4886031.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: February 11, 2016 EXTRA  Leonhard Stammler   Universität Ulm   Albert-Einstein-Allee 23   DE–89081 Ulm (Germany)   E-Mail leonhard.stammler   @   uni-ulm.de www.karger.com/nne DOI: 10.1159/000442827  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/2a/1e/nne-0006-0001.PMC4886082.pdf
"Key Words aaRapid eye movement sleep behavior disorder; Parkinson disease; Rapid eye movement screening questionnaire;  Unified Parkinson’s Disease Rating Scale; Pittsburg Sleep Quality Index.ORIGINAL ARTICLEhttp://dx.doi.org/10.14802/jmd.15039  /  J Mov Disord  2016 ;9(2):114-119 pISSN 2005-940X / eISSN 2093-4939 Received:  September 30, 2015    Revised:  December 1, 2015    Accepted:  December 17, 2015 Corresponding author:  Kee Hyung Park, MD, PhD, Department of Neurology, College of Medicine, Gachon University, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 21565, Korea / Tel: +82-32-460-3346 / Fax: +82-32-460-3344 / E-mail:  khpark@gachon.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.JMD Rapid eye movement (REM) sleep behavior disorder (RBD)  is characterized by the loss of muscle atonia during REM sleep  and dream enactment, which often leads to injury of the pa - tient or the bed partner.1 Although its precise pathophysiology  is unclear, RBD occurs more frequently in patients with neuro - degenerative disease than in the general population, and espe - cially in patients with α-synucleinopathy such as Parkinson’s  disease (PD), multiple systemic atrophy (MSA), and dementia  with Lewy bodies (DLB) compared to non-synucleinopathy.",Non-OADS,/arxiv_data1/oa_pdf/f0/6d/jmd-15039.PMC4886198.pdf
"Key Words aaCirrhosis; Hepatic encephalopathy; Bradykinesia; Parkinsonism; Intention tremor; Jerky pursuit.ORIGINAL ARTICLEhttp://dx.doi.org/10.14802/jmd.15047  /  J Mov Disord  2016 ;9(2):104-113 pISSN 2005-940X / eISSN 2093-4939 Received:  October 7, 2015    Revised:  January 1, 2016    Accepted:  February 22, 2016 Corresponding author:  Kulthida Metha wasin, MD,  Neurology Division, Department of Medicine, Faculty of Medicine, Srinakharinwirot University,  Ongkharak, Nakhon Nayok 26120, Thailand / Tel: +66-89-459-5785  / Fax: +66-37-587-025 cont.",Non-OADS,/arxiv_data1/oa_pdf/e7/c9/jmd-15047.PMC4886199.pdf
"11003  / E-mail:  kmmdsresearch@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.JMD Since the clinical and pathological studies of Victor, Adams,  and Cole in 1965, movement disorders in acquired hepatic cir - rhotic patients have been acknowledged.",Non-OADS,/arxiv_data1/oa_pdf/e7/c9/jmd-15047.PMC4886199.pdf
"126  Copyright © 2016 The Korean Movement Disorder SocietyLETTER TO THE EDITORhttp://dx.doi.org/10.14802/jmd.15052  /  J Mov Disord  2016 ;9(2):126-128 pISSN 2005-940X / eISSN 2093-4939JMD Dropped head syndrome (DHS) is commonly observed in  patients with parkinsonism, including those with multiple sys - tem atrophy and Parkinson’s disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/a4/6e/jmd-15052.PMC4886200.pdf
"The literature presents conflicting EMG results in cases Dropped Head Syndrome after Minor Trauma   in a Patient with Levosulpiride-Aggravated   Vascular Parkinsonism Soo Hyun Cho, Dokyung Lee, Tae-Beom Ahn Department of Neurology, Graduate School, Kyung Hee University, Kyung Hee University Hospital, Seoul, Korea Received:  November 9, 2015    Revised:  December 21, 2015    Accepted:  January 5, 2016 Corresponding author:  Tae-Beom Ahn, MD, PhD , Department of Neurology, Graduate School, Kyung Hee University, Kyung Hee University Hospital, 23  Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea / Tel: +82-2-958-8448 / Fax: +82-2-958-8490  / E-mail:  ricash@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/6e/jmd-15052.PMC4886200.pdf
